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ABSTRACT 
 
 
OPTIMIZATION OF ENGINEERED HEART VALVE TISSUE 
EXTRACELLULAR MATRIX 
 
 
George Carl Engelmayr, Jr., PhD 
 
University of Pittsburgh, 2005 
 
 
Prosthetic heart valves, whether biologically-derived or mechanical, have improved the 
quality of life of millions of patients worldwide since their introduction in the 1960's.  However, 
while currently available prosthetic valves perform sufficiently well in the short term, the side-
effects of anticoagulation therapy (mechanical valves) and the structural degeneration of 
bioprosthetic and homograft valves represent significant drawbacks in the long-term.  The 
limitations of these non-viable devices are especially pronounced in pediatric patients suffering 
from congenital valvular lesions, as none of the current prosthetic valves have the capacity to 
grow in tandem with the somatic growth of the patient. 
Tissue engineered heart valves (TEHV) are conceptually appealing for use in the surgical 
repair of valvular lesions because they harbor a living cell population potentially capable of 
orchestrating tissue self-repair, growth, and resistance to infection.  Since the mid-1990's, 
significant progress has been made toward the development of a functional TEHV, culminating 
in long-term implantation studies in sheep.  In these previous studies, TEHV were constructed by 
seeding vascular-derived smooth muscle and endothelial cells, or bone marrow-derived 
mesenchymal stem cells (BMSC), onto bioresorbable polymer scaffolds. The resultant TEHV 
were subsequently cultivated in a pulsatile flow loop bioreactor in which TEHV could be 
exposed to graduated increases in mechanical stimulation prior to implantation. 
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Importantly, it was demonstrated through these previous studies that mechanical 
stimulation is critical to the development of a functional TEHV.  In the absence of mechanical 
stimulation, TEHV exhibited significantly reduced extracellular matrix (ECM) formation, and 
thus upon scaffold degradation retained insufficient structural integrity for acute hemodynamic 
function.  However, because the various mechanical stimuli (e.g., cyclic flexure, tension, and 
fluid flow) were coupled in the pulsatile flow loop bioreactor, it could not be deduced how the 
individual modes of mechanical stimulation contributed to the overall TEHV developmental 
response.  Such information is essential, both for developing rationally designed mechanical 
conditioning regimens, and importantly for potential clinical applications, for quantifying the 
sensitivity of the tissue formation process to perturbations in these factors. 
To establish biomechanical end-points for evaluating TEHV, in the current study 
mathematical models were developed to predict the effective stiffness of TEHV biomaterials 
from the properties and structure of the individual constituents.  It was found that the effective 
stiffness of the nonwoven polymer scaffolds could accurately be predicted from the spring-like 
tensile properties and orientations of the scaffold fibers, and that the primary mechanical effect 
of ECM deposition was an increase in the number of fiber-fiber bond points.  Toward 
quantifying the independent and coupled effects of mechanical stimulation on TEHV 
development, a novel flex-stretch-flow (FSF) bioreactor was developed in which multiple TEHV 
specimens could be subjected to well-defined combinations of mechanical stimuli.  Finally, the 
FSF bioreactor was used to elucidate the independent and coupled effects of cyclic flexure and 
laminar flow on TEHV tissue formation by BMSC.  The combination of flexure and flow was 
found to synergistically accelerate tissue formation and BMSC differentiation, thus paving the 
way toward rational designs for TEHV conditioning regimens utilizing novel cell sources. 
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1.0 INTRODUCTION 
 
1.1 THE MAMMALIAN HEART AND ITS VALVES 
 
A common anatomical feature of humans and other mammals is the four-chamber heart 
(Figure 1).  While it is the function of the heart ventricles to pump blood to the lungs 
(deoxygenated; right ventricle) and the systemic circulation feeding the organs (oxygenated; left 
ventricle), it is the heart valves which serve to control blood flow through the heart [1]. 
   
 
Figure 1 Gross anatomy of the four-chamber mammalian heart.  Image adapted from 
Edwards Lifesciences, Irvine, CA (www.edwards.com/PatientsAndFamilies/MyHeart/Anatomy/). 
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 During the cardiac cycle, blood depleted of oxygen by the metabolic demands of the 
bodily organs is returned to the right atrium of the heart via the inferior and superior Vena Cava.  
This deoxygenated blood is pumped into the right ventricle through the tricuspid valve, and 
subsequently pumped to the lungs via the pulmonary valve and pulmonary artery.  Blood 
replenished with oxygen in the lungs returns to the left atrium of the heart via the pulmonary 
veins.  Completing the cycle, the oxygenated blood is pumped into the left ventricle through the 
mitral valve, and subsequently pumped back to the systemic circulation and organs via the aortic 
valve and aorta.  While healthy heart function is critically dependent on the efficient 
performance of each of the valves, the structures and functions of the semilunar valves (i.e., 
aortic, pulmonary) are both more simple, and more frequently subject to disease, than those of 
the muscularly-anchored atrio-ventricular valves (i.e, tricuspid and mitral valves).  Thus, in the 
following sections the semilunar aortic and pulmonary valves will be primarily considered.  
 
1.1.1 Organ-Level Structure of the Semilunar Valves 
 
The aortic and pulmonary valves exhibit a unique tri-leaflet structure, with each of the 
individual leaflets exhibiting a semilunar (i.e., half-moon) shape (Figure 2).  In light of the 
similarity of structure exhibited by the semilunar valves, only a detailed description of the aortic 
valve structure is presented here.  The aortic valve consists of the three valve leaflets and the 
surrounding aortic root.  The aortic valve is demarcated on the ventricular side by a semilunar 
line of attachment named the annulus fibrosis, and on the aortic side by a circular ridge of 
thickened tissue circumscribing the apices (i.e., commissures) of the semilunar leaflets referred 
to as the sinotubular junction [2].  The body of each leaflet spans from the annulus fibrosis to the 
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 free edge, forming a pocket-like cavity between the leaflet and its associated aortic root wall.  
During valve closure, these three pocket-like cavities fill with blood and ultimately press 
together in what is termed leaflet coaptation.  The several millimeters of leaflet tissue that when 
coapted form a seal against retrograde blood flow are called the coapting surfaces or lunulas 
(Figure 2; area descending from the free edge to the dotted black line).   At the center of each 
lunula is a small nodule of thickened tissue called the nodulus Arantii which supposedly reduces 
regurgitation.  Because each of the leaflets is roughly equal in size, the circumferential angular 
distance from commissure to commissure is approximately 120 degrees.  The triangular regions 
of aortic root descending from each of the three commissures and demarcated on either side by 
the semilunar lines of the annulus fibrosis are called the interleaflet triangles [2]. 
  
 
Figure 2 Surgical anatomy of a semilunar heart valve.  Image courtesy of Thubrikar [3]. 
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 1.1.2 Tissue-Level Structure of the Semilunar Valve Leaflets 
 
The tissue-level microstructure of the semilunar valve leaflet is uniquely adapted to 
withstand the repetitive loading of the cardiac cycle (Figure 3).  As in the above description of 
the organ-level structure, the tissue level description here will focus on the aortic valve.  The 
human aortic valve leaflet thickness ranges from approximately 700 microns at the annulus 
fibrosis to 200 microns at the free edge.  Through the thickness, the leaflets exhibit a tri-layered 
structure, with the individual layers designated as the fibrosa (aortic side), spongiosa (central), 
and ventricularis (ventricle side).  The fibrosa layer consists primarily of circumferentially-
oriented type I collagen fibers, and provides the strength required to withstand the 80 mmHg 
transvalvular pressures experienced during aortic valve closure (diastole).  In addition to the fiber 
level crimp intrinsic to type I collagen, the fibrosa also exhibits a macroscopic corrugated 
structure which is presumed to allow for radial leaflet expansion.  On the opposite side of the 
leaflet, the ventricularis layer consists primarily of elastin, with some loosely arranged type I 
collagen fibers.  First coined by Gross and Kugel [4], the ventricularis is thought to be important 
both in stabilizing the corrugated collagen structure of the fibrosa, and to provide a tensile pre-
load in the leaflet.  Situated between the fibrosa and ventricularis is the loosely organized, highly 
hydrated spongiosa layer, which consists primarily of water, proteoglycans, and 
glycosaminoglycans (GAG), with some small collagen fibers tethering the fibrosa to the 
ventricularis.  GAG are long, negatively-charged polysaccharides that serve to imbibe water 
within the spongiosa, both in their free form, as well as when bound to a protein core (i.e., 
proteoglycan) [5].  While not completely understood, the spongiosa is thought to reduce shear 
stresses and buckling during leaflet flexion, thus contributing to leaflet durability [6, 7]. 
4 
  
Figure 3 Tissue-level microstructure of a semilunar valve leaflet. 
 
1.1.3 Cellular-level Structure of the Semilunar Valve Leaflet Tissue 
 
The semilunar valve leaflets are populated by a mixed population of cells which are 
generally referred to as valvular interstitial cells (VIC).  These VIC express a phenotype 
intermediate between smooth muscle cells (SMC) and fibroblasts, and have been characterized 
as VA-type myofibroblasts due to their dual expression of fibroblast markers such as vimentin 
and SMC markers such as alpha smooth muscle actin (α-SMA) [8-10].  While the quiescent state 
of the VIC appears to be more fibroblastic, under conditions of fetal development and/or active 
remodeling, such as during the Ross procedure (see Section 1.4), the VIC express a more SMC-
like (i.e., α-SMA+) phenotype [11, 12].  Interestingly, recent studies have linked expression of 
the SMC-like phenotype to the contractile properties, leaflet stiffness, and mechanical 
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 environment of the valve [13, 14].  At the blood-leaflet interface, the leaflets are covered with a 
confluent lining of valvular endothelial cells (VEC).  VEC, while similar in many respects to 
other vascular endothelial cells, the VEC express certain unique phenotypic and morphologic 
attributes [15, 16].     
Collectively, the structures constituting the semilunar valves perform remarkably well, 
typically withstanding 3 x 109 cycles during an average human lifespan.  Conversely, disruption 
of the complex arrangement of these tissue and organ-level structures, either by congenital 
malformation or acquired by disease, can lead to clinical symptoms mandating valve 
replacement. 
 
1.2 HEART VALVE DISEASE AND CURRENT VALVE REPLACEMENTS 
 
Prosthetic heart valves are implanted in ~ 275,000 patients each year [17].  Conditions 
warranting replacement of either the semilunar (i.e., aortic or pulmonary) or atrio-ventricular 
(i.e., mitral or tricuspid) valves can be generally characterized as either congenital or acquired.  
Congenital lesions in pediatric patients (e.g., pulmonary atresia, tetralogy of Fallot) often require 
complete reconstruction of the valvular outflow tract [18-20].  In older patients (i.e., 8th decade), 
senile degeneration of the valve leaflets is common, clinically manifesting as either stenosis 
(decreased valvular orifice area), insufficiency (regurgitant blood flow), or a combination thereof 
[21].  While mechanical, bioprosthetic, and homograft valve replacements have significantly 
improved the quality of life of many patients since their inception in the 1960’s (Figure 4), 
currently available valve replacements continue to suffer from serious limitations [22]. 
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Figure 4 Overview of currently available replacement valves. 
 
Mechanical valves offer superior long-term durability; essentially lasting the lifetime of 
the recipient; however they require chronic anticoagulation therapy to reduce the potential for 
thromboembolism and are susceptible to infection [23].  These drawbacks are of particular 
concern in women of child-bearing age, who carry an elevated risk of valve-related thrombosis 
and anticoagulant-related embryopathy during pregnancy [24, 25].  Bioprosthetic heart valves 
(BHV), fabricated from chemically-treated porcine valves or bovine pericardium, provide 
excellent hemodynamics, thereby avoiding the requirement of anticoagulation.  Unfortunately 
BHV incur calcific and fatigue-related damage over a relatively short time frame of 10 to 15 
years, resulting either in surgical intervention or mortality [22, 26, 27].  Homograft valves from 
human cadavers represent the gold-standard in terms of hemodynamics and functionality; 
however their use is restricted by donor scarcity.  Efforts to improve the biocompatibility and 
durability of mechanical valves and BHV, respectively, will likely yield some degree of success 
in the future.  Traditional valve designs, however, all lack living cells and thus do not possess the 
capacity for growth that is conceptually appealing in reconstructing pediatric valvular lesions.  
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1.3 RECONSTRUCTION OF VALVULAR LESIONS IN PEDIATRIC PATIENTS 
 
Pediatric valvular lesions requiring reconstruction in early infancy are generally 
associated with severe cyanotic congenital heart diseases.  In cyanotic congenital heart disease, 
the lesions allow for a mixture of oxygenated and deoxygenated blood to be pumped into the 
systemic circulation, thus resulting in a bluish coloration.  The overall incidence of severe 
cyanotic congenital heart disease has been estimated at 1,391/million live births [28].  Based on 
the most recent (2003) official US Center for Disease Control (CDC) report of 4,089,950 live 
births [29], this translates to approximately 5689 new cases of severe cyanotic congenital heart 
disease per year in the US alone.  Of these cases, the most common conditions potentially 
warranting repair or replacement of the pulmonary valve in early infancy are Truncus Arteriosus, 
Tetralogy of Fallot, and Pulmonary Atresia [30] (Figure 5).  In Truncus Arteriosus, the normal 
ventricular septum (Figure 5A) separating the right and left ventricles is disrupted by a large 
ventricular septal defect resulting in the formation of a large, single great vessel (i.e., truncus) in 
which a mixture of oxygenated and deoxygenated blood is pumped to the lungs and systemic 
circulation (Figure 5B).  In Pulmonary Atresia, the pulmonary valve is entirely absent, with 
blood flow diverted to the systemic circulation via a Patent Ductus Arteriosus (Figure 5C), and 
in Tetralogy of Fallot the pulmonary valve is stenotic (i.e., narrowed), in addition to a ventricular 
septal defect and other lesions (Figure 5D). 
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Figure 5 Common congenital valvular lesions.  Adapted from the American Heart 
Association (www.americanheart.org). 
 
Surgical inventions to correct these severe valvular lesions currently rely on the use of 
cryopreserved valved homografts derived from human cadavers.  However, while current 
treatments are life-saving and perform well in the short-term, the cryopreserved valved 
homografts, while potentially retaining some degree of cellular viability, do not grow in tandem 
with the somatic growth of the neonate, and thus ultimately require reoperations and/or 
replacement [30].   The problem with size mismatch as a result of somatic growth is made clear 
in the following example.  In a retrospective study by Perron et al. [30] at Children’s Hospital 
Boston, at a mean operative age of 26 ± 28 days, the mean homograft size used was 9.0 ± 2 mm 
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 (84 patients).  At a mean time of 4.6 years, 37 patients (47%) had a reoperation, and the mean 
size of the new homografts was 17 ± 2 mm.  The probability of freedom from reoperation was 
found to depend upon the size class of the graft, with time to reoperation being shortest for the 
smallest 6/7/8 mm class 1 grafts, and longest for the 12/14/15 mm class 3 grafts (p = 0.01; 
Figure 6). 
 
 
Figure 6 Probability of freedom from reoperation according to homograft size over time.  
Adapted from Perron et al. [30]. 
  
Thus for the pediatric population, in particular for neonates requiring small valved 
conduits, there is demonstrated clinical motivation for the development of a valved conduit that 
can grow with the patient, potentially mitigating the need for subsequent reoperations.  One 
potential approach being investigated is the tissue engineered heart valve (TEHV).   
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1.4 TISSUE ENGINEERED HEART VALVES 
 
In contrast to currently available replacement valves and valved conduits, tissue 
engineered heart valves (TEHV) are designed around a living cellular component.  TEHV are 
typically constructed by seeding cells onto a porous, three-dimensional scaffold that resembles 
the anatomy of a native heart valve (Figure 7) [17, 31].  The majority of reports thus far have 
relied on vascular-derived cells, typically endothelial (EC) and smooth muscle cells (SMC) 
isolated from a section of carotid artery, aorta, or peripheral veins [32]. 
 
 
Figure 7 General steps in constructing a TEHV: isolate cells (1), expand cells (2), seed 
scaffold with cells (3), incubate cell-seeded scaffold (i.e., TEHV), and finally implant TEHV (5). 
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 More recently, investigators have addressed the morbidity issues associated with such 
sources by constructing tissue engineered cardiovascular constructs based on bone marrow [33-
35], cord blood [36], or peripheral blood-derived stem cells [37, 38].  The results of these new 
studies are encouraging; yielding similar results to that seen with vascular-derived cells; however 
the optimal cell source for TEHV has yet to be conclusively delineated.  Likewise, there is a 
large degree of disparity in the types of materials used for the scaffold.  Due to the acute 
mechanical strength criteria for valve replacements, the majority of TEHV developed thus far 
have relied on synthetic polymeric materials; such as polyglycolic acid (PGA) and poly-L-lactic 
acid (PLLA) [32, 33], or on biological materials, such as small intestinal submucosa (SIS) [39] 
and decellularized porcine valves [40].   
Both TEHV design paradigms have demonstrated significant early achievements, 
including the successful demonstration of TEHV function in the pulmonary circulation of a 
growing lamb for 120 days (SMC + EC; PGA scaffold) by Hoerstrup et al. [32], and recently a 1 
year follow-up on the first TEHV implanted in a human patient (EC; decellularized homograft) 
by Dohmen et al. [41].  More recently, Sutherland et al. [33] demonstrated that TEHV fabricated 
by seeding bone marrow-derived mesenchymal stem cells (BMSC) onto nonwoven 50:50 blend 
PGA/PLLA scaffolds could successfully function in the ovine pulmonary circulation for up to 
240 days.  However, while these results are encouraging, no study has demonstrated conclusively 
that TEHV have the capacity to grow in tandem with the somatic growth of the patient.  In the 
study by Hoerstrup et al. [32], it was noted that the mild to moderate regurgitation observed at 16 
and 20 weeks might have been a result of non-adaptation of the leaflets to the 4 mm growth in 
the pulmonary artery diameter over the 5 month period of the study.  Indirect evidence for the 
growth potential of a living graft comes from studies involving the Ross procedure.  First 
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 described by Donald N. Ross in 1967 [42], in the Ross procedure a diseased aortic valve is 
replaced with the patients own (i.e., autograft) pulmonary valve, while the pulmonary valve is 
typically replaced with a cryopreserved homograft valved conduit.  In a recent study of 
pulmonary autograft explants, Rabkin-Aikawa et al. [12] demonstrated pathologic evidence for 
adaptive remodeling in the aortic site.  Specifically, pulmonary autografts explanted after 3-6 
years had retained their native tri-layed tissue morphology while exhibiting a thickness (0.9 ± 0.2 
mm) similar to native aortic valves (0.7 ± 0.1 mm).  Moreover, 3-6 year pulmonary autograft 
explants exhibited phenotypic characteristics similar to the native aortic valve, including 
expression of EphrinB2, a marker specific for arterial endothelium [43].  These morphologic and 
phenotypic adaptations corroborate other studies in which evidence for growth of the pulmonary 
autograft has been demonstrated indirectly in humans [44], and directly in a porcine animal 
model [45, 46].  Collectively, these studies provide evidence that autologous valved conduits 
have the capacity to grow, and support the possibility that TEHV may have the capacity to grow. 
While the benefits of different cell sources, scaffold structures, and incubation conditions 
have been explored to an extent, little is known regarding the underlying mechanisms 
responsible for the development and maintenance of these engineered tissues.  As such, a rational 
basis for the optimization and prediction of TEHV properties does not currently exist. 
 
1.5 BIOMECHANICS AND FUNCTION OF NATIVE HEART VALVES 
 
Mammalian semilunar heart valves are unique among tissues in that they passively 
undergo complex large deformations in response to the coupled effects of pulsatile blood 
pressure and flow (fluid shear stress) (Figure 8) [3]. 
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Figure 8 The passive deformation of a semilunar valve leaflet in response to blood flow is 
similar to the motion of a flag in the wind.  The time series images were generated by surface 
meshing of data obtained by structured light projection upon a bioprosthetic heart valve leaflet in 
an in vitro pulsatile flow duplicator [47]. 
 
Their gross anatomical structure, extracellular matrix (ECM) microstructure, and 
concomitant mechanical properties appear to parallel physiological functional requirements (e.g., 
they exhibit a dense network of circumferentially oriented collagen fibers to support diastolic 
transvalvular pressure).  Work by the Sacks group and others have quantified the relationships 
between collagen network structure and leaflet tissue mechanical behavior [48].  Moreover, 
recent studies suggest that mechanical forces are required during embryogenesis for normal 
semilunar valve development [49].  Finally, at least in the case of the mitral atrio-ventricular 
valve, altered leaflet stresses associated with papillary muscle ischemia have been demonstrated 
to result in an upregulation of type I collagen production in vivo [50, 51].  Together, observations 
of these structural features and biomechanical phenomena in native valves suggest a potential 
role for mechanical factors in the development of TEHV. 
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1.6 MECHANICAL CONDITIONING OF TEHV 
 
It has been well documented that mechanical forces play a critical role in the homeostasis 
and remodeling of many load-bearing tissues and organs in vivo [52-54], as well as in the 
stimulation of native and engineered tissue biosynthesis and development in vitro [8, 55, 56].  As 
such, a number of investigators have developed systems to explore the role of mechanical 
stimulation in the context of their specific application [57, 58].  In order to prepare TEHV with 
sufficient mechanical strength for implantation, pulse duplicator bioreactors mimicking the in 
vivo mechanical environment have been developed [8, 32, 41, 59, 60].  The rational is that 
gradually increasing flow and pressure conditions will enhance and guide engineered tissue 
development, ultimately yielding mechanical properties suitable for suturing and acute 
hemodynamic function. 
While the benefit of such pre-implantation conditioning compared to static incubation has 
been demonstrated (Figure 9), the underlying biomechanical phenomena have not been 
elucidated, nor the conditioning regimens optimized.  In fact, pulse duplicator and flow loop 
bioreactors; while useful in developing three-dimensional, anatomical TEHV for implantation; 
have several drawbacks limiting their use in such biomechanical studies.  Because these 
bioreactors aim to mimic the complex in vivo environment, the potential mechanical stimuli—
such as shear stress, pressure, tension, and flexure—are inextricably coupled.  As such, it would 
be difficult, if not impossible, to isolate the individual contribution of any particular mechanical 
factor in an intact TEHV. 
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Figure 9 Pulse duplicator bioreactor (A) [59].  Representative H&E stained section of a 
TEHV cultivated for 14 days in a pulse duplicator bioreactor (B), and corresponding static 
control (C) [32].  Note the more robust tissue formation evident in the pulse duplicator TEHV. 
 
Toward developing an understanding of the individual role of simple modes mechanical 
stimulation in TEHV development, bioreactors have recently been developed to provide fluid 
shear stress [61], cyclic flexure [62, 63], and tension [64] to TEHV biomaterials.  The 
application of continuous laminar flow (fluid shear stress) in vitro was found to induce an 
approximately 1.5-fold increase in hydroxyproline concentration (a marker for collagen) in 
rectangular samples of TEHV by 14 days.  In a recent study in our laboratory, cyclic flexure was 
demonstrated to induce quantitative and qualitative changes in the flexural behavior of two 
candidate TEHV scaffolds [62].  Moreover, cyclic flexure reproduced many of the aspects of 
development observed in TEHV incubated for 14 days in pulse duplicator bioreactors, including 
a nearly two-fold increase in collagen accumulation compared to static controls, and strong 
expression of the intermediate filament vimentin, a marker associated with native valve cell 
phenotype [63].  While these results have provided a substantial basis for the individual role of 
simple modes of mechanical stimulation in TEHV development, optimization of these 
phenomena requires an understanding of the underlying cellular mechanisms. 
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1.7 MECHANICAL STIMULATION OF CELLS 
 
The first study to demonstrate that cyclic mechanical stretch can stimulate ECM synthesis 
in vitro was reported by Leung, Glagov, and Mathews [65].  In their seminal and innovative 
work, they developed a bioreactor in which rabbit aortic SMC were stretched on an elastin 
membrane derived from the media layer of bovine aorta (Figure 10).  They demonstrated that 
the application of cyclic stretch at an amplitude of 10% and frequency of 1 Hz resulted in 3-5 
fold increases in type I and type III collagen biosynthesis compared with static or agitated 
controls—all in the absence of any change in SMC proliferation. 
 
 
Figure 10 Examples of devices used to mechanically stimulate cells in 2-D tissue culture.  
The first device designed to mechanically stimulate cells was reported in 1976 and relied on an 
elliptical crank to stretch an elastin membrane (A).  Image adapted from Leung et al. [65].  More 
recent devices have been marketed (e.g., Flexercell®) which incorporate robust computer control 
systems (B).  Image courtesy of Dunn Labortechnik GmbH, Asbach, Germany 
(http://www.dunnlab.de). 
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 In light of the role of SMC-mediated fibrosis in atherosclerosis; work in this area 
continued over the ensuing decades.  Commercialization of the Flexercell® unit allowed 
researchers to focus on the biological aspects of cyclic mechanical stretch, without the difficulty 
of designing an experimental device [66].  A number of studies have investigated the effects of 
cyclic strain amplitude [65-70], frequency [71-73], and very recently, strain rate [74, 75], on cell 
phenotype, proliferation [76-78], apoptosis [79], and matrix synthesis in a two-dimensional (2D) 
cell culture setting.  Moreover, in some cases the mechanism has been isolated to paracrine 
factors [78-80] or mechano-sensitive actuators, including integrins [71, 79], cadherins [81], gap 
junctions [82]. 
While use of the Flexercell® system has become ubiquitous across fields, recent interest 
in the field of tissue engineering has spurred a renewed interest in understanding the effects of 
cyclic mechanical loading on a three-dimensional (3D), cell-seeded scaffold.  While the results 
of 2D studies appear to loosely parallel in vivo findings in native tissues, it is unclear if results 
established in 2D stretching systems can be directly scaled up to the 3D tissue engineering 
setting.  While continuum mechanics and finite element methods can be applied to translate the 
macroscopic deformation of a 3D tissue engineering scaffold into microscale strains which the 
cells might experience [83], there are other factors associated with the 3D setting which need to 
be taken into consideration.  First, the relative scale of the adhesive substrate to the cell may be 
considerably different in a tissue engineering scaffold (e.g., 10 µm diameter fiber) compared 
with in 2D culture (e.g., 185 cm2 surface), potentially resulting in dramatic differences in cell 
shape, with concomitant effects on cell behavior [84].  Secondly, there are mass transport 
limitations associated with a 3D construct; and these limitations change with time as the cells 
secrete their ECM.  Thirdly, the nature of the attachments to the substrate could be considerably 
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 different in a 3D case compared with 2D.  For instance, in 2D the cells could become artificially 
polarized based on their attachments to the underlying, 2D substrate, whereas in 3D, the cells 
could potentially attached to ligands in all directions surrounding the cell, perhaps in a manner 
more consistent with that which occurs in vivo [85].  While these studies have demonstrated 
potentially useful relationships between cyclic stretch and cell behavior, the differences between 
the 2D cell culture and 3D tissue engineering settings highlight the need to investigate these 
phenomena in the 3D situation. 
 
1.8 MICROSTRUCTURE AND MECHANOTRANSDUCTION IN TEHV 
 
During seeding, cells attach to tissue engineering scaffolds through specific interactions 
between serum proteins adsorbed to the scaffold material and membrane-bound receptors [85].  
As the majority of tissue engineering scaffolds are highly porous (greater than 90%), a large 
proportion of the seeded cells are initially adhered to themselves, rather than the scaffold 
(unpublished observations).  Vascular smooth muscle cells, one of the most widely utilized cell 
types in cardiovascular tissue engineering applications, typically express T, R, and N-cadherin 
receptors through which they can undergo such homophilic cell-cell interactions [86].  Recently, 
studies on fibroblasts have demonstrated that N-cadherin can mediate intercellular signaling by 
stretch-sensitive calcium-permeable channels [81, 87].  Considering that the PGA and PLLA 
fibers of the most widely used TEHV scaffolds are not elastomeric, it is possible that mechanical 
forces are transduced to the cells through the local deformation of the cellular network. 
As TEHV continue to develop in vitro, cells secrete and organize ECM, filling in the void 
space of the scaffold with tissue [8].  While standard histological methods have demonstrated the 
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 presence and gross organization of collagen, sulfated glycosaminoglycans (S-GAG), and elastin 
in TEHV, these methods provide little information regarding the three-dimensional attachment of 
the newly formed ECM to the scaffold.  To reveal such intricate details, scanning (SEM) and 
transmission (TEM) electron microscopic techniques are traditionally employed.  In one recent 
study, TEM of TEHV indicated the presence of actin/myosin filaments, collagen fibrils, and 
elastin fiber aggregates [35].  Furthermore, SEM demonstrated that TEHV incubated in a pulse 
duplicator bioreactor exhibited a confluent surface with cell orientation in the direction of flow 
[32].  Unfortunately, no TEHV study to date has performed the exhaustive electron microscopic 
analysis necessary to establish the interconnections between ECM components, cells, and 
scaffold.  The lack of detailed information on the 3D microstructure of TEHV represents a 
significant gap in the literature.                          
 
1.9 MATHEMATICAL MODELING OF TEHV DEVELOPMENT 
 
Theoretical models have been postulated to describe the mechanics of growth and 
remodeling in native and engineered tissues [88-92].  While these formulations are generally 
rigorous, they lack the detailed experimental data needed to validate their accuracy.  
Furthermore, none of these models can be directly applied to TEHV based on the most popular 
category of TEHV scaffolds—non-woven polymeric mesh scaffolds, such as PGA.  In describing 
the mechanical behavior of a TEHV based on a non-woven PGA scaffold, the composite 
material could potentially be approximated as a discontinuous fiber reinforced composite [93].  
While soft collagenous tissues generally exhibit non-linear, anisotropic mechanical properties, 
non-woven meshes of randomly oriented fibers can exhibit planar quasi-isotropy, depending 
20 
 upon the fabrication method [94].  Furthermore, studies in our laboratory have demonstrated that 
non-woven 50:50 blend PGA/PLLA scaffolds and cell-seeded constructs exhibit linear behavior 
in the low stress-strain regime of three-point flexure.  Thus, it may be that simplified linear 
theories will be sufficient in describing the composite material behavior of these scaffold 
materials [95]. 
 
1.10 MOTIVATION AND SPECIFIC AIMS OF THE PRESENT STUDY 
 
Tissue engineered heart valves (TEHV) are being developed for the surgical repair of 
congenital valvular lesions in pediatric patients [31].  Because TEHV are populated with viable 
cells, they may possess a capacity for coordinating the growth and remodeling of the TEHV in 
tandem with the somatic growth of pediatric patients.  Created by seeding vascular-derived cells 
onto synthetic scaffolds, TEHV exhibited enhanced extracellular matrix (ECM) development and 
improved mechanical properties when cultured under pulsatile flow and pressure conditions in 
vitro [32].  Moreover, native-like ECM microstructures [8] and mechanical properties [32] have 
been observed following 20 weeks implantation in the pulmonary circulation of sheep in vivo. 
While the results of these studies are encouraging, much work remains to complete our 
understanding of the TEHV developmental process before clinical trials would be warranted 
[96].  First, the flow and pressure environments of pulsatile flow loop bioreactors are complex 
and inextricably coupled, precluding isolation of the independent effects of individual 
mechanical factors or inter-factor coupling.  Such information is essential for the rational design 
of optimized TEHV conditioning regimens.  Moreover, such information would represent a key 
component of our understanding of the engineered tissue formation process, and thus would help 
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 guide investigators in TEHV design.  Ultimately, this information could help guide regulatory 
agencies in determining appropriate end-points for assessing TEHV structure and functional 
performance, as well as in delineating process validation requirements for bioreactors and 
conditioning protocols used in fabricating TEHV.   
Secondly, considering the load-bearing function of the valve, of paramount importance is 
the development of methods to predict how the mechanical strength and stiffness of the TEHV 
evolve with in vitro incubation and subsequent in vivo implantation.  TEHV are composite 
materials; prior to scaffold resorption, the effective mechanical properties will depend on the 
complex, time-varying interactions between the degrading scaffold and the ECM being deposited 
by the cells.  Moreover, the structural-mechanics of the nonwoven fabrics used as TE scaffolds 
are complex themselves [97-99].  As such, prior to the work presented herein, no methods have 
been developed to predict the mechanical properties of nonwoven TE scaffolds from the 
properties of the constituent fibers, let alone the mechanical properties of the cell-seeded TEHV 
constructs.  Again, this information represents another key component of our understanding of 
the engineered tissue formation process—specifically, the biomechanics of tissue deposition on 
nonwoven scaffolds—and could potentially lead to new scaffold biomaterials and designs.   
Finally, the majority of studies to date have utilized vascular-derived SMC and EC in 
constructing TEHV.  While these cell sources are acceptable for in vitro work and pre-clinical 
animal studies, one of the overall motivations behind tissue engineering is to circumvent the 
morbidity associated with the use of tissue autografts.  Thus, the field has been compelled to 
develop novel cell sources that can be isolated relatively non-invasively from patients, and that 
exhibit the phenotypic plasticity required for creating a TEHV, despite the fact that they were not 
derived from a native valve. 
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 Based on these three principal research areas, the specific aims of the present study were 
as follows:  
 
1. Quantify the effects of cyclic flexure on candidate TEHV scaffolds and on cell-
seeded TEHV constructs.  We hypothesized that cyclic flexure; one of the primary 
modes of deformation experienced by native semilunar heart valves; would have 
independent effects on the TEHV developmental process, and potentially on the TE 
scaffolds themselves.  To address these hypotheses, a cyclic flexure bioreactor was 
developed an implemented to investigate the effects of cyclic flexure on the structural-
mechanical properties of nonwoven TE scaffolds, as well as on cell-seeded TEHV 
constructs in vitro. 
   
2. Develop a bioreactor to independently modulate the application of cyclic flexure, 
tension, and flow (fluid shear stress) to multiple TEHV samples.  We hypothesized 
that each of the mechanical stimuli experienced by TEHV in pulsatile flow loop 
bioreactors, cyclic flexure, stretch, and fluid flow, might synergistically effects TEHV 
development.  To test this hypothesis, a novel flexure-stretch-flow (FSF) bioreactor was 
developed in which the individual FSF stimuli could be applied to multiple TEHV 
specimens independently or coupled. 
     
3. Quantify the independent and coupled effects of cyclic flexure and laminar flow on 
TEHV constructed using bone marrow-derived mesenchymal stem cells (BMSC).  
BMSC represent a potentially attractive cell source for TEHV because they can be 
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 isolated relatively non-invasively from a bone marrow biopsy, and because previous 
studies have demonstrated their remarkable pluripotency and phenotypic plasticity.  To 
address the hypothesis that BMSC would differentiate differently in response to 
independent and combined modes of mechanical stimulation, we used the FSF bioreactor 
to investigate the independent and coupled effects of cyclic flexure and laminar flow on 
TEHV tissue formation by BMSC. 
 
4. Develop and experimentally validate structural-based models to predict the effective 
stiffness (E) of nonwoven TE scaffolds and cell-seeded TEHV constructs.  To fully 
characterize the mechanical properties of TEHV based on nonwoven scaffolds under 
physiologically-relevant loading modes, we first developed a structural model for the 
flexural mechanics of nonwoven TE scaffolds.  We then developed additional 
experimental techniques for quantifying relevant structural features of TEHV (e.g., 
transmural collagen distribution), and implemented them in an extended structural model 
accounting for the composite properties of nonwoven nonwoven-ECM composites. 
 
 
 
 
 
 
 
 
24 
  
 
 
 
2.0 THE INDEPENDENT ROLE OF CYCLIC FLEXURE IN THE IN VITRO 
DEVELOPMENT OF AN ENGINEERED HEART VALVE TISSUE 
 
As a first step toward a systematic investigation of mechanical stimulation in TEHV, we 
initially designed and implemented a bioreactor for the purpose of subjecting samples of TEHV 
to well-defined, simple modes of cyclic flexure [62, 63].   
 
2.1 DESIGN AND QUALIFICATION OF A CYCLIC FLEXURE BIOREACTOR 
 
As highlighted above in Section 1.6, bioreactors have previously been designed to apply 
complex pulsatile flow fields [32, 59], and more simple modes of mechanical loading such as 
cyclic tensile strain [64] and continuous laminar flow (fluid shear stress) [61] to TEHV.  Cyclic 
flexure represents another important mode of deformation experienced by the semilunar heart 
valve leaflets during valve operation in vivo, and incubation in pulse duplicator bioreactors in 
vitro, and thus was hypothesized to have independent effects on TEHV development [62, 63]. 
The bioreactor was designed using Solidworks 3D CAD software (Solidworks Corp., 
Concord, MA), and the parts were fabricated by Apollo Precision, Inc. (Plymouth, MN).  The 
structural elements of the device were machined from polysulfone.  Neoprene gaskets were fitted 
between all joints to reduce the possibility of microbial contamination, and the bioreactor was 
assembled using 18-8 stainless steel screws (McMaster-Carr Supply Co., Cleveland, OH). 
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Figure 11 Photograph of the cyclic flexure bioreactor operating inside of a cell culture 
incubator. 
  
The bioreactor consists of two identical chambers (127 mm x 101.6 mm), each containing 
6 culture wells (25.4 mm diameter, 16 mm deep) (Figure 11).  Situated within each well are four 
stainless steel “stationary posts” arranged orthogonally around a central channel in the floor of 
the culture well (1.9 mm deep).  The device can thus accommodate a total of 12 rectangular 
samples (maximum dimensions approximately 25 mm x 7.5 mm x 2 mm), with each sample 
being positioned between the four stationary posts, orthogonal to the central channel (Figure 
12).  Cyclic flexural stimulation can be applied to each of the samples in the form of cyclic three-
point flexure by an environmentally-sealed linear actuator (UltraMotion, Mattitick, NY).  The 
piston of the actuator is rigidly coupled to a cross-arm in the form of a T-junction.  Conversely, 
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 the cross-arm is rigidly coupled to the arm of each chamber.  Each arm bifurcates and extends 
into a chamber (two penetrations per chamber).  Both arms terminate in six fingers through 
which “flexure pins” can be inserted to bracket the rectangular samples in the middle.  Therefore, 
each sample can be subjected to unidirectional or bi-directional three-point flexure.  Frequency, 
amplitude, acceleration, and deceleration profiles can be developed using Windows-based Si 
Programmer software (Applied Motion Products, Watsonville, CA).  The structural parts can be 
cold gas sterilized by ethylene oxide, and the bioreactor operates inside a humidified incubator. 
 
 
Figure 12 Schematic diagram of a representative culture well within the bioreactor.  The 
scaffold sample (white bar) is situated between 4 stainless steel stationary posts (black dots), and 
bracketed from above by 2 centrally-positioned flexure pins (black dots).  In the current study the 
linear actuator (not shown) cycled the flexure pins between the reference configuration (A) and 
the deformed configuration (B) at a frequency of 1 Hz and amplitude of 6.35 mm, corresponding 
with a flexure angle θ of approximately 62°.  Photograph of an individual culture well (C). 
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2.2 THE EFFECTS OF CYCLIC FLEXURE ON TEHV SCAFFOLDS 
 
2.2.1 Culture Medium 
 
The culture medium used in these experiments was Dulbecco’s Modified Eagle’s 
Medium with 4.5 g/L glucose and L-glutamine supplemented with 10% fetal bovine serum 
(BioWhittaker, Walkersville, MD).  Antibiotics were excluded in order to assess the sterility of 
the bioreactor. 
 
2.2.2 Scaffolds 
 
Scaffold materials consisted of a non-woven mesh of polyglycolic acid (PGA) fibers 
(Albany International Research, Mansfield, MA) dip-coated with poly-4-hydroxybutyrate 
(P4HB) (Tepha, Inc., Cambridge, MA), and a non-woven 50:50 blend mesh of PGA and poly-L-
lactic acid (PLLA) fibers (Albany International Research, Mansfield, MA) dip-coated with 
P4HB.  The PGA and PGA/PLLA scaffolds had an approximate fiber diameter of 0.012-0.015 
mm and density of 69 mg/ml.  Rectangular scaffold samples were cut to size (approximately 25 x 
7.5 x 2 mm) and dipped briefly into a solution of P4HB in tetrahydrofuran (1% wt/vol), resulting 
in a P4HB coating following solvent evaporation.  As described previously [32], P4HB is a 
bioresorbable thermoplastic that allows for scaffolds to be molded into any shape.  Scaffolds 
were cold gas sterilized with ethylene oxide prior to use. 
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 2.2.3 Flexure Experiments 
 
A total of 60 scaffold samples were prepared for evaluation in this study (30 x 
PGA/P4HB, 30 x PGA/PLLA/P4HB).  Two separate runs of the bioreactor were required to test 
all of the samples.  In the first run, PGA/P4HB scaffold samples were loaded into the culture 
wells of the bioreactor under aseptic conditions (n=12).  Control scaffold samples were loaded 
into identical culture wells maintained under static conditions inside a large Petri dish (n=12).  In 
addition, samples of the virgin scaffold material (time = 0) were retained for flexure testing and 
scanning electron microscopy (n=6). 
Approximately 6 ml of culture medium was added to each of the bioreactor and static 
control culture wells.  The linear actuator was programmed to flex the scaffold samples at a rate 
of 1 cycle per second (1 Hz) in order to emulate the cardiac cycle.  The center of each scaffold 
sample was displaced 6.35 mm in one direction, corresponding to a flexure angle of 
approximately 62º.  The direction of flexure is referred to henceforth as “with-flexure” (WF), 
and the opposing direction is referred to as “against-flexure” (AF).  After loading the bioreactor, 
the entire device was placed inside of a humidified incubator operating at 37 °C and 5% CO2.  
The culture medium was not changed. 
After 1 week (n=6) and 3 weeks (n=6) of cyclic flexure the scaffold samples were 
removed from the bioreactor under aseptic conditions to perform flexure testing and scanning 
electron microscopy.  Corresponding control samples were removed from the static culture wells 
at each time point.  In the second bioreactor run, PGA/PLLA/P4HB scaffold samples were 
loaded and incubated in the same manner as the PGA/P4HB scaffolds.  After 3 weeks (n=6) and 
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 5 weeks (n=6) of cyclic flexure the PGA/PLLA/P4HB scaffold samples were removed from the 
bioreactor, as well as the corresponding static control samples. 
 
2.2.4 Bioreactor Operation and Sterility Results 
 
The bioreactor demonstrated consistent operation throughout each of the two runs.  
Microscopic evaluation of the culture medium at each time point indicated that sterility was 
maintained throughout the course of each study (up to 5 weeks). 
 
2.2.5 Effective Stiffness Measurement Methods 
 
The device and methods used to measure the effective stiffness (E) of tissue samples have 
been described previously [62, 100].  Testing was performed in a bath of phosphate buffered 
saline at room temperature.  In the case of cell-seeded scaffolds, testing was performed within 30 
minutes post-culture.  In brief, rectangular samples were marked with 5 to 10 black dots (~ 0.3 
mm2) on one long edge using a marker and subjected to three-point flexure by a calibrated 
flexure bar.  The displacements of the sample markers, flexure bar marker, and a reference 
marker were recorded to video with a CCD camera and tracked using a custom C program 
(Figure 13-A, B).  Based on the resolution, post coordinates, load, displacement, and marker 
coordinates, the program output the applied moment, M, and resulting change in curvature, 
∆κ (Figure 14). 
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Figure 13 Effective stiffness testing video images.  Recording starts with the sample in the 
horizontal, un-deformed reference state (A).  During data analysis, the positions of the flexure 
bar (I), reference rod (II), and sample markers (III) are recorded throughout the entire breadth of 
the three-point flexure deformation (B).  Representative thickness measurement image from 
SigmaScan Pro (SPSS, Inc., Chicago, IL) (C).  Lines are traced across the thickness of the 
sample at five uniformly spaced locations along its length.  The mean of the five line lengths was 
used as the thickness in the data analysis calculations. 
 
The flexural rigidity, EI, was calculated by a least squares regression on M versus ∆κ.  
Regression yields a linear relationship with a slope equal to EI, per the Bernoulli-Euler moment-
curvature relationship [101]: 
 
 M EI κ= ∆  (1) 
            
 
The moment of inertia, I, was calculated from the following relation in which t and w are 
the thickness and width of the sample, respectively: 
 
 31
12
I wt=  (2) 
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Figure 14 Representative marker position (A) and moment-curvature (B) plots output from 
the Matlab data analysis program.   
 
Because non-woven PGA/PLLA scaffolds are highly compressible, t was measured using a 
calibrated digital image of each sample using SigmaScan Pro (SPSS, Inc., Chicago, IL) (Figure 
13-C).  The thickness, w, was measured using a slide caliper (accuracy ± 10 µm; The L.S. 
Starrett Co., Athol, MA), and E was calculated by dividing EI by I. 
 
2.2.6 Scanning Electron Microscopy (SEM) Methods 
 
One scaffold sample representing each flexed and static control time point (10 total) was 
prepared for scanning electron microscopy.  Dry scaffold samples were attached to aluminum 
sample stubs and sputter coated with a thin layer of gold-palladium alloy (~3 nm thickness) in a 
Cressington 108auto sputter coater with a Cressington MTM-20 thickness controller 
(Cressington Scientific Instruments, Inc., Cranberry Twp., PA).  Each scaffold sample was 
imaged at 40, 100, and 300-fold magnification at 5 kV on a JEOL JSM-6330F SEM (JEOL 
USA, Inc., Peabody, MA). 
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 2.2.7 Effective Stiffness Results 
 
E (mean ± SEM) of the virgin (time zero) PGA/P4HB scaffold samples was 844 ± 86 kPa 
(Figure 15).  E values were observed to decrease over time for samples incubated under both 
flexed and static conditions.  A significant decrease (p < 0.01) was observed in E between the 
virgin sample and the flexed sample at 1 week (-43%); no significant difference was observed 
between the virgin material and the static control sample at 1 week.  Taken together, these data 
indicated that cyclic flexure has a significant effect on E compared to static incubation conditions 
at 1 week.  Loss of stiffness was incurred by both static (-82%) and flexed (-91%) by 3 weeks, 
with a significant difference between groups (p < 0.05). 
 
 
Figure 15 Effective stiffness (E) of PGA/P4HB scaffolds. 
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 E of the virgin PGA/PLLA/P4HB scaffold samples was 1687 ± 151 kPa (Figure 16), 
about twice that of the PGA/P4HB.  There was no significant difference in the static control 
samples between times 0, 3, and 5 weeks.  There was a significant decrease in E between the 
flexed and static control samples at 3 weeks (-72%) and 5 weeks (-76%).  There was not any 
significant difference in E between the flexed samples at 3 and 5 weeks. 
 
 
Figure 16 E of PGA/PLLA/P4HB scaffolds. 
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 The effective stiffness ratio was calculated as the ratio of E measured in the “with-
flexure” (WF) direction divided by that measured in the opposing “against-flexure” (AF) 
direction. An effective stiffness ratio of unity indicates isotropic flexural behavior, whereas any 
significant deviation from unity would suggest anisotropic flexural behavior.  The effective 
stiffness ratio of the PGA/PLLA/P4HB scaffold samples is depicted in Figure 17. 
 
 
Figure 17 E ratio of PGA/PLLA/P4HB scaffolds. 
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 Static control samples did not exhibit a statistically significant deviation from one, 
indicating that they exhibited isotropic flexural behavior.  The effective stiffness ratio of flexed 
samples, however, exhibited a significant deviation from one (-42%) at 3 weeks and 5 weeks (-
29%) (p < 0.01), indicating that these samples were stiffer when flexed in the “against-flexure” 
direction.  The effective stiffness ratio of flexed and static PGA/P4HB samples did not deviate 
significantly from 1, indicating isotropic behavior. 
 
2.2.8 SEM Results 
 
Representative SEM images are depicted for comparison (Figure 18).  The fiber 
architecture of the virgin scaffold materials appeared to be random within and across samples 
(data not shown), the P4HB coating did not appear to be uniform over the fiber structure, but 
rather appeared as sparsely distributed aggregates (Figure 18-A, D), fiber diameter did not 
appear to diminish over three weeks (PGA/P4HB) or five weeks (PGA/PLLA/P4HB), fibers 
appeared to fragment during incubation, and this fragmentation appeared to be more pronounced 
in the cyclically flexed PGA/P4HB samples (Figure 18-F). 
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Figure 18 SEM images of scaffolds.  Note the fragmentation of fibers in cyclic flexed 
PGA/P4HB (F). 
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2.3 DISCUSSION 
 
In order to facilitate the systematic evaluation of candidate scaffolds and constructs, we 
developed a bioreactor for the incubation of biomaterial samples under conditions of cyclic 3-
point flexure, a simple mode of flexural stimulation.  While cyclic 3-point flexure is not identical 
to the mode of dynamic flexure exhibited by native heart valves in vivo, or by a TEHV in a 
pulse-duplicator, it allows us to isolate the effect of flexure from other potential modes of 
stimulation, such as pulsatile pressure or shear stress.  To our knowledge, the bioreactor 
described herein is the first device aimed to study the independent effect of dynamic flexure on 
TEHV biomaterials.  In these first experiments we have demonstrated the operation of the 
bioreactor and its ability to maintain sterility for at least 5 weeks in an incubator environment.  In 
addition, we implemented the bioreactor to investigate the effect of dynamic flexure on the E of 
two different TEHV scaffold materials, PGA/P4HB and PGA/PLLA/P4HB.   
PGA/P4HB and PGA/PLLA/P4HB were chosen primarily because they are currently 
being evaluated as candidate scaffolds for the fabrication of TEHV [32].  Based on recent studies 
which evaluated the effects of constant fluid flow [102] and dynamic compressive loading [103] 
on similar scaffold materials, we hypothesized that dynamic flexure in a non-flowing 
environment may augment the bulk degradation rate of the polymers or result in fatigue of the 
polymer fibers, with concomitant losses in effective stiffness.  Moreover, because these non-
woven fiber meshes scaffolds have been modified by P4HB dip-coating, we further hypothesized 
that they may be more susceptible to fatigue (e.g., disruption of dip-coating) under conditions of 
dynamic stimulation, potentially giving rise to unique mechanical properties.   
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 In accordance with our hypotheses, incubation under dynamic flexure led to a trend of 
decreased E compared to static conditions in both scaffolds, and induced directional anisotropy 
(p < 0.01) in PGA/PLLA/P4HB samples at 3 and 5 weeks.  SEM images of these samples hinted 
at some of the structural features and changes that may have been responsible for the E results.  
The heterogeneity observed in the virgin scaffold fiber structure, coupled with the observation 
that P4HB does not uniformly coat the samples, helps explain the variability in E measured for 
the virgin (time zero) replicates.  Fragmentation of fibers, as opposed to diminishing fiber 
diameter and mass loss, appears to be a primary mechanism for loss of E in dynamically flexed 
PGA/P4HB samples.  It is not clear from this study if dynamic flexure augmented the bulk 
degradation rate of the polymers, making them more susceptible to fracture.  Interestingly, 
significant fragmentation of fibers was not observed in any of the PGA/PLLA/P4HB scaffolds, 
indicating that PLLA fibers may shield the PGA fibers from mechanical disruption.   
Recent studies in our lab have demonstrated that uncoated PGA/PLLA scaffolds exhibit 
isotropic flexural behavior both at time zero, and after 3 weeks of static or dynamic flexural 
incubation (unpublished observations).  Furthermore, the effective stiffnesses of these uncoated 
PGA/PLLA scaffolds, both at time zero, and after 3 weeks of static or dynamic flexural 
incubation, were approximately equal to those of the 3 week dynamically flexed 
PGA/PLLA/P4HB scaffolds in the present study.  Collectively, these observations indicate that 
the contribution of the P4HB coating to the effective stiffness of the PGA/PLLA/P4HB scaffolds 
is removed by 3 weeks of dynamic flexural incubation.  Disruption of the P4HB bonding 
between the fibers could potentially explain this behavior, however this could not be observed 
from the electron micrographs.  These findings imply that P4HB dip-coating may be useful in 
modulating the response of non-woven PGA/PLLA scaffold flexural properties to dynamic 
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 flexure.  Hypothetically, properties of an anatomical TEHV scaffold might be modified by P4HB 
dip-coating such that regions of the scaffold subjected to dynamic flexure (e.g., the leaflets) 
become more compliant, while regions of the scaffold not subjected to dynamic flexure (e.g., the 
aortic root) retain their stiffness.  Further studies on anatomical TEHV scaffolds incubated in 
pulse duplicators would be necessary in order to conclusively demonstrate this behavior.  
Non-woven PGA and PLLA scaffolds have been widely applied in cardiovascular, 
cartilage, and soft tissue engineering [61, 104-107].  As the structural integrity of a TEHV 
scaffold is critical for acute hemodynamic function, it is imperative to evaluate the mechanical 
properties of candidate TEHV scaffold materials under controlled deformation modes resembling 
those that manifest in vivo.  Moreover, future advances in tissue engineering will likely stem 
from an improved understanding of the biomechanics of tissue growth and remodeling.  Thus, 
the flexure bioreactor can be utilized to evaluate candidate TEHV scaffolds and constructs, as 
well as to investigate the underlying mechanisms by which mechanical loading influences tissue 
development. 
 
2.4 EFFECTS OF CELL SEEDING ON CANDIDATE TEHV SCAFFOLDS  
 
2.4.1 Scaffolds. 
 
Scaffolds were a non-woven 50:50 blend of PGA and PLLA fibers (Albany International 
Research, Mansfield, MA).  The PGA/PLLA scaffolds had an approximate fiber diameter of 
0.012-0.015 mm and density of 61.75 mg/ml.  Rectangular scaffold samples were cut to size (25 
x 7.5 x 1 mm) and the initial (prior to sterilization) effective stiffness (E) of each sample was 
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 measured using a three-point flexure test (see Effective stiffness measurement).  Scaffolds were 
then cold gas sterilized with ethylene oxide prior to use. 
 
2.4.2 Culture Medium. 
 
The culture medium was Dulbecco’s Modified Eagle’s Medium with 4.5 g/L glucose and 
L-glutamine (GIBCO™, Invitrogen Corporation, Grand Island, NY) with 10% fetal bovine 
serum (GIBCO™), 1% antibiotic-antimycotic (GIBCO™), and 2 ng/ml human recombinant 
basic fibroblast growth factor (bFGF; BD Biosciences, Bedford, MA).  The medium was sterile 
filtered using a vacuum filtration unit (0.2 µm polyethersulfone (PES) membrane; Nalge-Nunc 
International, Rochester, NY). 
 
2.4.3 Primary Cell Isolation. 
 
Ovine vascular smooth muscle cells (SMC) were isolated and expanded as described 
previously [108, 109].  In brief, a 1 cm segment of carotid artery was harvested from an adult 
Dover sheep.  The media was isolated by surgically clearing the adventitia, opening the segment 
longitudinally, and wiping the endothelium from the luminal surface with sterile gauze.  The 
media was minced with scissors into small pieces (~ 1 mm2) and placed into polystyrene tissue 
culture dishes (100 x 20 mm; BD Falcon™, BD Biosciences, Franklin Lakes, NJ) containing 
culture medium.  After 7-10 days in a humidified cell culture incubator operating at 37°C and 
5% CO2, cells migrated from the minced tissue to form a confluent layer on the culture dish.  
SMC were characterized by immunohistochemical staining using a mouse monoclonal antibody 
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 to human SMC α-actin as the primary (Dako Corp., Carpinteria, CA), and a fluorescein 
isothiocyanate (FITC)-conjugated rabbit antibody to mouse IgG as the secondary (Dako Corp.). 
 
2.4.4 Cell Expansion and Seeding. 
 
The seeding apparatus and methods used in this study were adapted from Sutherland et al 
[108] and Nasseri et al [109].  One vial of SMC (approximately 7.5 x 106 cells, passage 9) cryo-
preserved in culture medium supplemented with 5% dimethyl sulfoxide (DMSO; Sigma, St. 
Louis, MO) was thawed, resuspended in culture medium, and plated into three 185 cm2 flasks 
(Nuclon™∆ SoLo flask; Nalgene Labware).  After two 1:3 and one 1:2 serial passages 
(approximately 28 days), a total of 54 confluent 185 cm2 flasks (passage 13) were ready for use.  
The flasks were trypsinized (0.25% trypsin, 1 mM EDTA; GIBCO™), and the SMC were 
resuspended to yield a seeding solution of approximately 8 x 106 cells/ml, as determined by cell 
counts with a hemacytometer (Hausser Scientific, Horsham, PA). 
 
 
Figure 19 Photograph of the cell seeding apparatus. 
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 Three scaffolds were placed into each of 4 seeding tubes.  Each seeding tube consisted of 
a 50 cc centrifuge tube (Product # 91050; TPP, Trasadingen, Switzerland) fitted with a vent filter 
cap from a 50 cc tissue culture tube(Product # 91253; TPP), thereby allowing for gas exchange 
during seeding.  Seeding solution (12 ml) was added to each tube to yield a seeding density of 
approximately 17 x 106 cells/cm2.  The tubes were rotated at 8 rpm (Labquake rotisserie rotator, 
Barnstead-Thermolyne, Dubuque, IA) inside an incubator operating at 37°C and 5% CO2 for 30 
hours, with the medium was changed every 6 hours due to the high cell density (Figure 19). 
 
2.4.5 DNA Quantification Methods. 
 
DNA was quantified by a technique adapted from Kim et al [110].  For each assay, thin 
samples (~ 25 x 1 x 1 mm) were cut from SMC-seeded scaffolds along their long axis and 
weighed (average wet weight 0.03 g) prior to extraction.  Each sample was placed in a 
microcentrifuge tube and extracted in 1 ml of 0.125 mg/ml papain solution for 10 hours in a 
60°C water bath.  The 0.125 mg/ml papain solution was made immediately prior to use by 
adding L-cysteine dihydrochloride (Sigma) to a phosphate buffered EDTA solution (PBE) to a 
concentration of 10 mM, clarifying the solution using a syringe-driven filter (0.2 µm Millex®-
LG PTFE membrane; Millipore, Bedford, MA), and adding papain (minimum 10 units/mg 
(P4762); Sigma) to a concentration of 0.125 mg/ml.  The PBE solution was made beforehand by 
adding sodium phosphate dibasic (Sigma) and ethylenediaminetetraacetic acid (EDTA; Sigma) 
to deionized water at concentrations of 100 mM and 10 mM, respectively.  The PBE solution 
was balanced to pH 6.5 with 0.5 N hydrochloric acid (Sigma) and sterile filtered using a vacuum 
filtration unit (0.2 µm PES membrane; Nalgene Labware).  The extracts were assayed using the 
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 PicoGreen dsDNA quantitation kit (Molecular Probes, Eugene, OR) per the manufacturer’s 
instructions and using the blue channel of a TBS-380 Mini-Fluorometer (Turner Biosystems, 
Sunnyvale, CA). 
           
2.4.6 Extracellular Matrix Analysis Methods. 
 
Collagen, elastin, and sulfated glycosaminoglycans (S-GAG) were assayed by techniques 
adapted from Brown et al [105].  For each assay, thin samples (~ 25 x 1 x 1 mm) were cut from 
SMC-seeded scaffolds along their long axis and weighed (average wet weight 0.03 g) prior to 
extraction. 
Total collagen was extracted from samples using a solution of 0.5 M acetic acid (Sigma) 
and pepsin (1 mg/ml Pepsin A (P-7000); Sigma).  Each sample was placed in a microcentrifuge 
tube and incubated in 1 ml of extraction solution overnight (~ 16 hours) on a rocker (Orbitron 
Rotator I™; Boekel Scientific, Feasterville, PA) in a refrigerator at 2-8°C. 
Elastin was extracted using a hot oxalic acid treatment.  Samples were placed in 0.5 ml of 
0.25 M oxalic acid (Sigma) in glass centrifuge tubes and incubated on a hot plate at 
approximately 85°C for 1 hour.  Subsequently, the extracts were centrifuged at 3000 x g for 10 
minutes at 4°C.  The supernate was collected and the entire treatment was repeated two more 
times.  The supernates from the three oxalic acid treatments were pooled, loaded onto Centricon 
RC/YM-3 centrifugal filters (Millipore, Bedford, MA), and centrifuged at 3000xg for an hour at 
room temperature.  The concentrate was solublized in cold (< 5°C) Precipitating Reagent 
(Fastin™ assay kit, Biocolor Ltd., Newtownabbey, N. Ireland). 
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 Proteoglycans and S-GAG were extracted using a solution of 4 M guanidine-HCl (Sigma) 
and 0.5 M sodium acetate (Sigma).  To minimize proteolysis during the extraction, 100 µl of 
protease inhibitor cocktail stock solution was added to each extraction solution.  The stock 
solution was prepared according to the manufacturer’s recommendations by dissolving one 
Complete Mini Protease Inhibitor Tablet™ (Roche Diagnostics, Basel, Switzerland) in 1.5 ml of 
deionized water.  Each sample was incubated in 1 ml of extraction solution overnight on a rocker 
table (Boekel Scientific) in a refrigerator at 2-8°C.  Following the extraction steps, the collagen, 
elastin, and S-GAG extracts were assayed according to the guidelines provided with the Sircol™, 
Fastin™, and Blyscan™ assay kits, respectively (Biocolor Ltd., Newtownabbey, N. Ireland) using 
a Genesys 20 spectrophotometer (Thermo Spectronic, Rochester, NY). 
 
2.4.7 DNA Quantification Results 
 
The 30 hour seeding period yielded a DNA concentration of 536 ± 38 µg/g wet weight. 
Assuming a DNA content of 7.6 pg/cell [111], an average of 30 ± 2 x 106 cells/scaffold were 
retained.  Based on the theoretical seeding density of 17 x 106 cells/cm2 determined from 
hemacytometer counts, these results suggest the seeding efficiency exceeded 90%. 
   
2.4.8 Extracellular Matrix Quantification Results 
 
Collagen was not detected biochemically at the 30 hour time point, while the S-GAG 
concentration was 1393 ± 145 µg/g wet weight.  It is noteworthy that S-GAG concentration 
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 correlated strongly with DNA concentration within each group (data not shown).  Elastin was not 
detected biochemically at the 30 hour or 3 week time points. 
    
2.4.9 Effective Stiffness Measurement Results 
 
E results for the unseeded scaffolds are summarized in Figure 20.  The initial E (prior to 
sterilization) was 234 ± 27 kPa in the flex group and 249 ± 31 kPa in the static group (N.S.).  
Following 3 weeks of incubation, E of unseeded scaffolds was 249 ± 36 kPa in the flex group 
and 252 ± 20 kPa in the static group (N.S.).  There were no significant differences in E between 
any of the unseeded scaffold sample groups.  E results for the SMC-seeded scaffolds are 
summarized in Figure 24.  The initial E (prior to sterilization) was 184 ± 22 kPa in the flex 
group and 164 ± 21 kPa in the static group (N.S.). 
 
 
Figure 20 E results for unseeded scaffolds.  Values presented are the mean of the 
measurements for 6 samples.  Error bars indicate standard error.  Insignificant comparisons are 
designated by “N.S.”.  Note that the non-woven 50:50 blend PGA/PLLA scaffolds exhibited no 
significant changes in E after 3 weeks of incubation under static or cyclic flexure conditions. 
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 2.5 EFFECTS OF CYCLIC FLEXURE ON TEHV DEVELOPMENT 
 
2.5.1 Cyclic Flexure Experiments 
 
A total of 30 scaffolds were prepared for evaluation, and two separate cell expansions 
were conducted to generate the required number of SMC.  With cells harvested from the first 
expansion, scaffolds (n=6) were seeded for 30 hours and immediately subjected to flexure testing 
and DNA and ECM quantification (see below), thus establishing a baseline for subsequent 
comparisons.  With cells from the second expansion, scaffolds (n=12) were seeded as described 
previously while unseeded control scaffolds (n=12) were maintained under identical conditions 
in cell-free culture medium.  Scaffolds were incubated under static conditions for 4 days in 6 ml 
of medium in 6-well plates (Costar Ultra Low Attachment; Corning, Corning, NY).  Following 
this period, SMC-seeded scaffolds (n=6) and unseeded control scaffolds (n=6) were loaded into 
the bioreactor and subjected to unidirectional cyclic flexure at a frequency of 1 Hz and a central 
displacement of 6.35 mm (corresponding to a flexure angle of approximately 62) for 3 weeks 
(flex group).  The remaining SMC-seeded scaffolds (n=6) and unseeded control scaffolds (n=6) 
were maintained under static conditions for 3 weeks (static group).  The bioreactor was removed 
from the incubator once daily (~ 30 minutes) to change the medium. 
 
2.5.2 Histology and Immunohistochemistry Methods. 
 
Histology was performed as described previously [8].  In brief, a thin sample of each 
SMC-seeded scaffold (~ 25 x 1 x 1 mm) was fixed in 10% formalin and embedded in paraffin.  
Serial sections (6 µm) were stained with hematoxylin and eosin (H&E) for morphology, and with 
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 a modified Movat pentachrome stain for ECM components.  Immunohistochemical staining 
(Dako Corp.) was graded with respect to SMC α-actin and vimentin (- = no appreciable staining; 
+ = weak staining < 50% of cells; ++ = strong in 10-50% of cells; and +++ = strong > 50% of 
cells). 
 
2.5.3 Histology and Immunohistochemistry Results 
 
H&E and Movat pentachrome stained sections revealed dense cellularity in the periphery 
(outermost 25%) of the scaffold thickness, with sparser cellularity in the central region (Figure 
21).  The flex group appeared to exhibit a more homogenous distribution of cells across the 
thickness compared with the static group, prompting quantification of the transmural cell 
distribution (see Transmural cell distribution analysis).  Furthermore, the static group appeared to 
exhibit more cell necrosis than the flex group (data not shown).  Movat pentachrome stained 
sections revealed the ECM to consist predominantly of proteoglycans (light blue), with sparse 
aggregates of collagen (yellow) (Figure 21).  Elastin was not observed histologically.  
Immunohistochemical staining revealed a readily observable increase in vimentin expression in 
the flex group (+++; Figure 22D) compared with the static group (+; Figure 22C).  SMC α-actin 
expression levels were comparable between groups (+++; Figure 22A, B). 
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Figure 21 Modified Movat pentachrome stained sections of SMC-seeded scaffolds after 3 
weeks of incubation (100x (A, B) and 400x (C, D) original magnification).  The tissue consisted 
predominantly of cells (dark purple), proteoglycans (light blue), and collagen (yellow) (note that 
the green staining represents segments of scaffold fibers retained in the section).  Tissue 
development in the periphery of the scaffold thickness (outermost 25%) was comparable 
between the static (A, C) and flex group (B, D).  More tissue development was observed in the 
central region in the flex group (B) compared to the static group (A). 
 
2.5.4 DNA Quantification Results 
 
Following 3 weeks of incubation, the DNA concentration decreased 36% to 344 ± 5 µg/g 
wet weight in the flex group (p < 0.01) and decreased 42% to 307 ± 23 µg/g wet weight in the 
static group (p < 0.01), with no significant difference (N.S.) between the flex and static groups 
(Figure 23). 
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Figure 22 Histology and immunohistochemistry of TEHV.  Note the more homogeneous 
transmural cell distribution and the dramatic upregulation of vimentin expression with cyclic 
flexure (D and F) compared to static (A and C), respectively. 
  
2.5.5 Extracellular Matrix Quantification Results 
 
By 3 weeks incubation, the collagen concentrations were 893 ± 133 and 546 ± 111 µg/g 
wet weight in the flex and static groups, respectively, indicating a 63% increase in collagen in 
the flex group compared to the static group (p < 0.05) (Figure 23).  The S-GAG concentration 
decreased 45% to 769 ± 151 µg/g wet weight in the flex group (p < 0.01) and decreased 41% to 
819 ± 93 µg/g wet weight in the static group (p < 0.01), with no significant difference between 
the flex and static groups (Figure 23).  Elastin was not detected biochemically at any time point. 
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Figure 23 Composition of SMC-seeded scaffolds after 3 weeks of incubation.  Values 
presented are the mean of the measurements for 6 samples.  Error bars indicate standard error.  
Insignificant comparisons are designated by “N.S.”  The flex group exhibited a 63% increase in 
collagen compared to the static group (p < 0.05), with DNA and S-GAG concentrations 
comparable between groups.  No elastin was detected at the 3 week time point. 
 
2.5.6 Effective Stiffness Measurement Results 
 
E results for the unseeded scaffolds are summarized in Figure 20.  The initial E (prior to 
sterilization) was 234 ± 27 kPa in the flex group and 249 ± 31 kPa in the static group (N.S.).  
Following 3 weeks, E of unseeded scaffolds was 249 ± 36 kPa in the flex group and 252 ± 20 
kPa in the static group (N.S.). 
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Figure 24 E results for SMC-seeded scaffolds.  Values presented are the mean of the 
measurements for 6 samples.  Error bars indicate standard error.  Insignificant comparisons are 
designated by “N.S.”.  E of SMC-seeded scaffolds increased 429% in the flex group (p < 0.01) 
and 351% in the static group (p < 0.01), with a trend of increased E in the flex group (N.S.). 
      
Following 3 weeks of incubation, E of SMC-seeded scaffolds increased 429% to 978 ± 
228 kPa in the flex group (p < 0.01) and increased 351% to 748 ± 130 kPa in the static group (p 
< 0.01), with a trend of increased E in the flex group (N.S.) (Figure 24).  It should be noted that 
there was no significant difference in the initial E (prior to sterilization) between the scaffolds 
that were ultimately seeded with SMC and the unseeded scaffolds. 
The mean E was plotted versus mean collagen concentration across all sample groups, 
and a positive linear relationship was observed (r2 = 0.991).  To assess the generality of the 
relationship, data from a TEHV cultured for 9 weeks in a roller bottle was included in the 
regression, yielding an increase in the coefficient of determination (r2 = 0.996) (Figure 25).  
Note the 9-week TEHV was made with non-woven PGA/PLLA, but with a different cell (ovine 
bone marrow stem cells) [34]. 
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Figure 25 E results for SMC-seeded scaffolds plotted versus collagen concentration.  Values 
presented are the mean of the measurements for 6 samples.  Error bars indicate standard error.  In 
order to assess the generality of the relationship between E and collagen concentration, 
supplementary results from a TEHV cultured for 9-weeks in a roller bottle were included in the 
regression.  Note that the 9-week TEHV was constructed using the same PGA/PLLA scaffold 
used in the current study, but with a different cell type (bone marrow-derived stem cells).  These 
results tentatively suggest that E depends primarily on the gross collagen concentration, and that 
given a comparable collagen output per cell, a variety of cell types may give rise to TEHV 
exhibiting similar mechanical properties. 
  
2.5.7 Transmural Cell and ECM Distribution Analysis Methods. 
 
High-magnification (400x) images were necessary to colorimetrically distinguish cell 
nuclei from the surrounding ECM.  Panoramic images of transmural cross-sections were 
concatenating from ~ 15 digitized images of Movat-stained sections into a single image using 
Image Expert 2000 (Jasc Software, Inc., Eden Prairie, MN).  Red-green-blue (RGB) color values 
corresponding with cell nuclei were determined using SigmaScan Pro (SPSS, Inc., Chicago, Il), 
and the images were analyzed using a program written in Matlab (The MathWorks, Natick, MA) 
to locate the coordinates of the cell nuclei with respect to the edges of the transmural cross-
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 section.  Each data set was analyzed by a histogram of normalized cell count versus normalized 
transmural thickness.  The transmural thickness was normalized to itself (total normalized 
transmural thickness = 100%) and divided into twenty 5% increments.  The normalized cell 
count was then calculated for each increment by dividing the number of cells located within that 
particular increment by the total number of cells counted over the entire transmural cross-section.  
One cross-section from the center of a 6 µm histological section was analyzed for each of 12 
samples. 
 
2.5.8 Transmural Cell and ECM Distribution Results. 
 
A histogram of normalized cell count versus normalized transmural thickness is depicted 
in Figure 26.  The total cells counted per transmural cross-section was 287 ± 35 cells in the flex 
group and 276 ± 31 cells in the static group (N.S.).  Best-fits to the histograms were obtained 
with quadratic equations for the flex (r2 = 0.223) and the static groups (r2 = 0.896).  The 
normalized cell count was significantly different between in 55% of the 20 transmural thickness 
increments, with the flex group exhibiting a lower count in the peripheral 25% of the thickness, 
and a higher count in the central 50%. 
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Figure 26 Histogram of normalized cell count versus normalized transmural thickness.  
Significant comparisons (p < 0.05) are indicated by asterisks.  Note that the normalized cell 
count was significantly different between groups in 55% of the 5% transmural thickness 
divisions, with the flex group consistently exhibiting a lower normalized cell count in the 
peripheral 25% of the transmural thickness, and a higher normalized cell count in the central 
50% of the transmural thickness. 
 
2.6 DISCUSSION 
 
The advent of a functional TEHV could represent a milestone in the treatment of valvular 
disease, in particular for women, who carry an elevated risk of valve-related thrombosis and 
anticoagulant-related embryopathy during pregnancy [24, 25], and for pediatric patients, in 
whom the growth potential of TEHV could mitigate the need for reoperations [19, 20, 30].  
However, despite early experimental trials in humans [41, 112], questions outstand regarding the 
maturation and homeostasis of TEHV which must be addressed before further such trials are 
warranted [96].   
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 BHV fabricated from glutaraldehyde-treated soft tissues are non-viable and susceptible to 
degeneration via calcification and fatigue [27, 113].  Living TEHV, in contrast, are hypothesized 
to have the capacity to actively remodel in response to in vitro and in vivo pulsatile flow 
conditions [8, 56, 59, 60].  This response is presumably due to the stimulatory effects of 
mechanical forces on the constituent cells; a phenomenon which has been documented in a 
variety of tissue culture and tissue engineering settings.  Pulse duplicators, much like their native 
counterpart—the circulatory system—generate a complex milieu of coupled forces, any one of 
which may contribute independently or synergistically toward modulating TEHV development. 
In the current study, the specific role of cyclic flexure was investigated by subjecting 
SMC-seeded scaffolds to cyclic three-point flexure at a physiological frequency and amplitude 
for 3 weeks.  The argument for cyclic flexure is multifaceted.  It represents a major mode of 
deformation in the native valve [47], generating a distribution of stresses and strains through the 
leaflet thickness which may potentially serve to transduce specific mechanical cues to the cells of 
the individual layers.  Furthermore, from a practical standpoint, cyclic flexure is well-tolerated 
by non-woven scaffolds; the application of modest tensile strains of 2-10% induce permanent set, 
which complicates both the execution of such studies, and the interpretation of results [64, 114]. 
In a previous study we developed a bioreactor with the capacity to provide cyclic three-
point flexure to up to 12 rectangular biomaterial samples [62].  Cyclic flexure of non-woven 
PGA and PGA/PLLA scaffolds modified with a P4HB dip-coating resulted in both qualitative 
and quantitative changes in E that were consistent with a physical disruption of the P4HB.  In the 
current study we demonstrated that unmodified non-woven PGA/PLLA scaffolds incur no 
significant changes in E over 3 weeks of static or cyclic flexural incubation (Figure 20).  Thus 
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 another advantage of this study was the ability to measure tissue-dependent changes in E in 
response to cyclic flexure, independent of changes in E due to scaffold degradation.      
 
2.6.1 Cell Seeding Techniques 
 
The seeding techniques used in this study were adapted from Sutherland et al [108] and 
Nasseri et al [109], with a few noteworthy modifications.  We used a vented seeding tube in 
favor of a sealed tube, and thus were able to use the controlled gas environment of a cell culture 
incubator rather than requiring a manual gas exchange.  Furthermore, the vented seeding tubes 
allowed for the use of an inexpensive rotisserie (~ $300) rather than a hybridization oven (~ 
$1500).  In the case that larger scaffolds are required, such as for a TEHV, sterile vent filter caps 
are available for 35 x 150 mm Pyrex® hybridization tubes (Corning, Corning, N.Y.).  Caution is 
advised, however, when combining caps with different tubes, as mismatched brands (TPP® cap 
to Falcon™ tube) were found to leak. 
 
2.6.2 Tissue Development due to Cell Seeding 
 
In order to establish a baseline for subsequent comparisons, E, DNA, and ECM content 
of SMC-seeded scaffolds was evaluated immediately after the 30 hour seeding period.  A 
seeding efficiency exceeding 90% was achieved without pre-coating the non-woven PGA/PLLA 
scaffolds with supplementary cell adhesion proteins (e.g., collagen, poly-L-lysine) [61], 
suggesting that these relatively expensive—and potentially phenotype-altering [115]—factors 
may be unnecessary in this particular scaffold/cell system.  The seeding efficiency observed here 
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 corresponded well the 93% seeding efficiency reported for similar PGA/P4HB scaffolds by 
Nasseri et al [109], albeit the 17-fold higher seeding density used in the current study.  Secondly, 
a significant concentration of S-GAG (a measure of both free and proteoglycan-bound S-GAG) 
was detected biochemically, which correlated positively with DNA concentration (r2 = 0.698) 
within the sample group (data not shown).  In contrast, no collagen or elastin was detected 
biochemically at the 30 hour time point, suggesting that proteoglycan/S-GAG secretion precedes 
collagen and elastin secretion in TEHV development, potentially in a manner similar to that 
observed during fetal semilunar valve development [116].  Moreover, no significant change in E 
was measured after the 30 hour seeding period, suggesting that the attachment of cells to the 
scaffold fibers and subsequent accretion of proteoglycan/S-GAG was insufficient for increasing 
E at this early time point. 
 
2.6.3 Tissue Development due to Cyclic Flexure 
 
Following 3 weeks of incubation, E of SMC-seeded scaffolds increased 429% in the flex 
group (p < 0.01) and 351% in the static group (p < 0.01), with a trend of increased E and a 
significant 63% increase in collagen concentration (p < 0.05) in the flex group.  DNA and S-
GAG concentration were comparable between groups, and no elastin was detected 
biochemically.  It should be noted that the increase in collagen concentration in the flex group 
remained significant when the collagen concentration was normalized to the DNA concentration 
(data not shown).  Collectively, these results suggest that the collagen output per SMC was 
increased 63% in the flex group compared to the static group. 
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 2.6.4 Cyclic Flexure versus other Mechanical Factors 
 
In a recent study by Mol et al [64], the application of cyclic tensile strain (amplitude = 
9%) to myofibroblast-seeded non-woven PGA/P4HB scaffolds resulted in a 71 ± 23% increase 
in hydroxyproline concentration (a surrogate marker for collagen) compared to static incubation 
by 3 weeks.  A simultaneous increase of 112 ± 47% in DNA concentration was observed, 
suggesting that the increase in collagen concentration was due to the increased cellularity of the 
myofibroblast-seeded scaffold, and that the collagen output per cell was decreased.  In another 
study by Jockenhoevel et al [61], the exposure of myofibroblast-seeded non-woven PGA 
scaffolds to continuous laminar flow for 2 weeks resulted in an increase of approximately 52% in 
hydroxyproline concentration.  The DNA content was not quantified in that study, precluding 
estimation of the collagen output per cell.  Most strikingly, in a pioneering study by Hoerstrup et 
al [32], incubation of SMC and endothelial cell (EC)-seeded PGA/P4HB scaffolds for 21 days in 
a pulse duplicator bioreactor resulted in an increase of approximately 1075% in hydroxyproline 
concentration compared with static incubation, with a simultaneous increase of 261% in DNA 
concentration.  These data suggest that the collagen output per cell increased approximately 
409%—roughly 6.5 times that observed in the current study under conditions of cyclic flexure 
alone.   
Tentatively, these results suggest two potentially complementary hypotheses that warrant 
further investigation: i) that the stimulatory effects of cyclic flexure, cyclic tensile strain, and/or 
shear stress combine synergistically when coupled in a pulse duplicator bioreactor, and ii) that 
EC transduce mechanical signals present in pulse duplicator bioreactors (e.g., shear stress) in 
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 such as way as to augment the stimulatory effects observed in scaffolds seeded with only SMC 
or myofibroblasts. 
      
2.6.5 E versus Collagen Concentration 
 
In an effort to explain the increase in E in SMC-seeded scaffolds by 3 weeks, the mean E 
was plotted versus the mean DNA, S-GAG, or collagen concentration across all sample groups.  
While no significant correlations were found between the mean E and mean DNA or S-GAG 
concentration (data not shown), a positive linear relationship (r2 = 0.991) was found between the 
mean E and mean collagen concentration.  In order to assess the generality of the relationship, 
supplementary data from a TEHV incubated for 9 weeks in a roller bottle was included in the 
regression, yielding an increase in the coefficient of determination (r2 = 0.996) (Figure 25) [108, 
109].  These results may at first appear trivial—that the stiffness of a soft tissue is derived from 
its collagen content—however a review of the current literature suggests that this is the first 
study to demonstrate such a strong relationship in an engineered tissue constructed using a 
synthetic scaffold.  Our ability to establish this relationship likely stemmed from the sensitivity 
of the three-point flexure test in evaluating E in a low stress-strain regime.  Interestingly, the 
TEHV from which the supplementary data was derived was made using the same non-woven 
PGA/PLLA scaffold used in the current study, but with a different cell type (ovine bone marrow-
derived stem cells) [117].  These data tentatively suggest that E depends primarily on the gross 
collagen content, and that given a comparable collagen output per cell, a variety of cell types 
may give rise to TEHV exhibiting similar mechanical properties.  This finding could have 
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 important implications for the development of a clinically-feasible TEHV, as the majority of 
studies thus far have been conducted using cells derived from resected blood vessel segments. 
    
2.6.6 Histology and Immunohistochemistry. 
 
The quantitative analyses described above were corroborated by the histology, which 
revealed predominant proteoglycan and collagen accumulation consistent with a TEHV 
incubated for 14 days in a pulse duplicator bioreactor [8, 32], and suggested a more homogenous 
transmural cell and ECM distribution in the flex group (Figure 21).  Interestingly, 
immunohistochemical staining demonstrated a significant increase in vimentin expression in the 
flex group (+++; Figure 22D) compared with the static group (+; Figure 22C), suggesting that 
cyclic flexure contributes to the maintenance of vimentin expression in TEHV, and possibly in 
the native ovine pulmonary valve (PV) [8].  These results are supported by previous reports in 
which the expression and organization of the intermediate filament vimentin has been correlated 
with in vivo hemodynamic parameters in endothelial cells [118], and with mechanical loading in 
chondrocytes [119].  In contrast to vimentin, SMC α-actin expression was elevated with respect 
to the native ovine PV (-; [8]) in both sample groups (+++; Figure 22A, B) [8].  Collectively, the 
immunohistochemical staining suggests that cyclic flexure induces a VA-type myofibroblast 
phenotype [120] consistent with the progression of TEHV development observed in a pulse 
duplicator bioreactor in vitro, and following implantation in vivo, yet independent of the 
additional mechanical factors (e.g., cyclic shear stress, pressure) generated by pulsatile flow [8]. 
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 2.6.7 Transmural Cell Distribution Analysis 
 
The transmural cell distribution quantified by digital image analysis agreed well with 
microscopic observations, suggesting that cyclic flexure induces a more homogenous transmural 
cell distribution, with a lower fraction of nuclei localized in the peripheral 25% of the transmural 
thickness, and a greater fraction of nuclei localized in the central 50% of the transmural thickness 
compared with the static group.  These results agreed with those of a recent study in which a 
similar homogenization of the transmural cell distribution was induced by cyclic uniaxial tensile 
loading of a gelatin sponge scaffold seeded with human heart cells [121].  It is unclear if this 
effect was due explicitly to the transmural distribution of tensile and compressive stresses and 
strains associated with flexure, or simply a result of increased convective mass transport induced 
by the cyclic flexure of the scaffold.  It is noteworthy that no significant difference in thickness 
was measured between the flex and static groups (data not shown).  Furthermore, while the 
transmural ECM distribution appeared to parallel the cell distribution, we were unable to 
establish this quantitatively, as the difference in the RGB color value of ECM components in 
digitized photomicrographs of Movat pentachrome stained sections was not sufficient for reliable 
thresholding. 
 
2.6.8 Mechanotransduction in TEHV. 
 
In the current study we demonstrated that cyclic flexure can independently yield many 
aspects of TEHV development observed in pulse duplicator bioreactors; however the mechanism 
by which mechanotransduction occurs remains unknown.  In a study by Nikolovski and Mooney 
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 [85], SMC adhesion to PGA was shown to occur via vitronectin and fibronectin adsorbed from 
the serum, suggesting that integrins αvβ5 and α5, respectively may act as mediators of 
mechanotransduction.  This conclusion is supported by a study in which integrin αvβ3-mediated 
mechanotransduction was quantified in SMC [71].  However, while SMC adhesion to ECM via 
integrins is predominant in vivo, tissue remodeling events in which the ECM is degraded induce 
increased cell-cell contacts via cadherins [86].  Moreover, cadherins have been demonstrated to 
mediate mechanotransduction in human gingival fibroblasts [81].  Thus, since SMC-seeded 
scaffolds are actively remodeling tissues, as evidenced by their elevated levels of SMC α-actin 
expression (Figure 22A, B), the potential role of cadherins in mediating mechanotransduction in 
TEHV warrants further investigation. 
 
2.6.9 Summary 
 
The current study is the first to demonstrate that cyclic flexure can independently 
influence the in vitro development of a TEHV.  A trend of increased E, a 63% increase in 
collagen concentration (p < 0.05), increased vimentin expression, and a more homogenous 
transmural cell distribution were observed in SMC-seeded scaffolds subjected to 3 weeks of 
cyclic flexure compared to static incubation.  The combination of a simple mode of deformation 
with a mechanically stable scaffold yielded a model system in which tissue-dependent changes in 
E could be measured independent of the confounding effects of scaffold degradation.  Thus, the 
goal of this study was not to reproduce the material properties of native semilunar valve tissue, 
but rather to develop a fundamental understanding of how cyclic flexural loading affects the 
development of TEHV, in particular the development of ECM in TEHV, and, concomitantly, E.   
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 A positive linear relationship (r2 = 0.996) was found between the mean E and mean 
collagen concentration (Figure 25), to the best of our knowledge a first in the case of an 
engineered tissue based on a synthetic scaffold.  The correlation depicted in Figure 25 may be 
useful in predicting the mechanical properties of a TEHV based on a more rapidly degrading 
non-woven scaffold, as it provides a starting point for estimating E, given knowledge of the 
degradation profile of the unseeded scaffold.  A comparison with previous studies on the effects 
of cyclic tensile strain, laminar flow (shear stress), and a pulse duplicator bioreactor tentatively 
suggests that the stimulatory effects of individual mechanical factors may combine 
synergistically in a coupled mechanical environment, and/or that EC may modulate the basal 
response of SMC-seeded TEHV to mechanical stimulation.  Further in vitro studies, in which the 
coupled mechanical environment of a pulse duplicator bioreactor is reconstructed piecewise 
(e.g., independently combining flexure, flow, and tension), would be necessary in order to better 
understand and control the development of a TEHV, and may help illuminate the role of 
mechanical factors in the development and homeostasis of native and TEHV in vivo. 
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3.0 THE FLEX-STRETCH-FLOW BIOREACTOR 
 
3.1 INTRODUCTION 
  
While rudimentary aspects of TEHV development (e.g., cell proliferation, collagen 
secretion) can be stimulated in vitro by growth factors [122], higher level tissue morphogenesis 
(e.g., layer specialization in TEHV [8]) is seldom observed without mechanical stimulation.  In 
contrast to growth factors, which generally interact with only one cell surface receptor, 
mechanical forces can be transduced through multiple cell surface receptors, deformation of 
intracellular cytoskeletal proteins, as well as deformation of the nucleus and its contents, and 
thus one mode of mechanical stimulation may initiate multiple signal transduction pathways.  
Moreover, the pleiotropic actions of mechanical stimulation can both accelerate the de novo 
synthesis of collagen [61, 63, 64], as well as guide its structural organization [123, 124].  For 
example, while DNA and collagen can approach native-like concentrations over 4 weeks static 
culture with basic fibroblast growth factor (bFGF) [122], it is only with 3-4 weeks bioreactor 
cultivation that layer stratification begins [32, 63], and not until several months in vivo that a tri-
layered morphology reminiscent of a native semilunar valve develops [8, 33]. 
While it remains to be determined which morphological features of TEHV explants are 
due solely to hemodynamics and which to host cell infiltration and remodeling, mechanical 
forces are expected to play a significant role.  As introduced in Section 1.5, previous studies have 
demonstrated that perturbation of the in vivo mechanical environment can influence embryonic 
65 
 valvulogenesis [49], and can lead to pathological remodeling of the native mitral valve [50, 51].  
Moreover, while few long-term in vitro bioreactor studies have been reported, in at least one 
study reported by Kim et al. [115] it was observed that TE smooth muscle continues remodeling 
for at least 20 weeks in response to in vitro cyclic stretch, further suggesting that the coupled 
mechanical stimuli of pulsatile flow contribute to the in vivo development of TEHV.     
 Pulsatile flow loop bioreactors provide pressure and flow stimuli to native and engineered 
tissues targeted within the context of the tissue’s ultimate physiomechanical function. [59].  
More advanced designs incorporate control algorithms and regulators for independently 
modulating pressure and flow, thereby allowing for the simulation of sub to supra-physiologic 
hemodynamic conditions [125].  Thus, for the purpose of mechanically conditioning 
anatomically-shaped TEHV for implantation, pulsatile flow loop bioreactors are virtually 
indispensable.  However, for developing a fundamental understanding of how individual modes 
of mechanical stimulation influence the tissue formation and remodeling process, a different 
bioreactor approach in which tissue deformations and strains are decoupled from flow and 
pressure stimuli is necessary.  Toward this goal, we and others have designed bioreactors for 
investigating the independent effects of flexure [62, 63], tension [64], and fluid shear stress [61] 
on TEHV. 
 We previously demonstrated that cyclic flexure can independently stimulate many 
aspects of TEHV development observed in pulse duplicators, including increased collagen 
synthesis with concomitant increases in effective stiffness [63].  Interestingly, the increase in 
collagen output per cell observed under conditions of cyclic flexure (+ 63%) [63] was 
comparable to that observed by others under conditions of continuous laminar flow (+ 52%) [61] 
and significantly less that that observed in pulsatile flow loop bioreactor studies (+ 409%) [32].  
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 Collectively, these findings suggested that the individual modes of mechanical stimulation may 
act synergistically to accelerate or amplify collagen synthesis.  Accelerated collagen synthesis is 
critically important when using scaffolds based on rapidly degrading synthetic polymers such as 
poly(glycolic acid) (PGA), as the kinetics of scaffold degradation mandate a commensurate rate 
of tissue formation for the maintenance of structural integrity.  If systematically quantified, the 
unique effects of individual mechanical stimuli could be recombined in novel ways to optimize 
in vitro TEHV development. 
 In the current paper we describe a novel bioreactor which will allow us to explore the 
independent and coupled effects of cyclic flexure, stretch, and flow (FSF) on TEHV tissue 
formation in vitro.  Cyclic flexure and stretch can be applied via a linear actuator and novel 
“spiral-bound” tissue-gripping system.  The FSF bioreactor generates flow via a magnetically-
coupled paddlewheel rather than an external pump circuit, providing a closed system to help 
ensure sterility, while maintaining a compact footprint for placement inside a standard cell 
culture incubator.  Toward qualifying the FSF bioreactor design for subsequent experiments 
using cell-seeded scaffolds, we report here on computational simulations assessing the response 
of flow and fluid shear stress profiles to changes in paddlewheel angular velocity, culture 
medium dynamic viscosity, and the spatial arrangement of specimens within the flow field.  The 
CFD model was experimentally validated by particle image velocimetry (PIV). 
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3.2 METHODS 
 
3.2.1 FSF bioreactor design. 
 
The design methodology and materials of construction used in the FSF bioreactor was 
similar to that for our previous cyclic flexure bioreactor [62, 63].  The structural components of 
the FSF bioreactor were designed using Solidworks 3D CAD software (Solidworks, Corp., 
Concord, MA).  Machined parts were fabricated from polycarbonate by Astro Automation, Inc. 
(Irwin, PA).  Rubber bellows were custom ordered from Minor Rubber Company, Inc. 
(Bloomfield, NJ).  The paddlewheel was fabricated by high resolution stereolithography 
(FineLine Prototyping, Inc., Raleigh, NC) using a Viper Si2™ SLA® system (3D Systems Corp., 
Valencia, CA) and a high strength, water resistant resin (ProtoTherm 12120™; DSM Somos®, 
Newcastle, DE) (Figure 29).  Two cylindrical (1/4 x 3/4 in.) nickel-coated, grade N38 
neodymium (NdFeB) magnets (K&J Magnetics, Inc., Jamison, PA) were press-fit into 
prefabricated slots on one side of the paddlewheel.  The magnets were oriented with their poles 
in the same direction.  Synthetic sapphire ring jewel bearings (Bird Precision, Waltham, MA) 
were press-fit into either side of the paddlewheel to provide the low starting torque and friction 
characteristics necessary for effective magnetic torque transmission.  All metallic components 
were made from 316 stainless steel.  Platinum-cured silicone tubing will be used for culture 
medium perfusion. 
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Figure 27 Photograph of the FSF bioreactor. 
 
The bioreactor consists of two identical chambers, each containing 12 stainless steel 
“stationary posts” to which tissue specimens can be affixed (Figure 27).  To attach specimens 
we developed an inexpensive yet high effective “spiral-bound” grip method.  Spiral grips were 
fabricated by manually winding a length of stainless steel wire (316V, 0.009” diameter; Small 
Parts, Inc., Miami Lakes, FL) about a 2 mm diameter steel mandrel using a drill.  Grips were cut 
to length and twisted onto both sides of specimens (Figure 28A).  The device can thus 
accommodate a total of 24 rectangular samples (maximum dimensions approximately 25 mm x 
7.5 mm x 2 mm).  Cyclic flexure and/or stretch were applied by an environmentally-sealed linear 
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 actuator (UltraMotion, Mattitick, NY).  The piston of the actuator is rigidly coupled to a cross-
arm in the form of a T-junction.  Conversely, the cross-arm is rigidly coupled to the arm of each 
chamber (Figure 27).  Frequency, amplitude, acceleration, and deceleration profiles can be 
developed using Windows-based Si Programmer software (Applied Motion Products, 
Watsonville, CA).  The structural elements of the device can be cold gas sterilized by ethylene 
oxide, and the entire device was designed to be operated inside of a standard humidified 
incubator. 
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Figure 28 Photograph of a scaffold specimen “spiral-bound” between stationary and 
movable posts (A).  Stainless steel wire (316V, 0.009” diameter; Small Parts, Inc., Miami Lakes, 
FL) was manually turned using a drill and mandrel (2 mm diameter) to form the spiral tissue 
binders.  The binders were then wound through the scaffold specimens.  Photograph of scaffold 
specimens in the neutral configuration (B).  Scaffold specimens can be subjected to cyclic tensile 
loading by moving the movable posts to the left via the linear actuator (not shown).  Photograph 
of scaffold specimens subjected to a tensile deformation (C).  To ensure that all scaffold 
specimens bend in the same direction they are gently pushed in one particular direction using 
sterile forceps during after they are situated in the bioreactor.  Scale bars = 1 cm. 
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Figure 29 Overview of the paddlewheel flow system.  Detail photograph of a single 
paddlewheel (A).  Two neodymium magnets (1) are press-fit into holes in one side of the 
paddlewheel and are oriented with their poles in the same direction.  Sapphire ring jewel 
bearings (2) are press-fit into holes on both sides of the paddlewheel and mate with stainless steel 
pivots (3) installed in the main chamber and opposite wall of the FSF.  Detail photograph of a 
customized magnetic stirrer (B).  The motor was installed in a custom housing (1) and the stock 
magnets were replaced with powerful neodymium magnets (2) to provide stronger torque 
coupling.  The motor speed is controlled by a potentiometer (3).  Overview photograph of the 
paddlewheel flow circuit (C).  The magnetic stirrer (not shown) attaches to the FSF bioreactor 
chamber and mates with the paddlewheel.  The fluid flow circuit is shaded gray and the direction 
of culture medium flow is indicated by black arrows.  Scale bars = 1 cm. 
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 3.2.2 Particle Image Velocimetry 
 
The Particle image velocity (PIV) device used to experimentally quantify the flow field 
generated by the paddlewheel has been described previously [126].  In brief, the FSF bioreactor 
was filled with a solution of neutrally buoyant fluorescent polymer micro-spheres (35-6C, Duke 
Scientific, Palo Alto, CA) in 37°C water.  The paddlewheel angular velocity was set to a 
predetermined value (350, 500, 1000, 1500, 2000) using a non-contact digital laser tachometer 
(ST6236B; Reed Instruments, Quebec, Canada).  The FSF was then positioned for visualization 
by the PIV device (Figure 30).  A Nd:YAG laser system (Solo PIV III 15 Hz, New wave 
Research Inc., Fremont, CA) emitting a 532 nm laser pulse was focused into a 2mm thick sheet 
using a cylindrical lens (Edmund Optics, Barrington, NJ), and was projected into the FSF from 
above (note that a temporary transparent lid was positioned directly atop the fluid to mimic the 
configuration of the 2-D CFD simulations).  Particles were imaged through the transparent side 
of the FSF by a Kodak CCD camera (Megaplus ES 1.0, Eastman Kodak Company, San Diego, 
CA), a close-up lens (60 mm f2.8D AF Micro-Nikkor, Nikon, Japan), and XCAP-standard v.2.2 
imaging software (EPIX Inc, Buffalo Grove, IL).  Sets of two sequential images were captured 
within microseconds using the triggered double exposure mode of the camera, a frame grabber 
(PIXCI® D2X, EPIX Inc, Buffalo Grove, IL), and an eight analog output data acquisition card 
(NI-6713, National Instruments, Austin, TX).  Images thus acquired were analyzed using custom 
software to extract the velocity profiles for subsequent comparison with CFD simulations. 
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Figure 30 Particle image velocimetry (PIV) setup for experimental validation of the 2-D 
CFD models.  The PIV device and experimental methods have been described previously by 
Budilarto et al.  The pulsed laser sheet (1) was directed by a series of mirrors and lenses (2) into 
the top of the FSF bioreactor (3).  The camera (4) imaged the laser-illuminated particles.  The 
path of the laser sheet is highlighted by a red dashed line. 
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 3.2.3 CFD Simulations 
 
To validate the flow rate and fluid shear stress patterns generated by the novel 
paddlewheel flow system, we developed a computational fluid dynamics (CFD) model using 
GAMBIT® and FLUENT® (v6.2) software (Fluent, Inc., Lebanon, NH).  The geometry of the 
paddlewheel and associated components of the FSF Bioreactor bath were exported from 
Solidworks® (Solidworks, Corp., Concord, MA) and reconstructed in the preprocessor 
GAMBIT.  For simulating the relationship between paddlewheel rotational velocity and flow 
rate, a two-dimensional (2-D) model was developed in GAMBIT using a dynamic mesh of 
50,000 triangular elements for the fluid phase (Figure 31A).  The unsteady-state simulation was 
solved using FLUENT.  Once the velocity profiles were solved using the 2-D model, velocity 
profiles were extruded into the third dimension and directly applied upstream of the tissue 
specimens in a local 3-D simulation to predict the wall shear stress profiles on the various 
specimens (Figure 32).  Specimen-to-specimen variations in wall shear stress were not 
significant.   
 
3.3 RESULTS 
 
3.3.1 FSF bioreactor operation results 
 
Operation of the bioreactor was straightforward and similar to our previously described 
cyclic flexure bioreactor [62, 63].  The culture medium capacity of each chamber was 
approximately 300 ml.  Compared with the ~72 ml per chamber capacity of our previous cyclic 
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 flexure bioreactor, this allowed for a longer time between culture medium changes (generally 
every 3 days, versus everyday in the previous bioreactor).  Loading scaffold specimens into the 
FSF was simplified by the spiral-bound gripping method (Figure 28A).  Using sterile forceps, 
the stainless steel spiral grips could be positioned on the posts within the FSF with relative ease 
beneath a laminar flow hood. 
   
3.3.2 2-D CFD simulation results 
 
The 2-D simulations were run at 5 different paddlewheel rotational velocities for the 
standard culture medium dynamic viscosity (µ = 0.0076 dyne-s/cm2), and at the lowest and 
highest velocities for two higher viscosity (µ = 0.0223 and µ = 0.037 dyne-s/cm2) (Figure 31).  
The highest viscosity value corresponds with the viscosity of blood at a physiologic shear rate, 
and can potentially be simulated by adding the appropriate concentration of Dextran 40.  The 
average velocities predicted using the 2-D model are summarized in Table 1.  Results indicated 
that viscous energy loses along the length of the fluid flow circuit resulted in significantly 
decreased fluid velocities with increased fluid viscosity. 
 
Table 1 Average culture medium velocities as a function of culture medium dynamic 
viscosity and paddlewheel rotational velocity. 
Dynamic 
Viscosity 
(dyne-s/cm2) 
350 RPM 500 RPM 1000 RPM 1500 RPM 2000 RPM 
0.0076 0.167 cm/s 0.392 cm/s 1.68 cm/s 3.73 cm/s 5.79 cm/s 
0.0223 0.060 cm/s n/a n/a n/a 2.15 cm/s 
0.037 0.048 cm/s n/a n/a n/a 1.34 cm/s 
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Figure 31 Two-dimensional CFD model and PIV experimental validation results.  The 2-D 
model consisted of ~50,000 dynamic fluid elements (A).  CFD predictions (solid lines) and PIV 
experimental measurements (open circles) of the x-component velocity profile for 1000 (B), 
1500 (C), and 2000 (D) RPM paddlewheel rotational velocities.  Similar agreement was found 
for velocity profiles at 350 and 500 RPM (data not shown).  Depicted velocity profiles were 
taken at a dynamic viscosity (µ) of 0.0076 dyne-s/cm2 corresponding with the viscosity of water 
(and culture medium) at 37°C.   Y-component velocities were approximately three orders of 
magnitude less than x-component velocities and thus were not considered in the analysis. 
 
 
3.3.3 3-D CFD simulation results 
 
The 3-D simulations were run at 5 different paddlewheel rotational velocities for the 
standard culture medium dynamic viscosity (µ = 0.0076 dyne-s/cm2), and at the lowest and 
highest velocities for two higher viscosity (µ = 0.0223 and µ = 0.037 dyne-s/cm2).  A minimal 
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 FSF bioreactor bath geometry was constructed using GAMBIT (Figure 32).  The upstream 
velocity and downstream pressure profiles obtained from the 2-D simulations were applied as 
boundary conditions at points 1 and 2, respectively.  The Reynold’s number and average shear 
stress per specimen was plotted as a function of paddlewheel rotational velocity (Figure 33).  At 
the standard culture medium viscosity, the maximum predicted fluid shear stress was 1.145 ± 
0.038 dyne/cm2.  Inter-specimen (Table 2) and intra-specimen (Figure 34) variations in shear 
stress were not significant. 
 
 
Figure 32 Specimen configurations within the three-dimensional CFD model.  In the first 
specimen configuration analyzed, a total of 8 specimens (25 x 7.5 x 1 mm) were located in two 
rows of 4 (A).  In the second specimen configuration (not shown), a total of 12 specimens were 
located in two rows of 6.  Note that in the actual CFD simulations the 3-D model was partitioned 
along its symmetry plane to minimize processing time.  The half-chamber 3-D model consisted 
of ~50,000 fluid elements. 
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Figure 33 Three-dimensional CFD model results.  The CFD predicted Reynold’s number 
versus paddlewheel rotational velocity (A).  Note that Reynold’s number values were well within 
the laminar flow region (< 1000) within the vicinity of the specimens.  The CFD predicted 
average fluid shear stress per specimen versus paddlewheel rotational velocity (B).  The lowest 
dynamic viscosity simulated (m = 0.0076 dyne-s/cm2) corresponds to water (and culture 
medium) at 37°C, while the highest (m = 0.037 dyne-s/cm2) simulates the viscosity of blood at a 
physiologic shear rate.  Experimentally, the culture medium viscosity can be augmented by the 
addition of appropriate concentrations of Dextran. 
 
Table 2 Inter-specimen variation in fluid shear stress as a function of paddlewheel 
rotational velocity.  Fluid shear stress (τ) values are reported in units of dyne/cm2 with 
corresponding standard deviations (σ).  Specimens were located symmetrically about the central 
axis of each FSF bioreactor chamber, and thus only 4 of the 8 specimens are presented below. 
350 RPM 500 RPM 1000 RPM 1500 RPM 2000 RPM Specimen 
location τ σ τ σ τ σ τ σ τ σ 
inflow 
proximal 0.012 0.006 0.032 0.018 0.202 0.129 0.602 0.401 1.157 0.765 
inflow 
distal 0.013 0.006 0.034 0.018 0.221 0.142 0.676 0.441 1.311 0.839 
outflow 
proximal 0.012 0.006 0.031 0.016 0.186 0.102 0.541 0.296 1.020 0.552 
outflow 
distal 0.013 0.006 0.032 0.016 0.194 0.103 0.579 0.311 1.114 0.590 
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Figure 34 Intra-specimen variation in fluid shear stress at paddlewheel rotational velocities 
of 350 RPM (A) and 2000 RPM (B).  Specimens designated as proximal were located nearest the 
wall of the FSF bioreactor chamber, and distal specimens were located toward the center of the 
chamber.  Note that the highest fluid shear stress values (red) were predicted at the inflow (right 
hand) side of each specimen, and that the lowest values (blue) were predicted along the bottom 
edge of each specimen.  Note that the color scale bar for 350 RPM ranges from 0 to 0.02 
dyne/cm2 (A), and that the color scale bar for 2000 RPM ranges from 0 to 2.21 dyne/cm2 (B). 
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3.4 DISCUSSION 
 
 Semilunar heart valves are subjected to three major modes of mechanical loading due to 
pulsatile blood flow: tensile loading during valve closure (i.e., diastole), flexural loading during 
the opening and closing phases, and fluid shear stress during ventricular ejection (i.e., systole).  
In the native valve in vivo, and in a pulse duplicator bioreactor (i.e. pulsatile flow bioreactor) in 
vitro, the three major modes of mechanical loading are inextricably coupled (e.g., pressure-flow 
relationship), thus precluding isolation of the independent effects of any individual mechanical 
factor.  In the flex-tension-flow (FSF) bioreactor these candidate modes of mechanical 
stimulation are decoupled, allowing for independent control of tensile, flexural, or fluid shear 
stress loading. 
 The reported speed range of the Corning 75mm immersible stirrer is 350-2000 RPM.  
Thus, using experimentally validated CFD models with a culture medium dynamic viscosity 
equal to that of water (0.0076 dyne-s/cm2 at 37°C), the average shear stress range generated in 
the FSF bioreactor was predicted to be ~ 0.0125 – 1.1505 dyne/cm2.  While this range of shear 
stresses is much lower than the physiological shear stresses to which a native aortic valve is 
exposed to during systole (3-79 dyne/cm2; Weston et al. [127]), studies have demonstrated that 
shear stresses in this relatively low range can effect collagen concentration in a TEHV similar to 
that under investigation in the current study (e.g., ~ 46% increase in hydroxyproline 
concentration upon 7 days exposure to ~ 0.066 dyne/cm2, followed by a step change to ~0.13 
dyne/cm2 for an additional 7 days; Jockenhoevel et al. [61]).  (Note that we estimated the shear 
stresses generated in the study by Jockenhoevel et al. from the dimensions of their laminar flow 
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 chamber using the equation τw = (6µQ)/(bh2) [128], in which Q is the flow rate, b is the width of 
the rectangular flow chamber, and h is the height of the rectangular flow chamber). 
We initially hypothesized that the shear stresses could be increased by increasing the 
viscosity of the culture medium to approximate the viscosity of blood at physiological shear rates 
(~ 0.037 dyne-s/cm2 at 37°C).  This can be accomplished by adding the appropriate amount of 
the polysaccharide Dextran-40 to the culture medium.  We found, however, that the increased 
viscous loses along the length of the fluid flow circuit led to significant decreases in velocity that 
abrogated any effect of increased dynamic viscosity of fluid shear stress.  Thus, the most feasible 
way of increased the fluid shear stress range of the FSF would be to incorporate a faster motor 
for spinning the paddlewheel. 
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4.0 INDEPENDENT AND COUPLED EFFECTS OF CYCLIC FLEXURE AND 
LAMINAR FLOW ON ENGINEERED HEART VALVE TISSUE FORMATION BY 
BONE MARROW-DERIVED MESENCHYMAL STEM CELLS 
    
4.1 Introduction 
 
As introduced in Section 1.1.3, the interstitium of native semilunar heart valve leaflets are 
populated by a mixed community of cells referred to as valvular interstitial cells (VIC).  These 
VIC express a phenotype intermediate between smooth muscle cells (SMC) and fibroblasts, and 
have been characterized as VA-type myofibroblasts due to their dual expression of vimentin and 
alpha smooth muscle actin (α-SMA) [8].  At the blood-leaflet interface, the leaflets are covered 
with a confluent lining of valvular endothelial cells (VEC).  VEC, while similar in many respects 
to other vascular endothelial cells, due express certain unique phenotypic and morphologic 
attributes [15, 16].  In designing a TEHV for potential future clinical applications, it is generally 
assumed that some other cell types will be utilized in lieu of the native VIC and VEC, which 
could only be isolated by highly invasive biopsy techniques.  As introduced in Section 1.4, early 
attempts to develop a TEHV have successfully relied on carotid artery-derived vascular smooth 
muscle cells and endothelial cells [32].  In fact, TEHV explanted 20 weeks after implantation in 
the pulmonary circulation of sheep exhibited many of the phenotypic characteristics of the native 
ovine pulmonary valve, included prominent vimentin expression and diminished a-SMA 
expression that was localized primarily to the immediate sub-endothelial layer [8].  However, as 
the TEHV becomes more refined, the reality of potential future clinical applications has 
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 demanded the development of novel autologous cell sources that could be isolated relatively 
non-invasively from patients.  In light of their potential to transdifferentiate toward a 
mesenchymal phenotype, peripheral blood-derived endothelial progenitor cells (EPC) have 
received much attention, as they could potentially be used as a single source for generated VIC-
like and VEC-like cells for TEHV [15, 37, 129].  However, while the utility of EPC in 
developing a TEHV is still under investigation, preliminary functional assessment of EPC-
seeded nonwoven scaffolds under mechanically active conditions suggest that EPC may require 
specialized culture medium/scaffold coating combinations in order to optimize EPC attachment 
and ECM synthesis.  In tandem with EPC-based studies, investigators have also considered bone 
marrow-derived mesenchymal stem cells (BMSC) as a potential single cell source for TEHV 
[33-35, 130]. 
Bone marrow-derived mesenchymal stem cells (BMSC) represent a potentially attractive 
cell source for use in cardiovascular tissue engineering. BMSC can be isolated from adult 
patients relatively non-invasively, and BMSC have a pluripotent differentiation potential—
previous studies have demonstrated their capacity to differentiate into bone, cartilage, tendon, 
fat, muscle, and early progenitors of neural cells.  While the pluripotency of BMSC is potentially 
attractive, it also mandates stringent control over the differentiation process such that unwanted 
differentiation events are avoided. 
Sutherland et al. [33] recently demonstrated that BMSC isolated from juvenile sheep can 
be used to fabricate TEHV, and that these TEHV can successfully function in the pulmonary 
outflow tract of sheet for at least 8 months.  In this landmark study—the first long-term animal 
trial of a TEHV fabricated using non-invasively accessible adult stem cells—it was shown that 
BMSC-seeded scaffolds evolved a tri-layered morphology reminiscent of a native semilunar 
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 valve.  Importantly, though BMSC-seeded TEHV stained negative for endothelial cell markers 
prior to implantation, 8 month explants exhibited a continuous von Willebrand factor (vWF) 
positive surface.  It was not clear whether the endothelial cells were host derived, or whether 
they provided evidence of mesenchymal-to-endothelial transdifferentiation of the seeded BMSC, 
however previous 2-D tissue culture studies have shown that murine embryonic mesenchymal 
progenitors can undergo such transdifferentiation events in response to in vitro laminar flow 
[131].  Other studies have demonstrated that human BMSC can transdifferentiate into endothelial 
cells in vitro in response to low (2%) fetal calf serum and 50 ng/ml VEGF [132]. 
Toward developing optimized bioreactor conditioning regimens for BMSC-seeded 
TEHV, in the current study we investigated the independent and coupled effects of cyclic flexure 
and laminar flow on BMSC-seeded nonwoven scaffolds.  BMSC were isolated from juvenile 
sheep, expanded in vitro, and seeded onto nonwoven 50:50 blend PGA/PLLA scaffolds.  
Following 4 days static culture, BMSC-seeded scaffolds were loaded into the FSF bioreactor and 
either maintained under static conditions (static group), or subjected to cyclic flexure (flex 
group), laminar flow (flow group), or combined cyclic flexure and laminar flow (flex-flow 
group) for 1 and 3 weeks.  At each time point, specimens were characterized by DNA and ECM 
content, tissue effective stiffness (E), and by histology, immunohistochemistry, and scanning 
electron microscopy. 
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4.2 Methods 
 
4.2.1 Bone marrow mesenchymal stem cell (BMSC) isolation 
 
Bone marrow mesenchymal stem cells (BMSC) were isolated and characterized by Virna 
L. Sales, M.D. at Children’s Hospital Boston as described previously by Sutherland et al [33].  
Juvenile sheep (Dover/Suffolk cross) were sedated with ketamine at 25 mg/kg IM and xylazine 
at 0.05 mg/kg IM, intubated, and maintained on an inhaled 0.5% to 2% isoflurane/oxygen 
mixture.  A stab incision was made over the mid part of the sternum and approached with an 11-
gauge bone marrow biopsy needled (MDTech).  Then, 15 ml of marrow was aspirated into a 
syringe containing 5 ml of 1000-IU/ml heparin sodium (Elkins-Sinn, Inc.).  BMSC were 
obtained from ovine bone marrow using the method of Pittenger et al [133].  Medium was 
changed at 24, 48, and 72 hours, by which time colonies of spindle-shaped cells were observed.  
Cells were passaged at low density (<104 cells/cm2) into successively larger tissue culture flasks 
and then into 1750 cm2 polystyrene roller bottles (Corning, Inc.).  The culture medium 
comprising DMEM supplemented with 10% FBS and 1% antibiotic/antimycotic solution 
(GIBCO).  Air in the roller bottles was displaced with a 5% CO2/air mixture, and bottles were 
rotated at 0.2 cycles per minute and 37°C.  Cells were characterized by indirect 
immunofluorescence prior to use. 
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 4.2.2 Indirect Immunofluorescence 
 
BMSC were characterized by indirect immunofluorescence by Virna L. Sales, M.D. at 
Children’s Hospital Boston as described previously by Sutherland et al. [33].  Cells were plated 
into 8-well chamber slides (Nalge Nunc International) for 24 hours before staining.  Cells were 
washed with PBS and fixed with cold methanol.  Slides were incubated for 1 hour at room 
temperature with mouse anti-human vimentin monoclonal antibody (Dako) at 1:300 dilution or 
anti-α-smooth muscle actin (SMA) monoclonal antibody (Sigma) at 1:1000 dilution.  Cells were 
then washed in PBS and incubated with FITC-conjugated goat anti-mouse IgG as a secondary 
antibody (Vector) at 1:200 dilution.  Cells were examined by fluorescence microscopy with a 
Nikon microscope and IP Laboratory imaging software.  Characterized BMSC (passage 4) were 
cryopreserved in culture medium supplemented with 5% dimethyl sulfoxide (DMSO) and were 
shipped to University of Pittsburgh on dry ice. 
 
4.2.3   Cell expansion and scaffold seeding 
 
The general BMSC expansion and seeding techniques were the same as described above 
in Section 2.4.4 with the exception that twenty 500 cm2 flasks (Nuclon™∆ TripleFlask; Nalgene 
Labware) were used in lieu of the 54 T185 flasks used previously.  The culture medium was the 
same as described in Section 2.4.2, with the exception that bFGF was not added during BMSC 
expansion.  The PGA/PLLA scaffolds were prepared the same as described above in Section 
2.4.1, with the exception that scaffolds were “spiral-bound” by threading with stainless steel 
spiral wires as described above in Section 3.2.1 prior to ethylene oxide sterilization.  Following 
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 30 hours seeding, BMSC-seeded scaffolds were maintained in static culture for 4 days prior to 
loading into the FSF bioreactor.    
 
4.2.4 Independent and coupled cyclic flexure and laminar flow bioreactor studies 
 
A total of 48 BMSC-seeded scaffold specimens were prepared for evaluation in this 
study.  Two separate runs of the bioreactor were required to test all of the specimens.  In the first 
run, BMSC-seeded scaffolds were loaded into the bioreactor under aseptic conditions and 
incubated under static (n=12) or cyclic flexure (n=12) conditions.  Cyclic flexure was applied at 
a frequency of 1 Hz and ∆κ of 0.554 mm-1.  In the second run, BMSC-seeded scaffolds were 
incubated under laminar flow (n=12) or laminar flow/cyclic flexure (n=12) conditions.  Laminar 
flow was applied by setting the paddlewheel rotational velocity to the maximum value of 2000 
RPM, which was shown above to yield an average fluid shear stress of 1.1505 dyne/cm2.  
Specimens from each mechanical loading group were removed following 1 (n=6) and 3 (n=6) 
weeks.  Following removal from the bioreactor, specimens were characterized as described 
above in Sections 2.2.5, 2.2.6, 2.4.5, 2.4.6, and 2.5.2. 
 
4.2.5 Immunohistochemistry 
 
In addition to the histology and immunohistochemistry described in Section 2.5.2, 
BMSC-seeded scaffolds were also evaluated for expression of collagen type I, collagen type III, 
fibronectin, CD31, and vWF. 
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 4.3 RESULTS 
 
4.3.1 DNA and ECM assay results 
 
Following 1 week of incubation, the average DNA concentrations were 29.1 ± 3.8, 15.1 ± 
1.3, 45.8 ± 3.6, and 59.8 ± 8.5  µg/g wet weight in the static, flex, flow, and flex-flow groups, 
respectively (Figure 35).  By 3 weeks, the average DNA concentrations had decreased to 3.1 ± 
0.5 (-89%; p<0.001), 3.8 ± 0.6 (-75%; p<0.001), 35.1 ± 1.8 (-23%; p<0.05), and 47.0 ± 4.8 (-
21%; N.S.) µg/g wet weight in the static, flex, flow, and flex-flow groups, respectively.  All 
DNA concentrations measured for BMSC-seeded constructs were significantly lower than values 
measured for ovine vascular SMC (Section 2.5.4) [63]. 
 
 
Figure 35 DNA assay results for BMSC-seeded 50:50 PGA/PLLA scaffolds.  Note that the 
long and short dashed lines indicate the DNA concentration measured for SMC-seeded 50:50 
PGA/PLLA scaffolds following either 3 weeks cyclic flexural or static incubation, respectively 
[63] (A).  DNA results plotted on a reduced y-axis to facilitate visualization of the differences 
between experimental groups (B).  Significant comparisons are indicated by asterisks (*). 
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 4.3.2 S-GAG Assay Results 
 
Following 1 week of incubation, the average S-GAG concentrations were 2997 ± 220, 
2792 ± 189, 2237 ± 196, and 2482 ± 231  µg/g wet weight in the static, flex, flow, and flex-flow 
groups, respectively (Figure 36).  By 3 weeks, the average S-GAG concentrations had increased 
to 3636 ± 345 (+21%; N.S.), 5637 ± 897 (+102%; p<0.01), and 2268 ± 67 (+1%; N.S.) µg/g wet 
weight in the static, flex, and flow groups, respectively, and had decreased to 1919 ± 54 (-23%; 
p<0.05) µg/g wet weight in the flex-flow group.  All S-GAG concentrations measured for 
BMSC-seeded constructs were significantly higher than values measured for ovine vascular 
SMC (Section 2.5.4) [63]. 
 
 
Figure 36 Sulfated glycosaminoglycan (S-GAG) assay results for BMSC-seeded 50:50 
PGA/PLLA scaffolds.  Note that the long and short dashed lines indicate the DNA concentration 
measured for SMC-seeded 50:50 PGA/PLLA scaffolds following either 3 weeks cyclic flexural 
or static incubation, respectively [63].  Significant comparisons are indicated by asterisks (*). 
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 4.3.3 Collagen Assay Results 
 
Following 1 week of incubation, collagen could not be detected biochemically in any of 
the test group specimens (Figure 37).  By 3 weeks, the average collagen concentrations 
measured were 422 ± 98, 530 ± 106, 498 ± 95 and 844 ± 278 µg/g wet weight in the static, flex, 
flow, and flex-flow groups.  The collagen concentrations measured for the static, flex, and flow 
groups were not significantly different from the value measured for SMC-seeded scaffolds 
incubated  for 3 weeks under static conditions, and the collagen concentration measured for the 
flex-flow group was not significantly different from the value measured for SMC-seeded 
scaffolds incubated for 3 weeks under cyclic flexure conditions (Section 2.5.4) [63]. 
 
 
Figure 37 Collagen assay results for BMSC-seeded 50:50 PGA/PLLA scaffolds.  Note that 
the long and short dashed lines indicate the DNA concentration measured for SMC-seeded 50:50 
PGA/PLLA scaffolds following either 3 weeks cyclic flexural or static incubation, respectively 
[63].  Significant comparisons are indicated by asterisks (*). 
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 4.3.4 Scanning electron microscopy (SEM) results 
 
 
 
Figure 38 Scanning electron micrographs (SEM) of BMSC-seeded 50:50 PGA/PLLA 
scaffolds incubated under static (A, E), cyclic flexure (B, F), laminar flow (C, G) and cyclic 
flexure-laminar flow (D, H) culture conditions for 1 (A-D) and 3 (E-H) weeks in the FSF 
bioreactor.  Note the dramatic increase in tissue formation exhibited by 1 and 3 weeks in the 
flex-flow specimens (D and H, respectively). 
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 4.3.5 Histology Results 
 
 
Figure 39 H&E stained sections of BMSC-seeded 50:50 PGA/PLLA incubated for 3 weeks 
under conditions of combined cyclic flexure and laminar flow (flex-flow) imaged at 40x (A), 
100x (B), and 400x (C).  
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 4.3.6 Immunohistochemistry Results 
 
Within the 3-week flex-flow group, cells expressed α-SMA (Figure 40A, C), with 
qualitatively higher levels at the surface (A) versus the interstitium (C).  While fibronectin and 
type I collagen were only weakly detected (data not shown), type III collagen was detected 
primarily at the surface (B) compared with the interstitium (D). 
 
 
Figure 40 Immunohistochemistry results for a-SMA (A, C) and collagen type III (B, D) in 
3-week flex-flow specimens (brown color indicates positive labeling). 
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 Evidence for mesenchymal-to-endothelial transdifferentiation was found in the 3 week 
flex-flow group (Figure 41), with elevated expression of CD31 at the surface (A) compared with 
negligible expression in the interstitial region (D), elevated expression of vWF at the surface (B) 
compared with moderate expression in the interstitial region (E), and elevated expression of 
laminin at the surface (C), compared with negligible expression in the interstitium (F). 
 
 
Figure 41 Immunohistochemistry for CD31 (A, D), vWF (B, E), and laminin (C, F) 
expressed at the surface (A-C) and in the interstitium (D-F) of 3-week flex-flow BMSC-seeded 
scaffolds (brown color indicates positive labeling). 
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 4.3.7 Effective Stiffness Testing Results 
 
Following 1 week of incubation, the average E values had increased from 206 ± 16 kPa 
(unseeded scaffold) to 226.76 ± 22.10 (+10%; N.S.), 235.83 ± 36.08 (+15%; N.S.), 252.63 ± 
33.23 (+23%; N.S.), and 356.44 ± 42.93 kPa (+73%; p<0.05) in the static, flex, flow, and flex-
flow groups, respectively (Figure 42).  By 3 weeks, the average E values had increased further 
to 562.99 ± 143.97 (+148%; p<0.01), 677.31 ± 179.46 (+187%; p<0.01), 653.12 ± 185.60 
(+159%; p<0.01), and 946.34 ± 232.57 (+166%; p<0.05) kPa in the static, flex, flow, and flex-
flow groups, respectively.  A trend of increased E was observed in the flex-flow specimens at 1 
and 3 weeks. 
 
 
Figure 42 Effective stiffness (E) results for BMSC-seeded scaffolds. 
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4.4 DISCUSSION 
 
In the current study we used the FSF bioreactor to investigate the independent and 
coupled effects of cyclic flexure and laminar flow on engineered heart valve tissue formation.  
The decision to shift from SMC to BMSC was motivated by the need to develop non-invasive 
cell sources for potential future clinical applications. 
 
4.4.1 Implications of Proteoglycan / Sulfated-Glycosaminoglycan Results 
 
In the current study we demonstrated that different modes of mechanical stimulation—
cyclic flexure and laminar flow—had differential effects on the sulfated-glycosaminoglycan (S-
GAG) concentration of BMSC-seeded scaffolds.  As mentioned in Section 2.6.2, S-GAG 
concentration represents a measure of both free and proteoglycan-bound S-GAG.  These 
previous results for SMC-seeded scaffolds demonstrated that proteoglycan/S-GAG secretion 
precedes collagen secretion in TEHV, with significant changes in S-GAG concentration 
occurring following 3 weeks bioreactor incubation [63].  Given that the initial ECM deposited 
within the scaffold consists predominantly of proteoglycans and S-GAG, it stands to reason that 
these molecules could have a significant impact on the phenotype and subsequent synthetic 
behavior of the constituent cells. 
The role of small leucine-rich proteoglycans (SLRP) in modulating collagen 
fibrillogenesis has received much attention recently, as various gene knock-out models have 
demonstrated the important role of SLRP in several disease states.  Some of the most actively 
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 studies SLRP are decorin, biglycan, fibromodulin, lumican.  Each of these SLRP has 
demonstrated an important role in modulating the assembly of collagen molecules and fibers, and 
recently has been implicated in controlling the fate of BMSC [134].  Using a biglycan and 
decorin knock-out (bgn/dcn-) mouse, Bi et al. demonstrated that bgn/dcn- BMSC shift from 
growth to apoptosis in response to excess TGF-β signaling due to the lack of proper 
sequestration of TGF-β by biglycan and decorin. 
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5.0 A STRUCTURAL MODEL FOR THE FLEXURAL MECHANICS OF NONWOVEN 
TISSUE ENGINEERING SCAFFOLDS 
 
5.1 INTRODUCTION 
 
 Nonwovens of bioresorbable aliphatic polyesters (e.g., polyglycolic acid (PGA), poly-L-
lactic acid (PLLA)) represent one of the earliest, and to date, most ubiquitous biomaterials used 
as TE scaffolds [135].  Their commercial availability and amenability to tissue formation, 
however, belies their intricate microstructure [97] and mechanics [98, 99].  The complexity of 
mechanical interactions between the nonwoven scaffold, cells, and ECM has only begun to be 
addressed.  For example, while we recently demonstrated a positive linear relationship between 
effective stiffness (E) and collagen concentration [63], determining the collagen’s specific 
stiffness (i.e., stiffness/concentration) was compounded by concurrent variations in its transmural 
distribution.  Thus, while the paradigm of seeding a nonwoven scaffold with cells has yielded 
promising results for applications as diverse as heart valves [32, 33], bladder [136], blood vessels 
[56], and cartilage [137], investigators still possess no basis for rational design; no 
experimentally validated framework for predicting the mechanical properties of cell-seeded 
nonwoven scaffolds, let alone their response to mechanical conditioning, currently exists. 
To account for the strong sensitivity to fiber orientation, we have previously taken a 
structural approach toward describing the mechanical response of soft planar tissues under 
biaxial loading conditions [138].  Structural models provide a direct link between the intrinsic 
properties of individual tissue constituents, their microstructural arrangement, and gross tissue 
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 behavior, and thus lend themselves naturally to describing the interacting fiber populations (e.g., 
collagen, PGA, PLLA) within engineered tissues based on nonwoven scaffolds.  While 
phenomenological models are useful in predicting the overall mechanical behavior of tissues, 
such as for bioprosthetic heart valve simulations [139], they generally cannot predict the internal 
mechanical environment experienced by the cells.  Such information can only be predicted from 
a properly formulated structural model.  A prerequisite for developing a structural model for a 
cell-seeded nonwoven scaffold, however, is an accurate model of the nonwoven scaffold itself. 
Pioneering investigations into the structural mechanics of nonwoven textiles began in 
earnest with Backer and Petterson’s [140] application of the fiber network theory proposed by 
Cox [141].  Later investigators refined this theory, quantifying and modeling the influence of 
fiber properties, bond properties [142], and fiber orientation [143] on the mechanical response of 
the fabric.  Formally introduced as a TE scaffold by Freed et al. [135], needled nonwovens are a 
particular textile class characterized by discontinuous fibers and labile physical bonds [97].  The 
physical bonds are introduced by punching an array of barbed needles through a multi-layer fiber 
web, reorienting some fibers out of the horizontal plane into vertical loops about which 
neighboring fibers are entangled.  Needling is an attractive bonding method for TE scaffolds 
because it yields a strong [144], highly interconnected porous structure from a single polymer, 
however fiber slippage results in limited elastic recovery under tensile loading [64, 114, 145].  In 
contrast, we recently demonstrated that nonwoven scaffolds can exhibit extended mechanical 
stability under cyclic flexural loading [63].              
As discussed above in Section 3, cyclic flexure is a major mode of deformation 
experienced by native and tissue engineered heart valves (TEHV) during the opening and closing 
phases of normal valve function.  We recently developed a bioreactor [62] and a sensitive three-
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 point bending test [62, 100] to investigate the effects of cyclic flexural loading on TEHV 
biomaterials.  While 50:50 PGA/PLLA nonwoven scaffolds dip-coated with poly-4-
hydroxybutyrate (P4HB) incurred significant decreases in E with cyclic flexure [62], the 
unmodified 50:50 PGA/PLLA scaffold was found to be mechanically stable over a period of at 
least 3 weeks [63].  In smooth muscle cell (SMC)-seeded scaffolds [63], this property recently 
allowed us to demonstrate several-fold increases in E with the accretion of relatively small 
quantities of collagen independent of measurable changes in scaffold mechanical properties. 
 As a key step toward predicting the contribution of ECM formation on E of a cell-seeded 
nonwoven scaffold, in this section we developed a structural model for E of a nonwoven scaffold 
in bending.  The model was formulated based on Freeston and Platt’s “no freedom” of relative 
fiber motion model [146], with new assumptions introduced to describe the unique flexural 
mechanics of needled nonwovens.  Specifically, the spring-like behavior of the crimped fibers 
was accounted for by calculating effective fiber stiffnesses using a model proposed by Lee and 
Argon [147].  Structural and mechanical properties of PGA and PLLA fibers and PGA, PLLA, 
and 50:50 PGA/PLLA scaffolds were measured and input into the model.  The predicted values 
of E were compared with experimental measurements for scaffold specimens oriented in both the 
preferred (PD) and cross-preferred (XD) fiber directions.  To assess the general predictive 
capability of the model, the predicted dependence of E on fiber diameter was compared with 
experimental measurements.  Furthermore, to explore the utility of the model in nonwoven 
scaffold design, a sensitivity analysis was conducted on the key model parameters. 
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5.2 MATHEMATICAL FRAMEWORK 
 
5.2.1 Structure of Needled Nonwoven TE Scaffolds 
 
 An accurate mathematical representation of a needled nonwoven TE scaffold first 
requires consideration of the fiber and fabric structures.  These structures are introduced by an 
essentially three-step fabrication process [135].  First, the multifilament PGA or PLLA yarn is 
crimped and cut into 40 mm long segments.  The crimping process imparts an intrinsic sinusoidal 
curvature to the individual fibers that can be observed by light microscopy (Figure 43A), and 
which we will later show is essential to the fiber and fabric mechanics.  Secondly, the crimped 
yarn segments are carded (i.e., mechanically brushed) into a multi-layer fiber web exhibiting 
distinct PD and orthogonal XD fiber directions (Figure 43B).  As mentioned previously, in the 
final fabrication step the oriented fiber web is physically bonded by needling.  Needling 
discretizes the fiber web into a regular array of fibrous cubes demarcated at each corner by a 
physical bond of vertically-oriented fiber loops (Figure 43C).  In the subsequent mathematical 
treatment, these cubes are considered as the representative volume elements (RVE). 
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Figure 43 Representative photomicrograph of a crimped PGA fiber teased from a nonwoven 
PGA scaffold (40x original magnification, Scale bar = 100 µm) (A).  The image was calibrated 
to the fiber diameter and the intrinsic crimp wavelength Λ and amplitude ao were measured 
using the Trace Measurement Mode of SigmaScan Pro (SPSS, Inc.).  SEM image depicting the 
planar microstructure of a 50:50 PGA/PLLA scaffold (100x original magnification, Scale bar = 
100 µm) (B).  The angular orientation of the preferred fiber direction (PD) was arbitrarily 
designated as Φ = 0 degrees, with the orthogonal cross-preferred direction (XD) at Φ = ± 90 
degrees.  Schematic illustrating how the planar microstructure depicted in panel (B) relates to the 
three-dimensional structure of the needled nonwoven scaffold (C).  The distance between the 
vertically-oriented loops of fibers introduced by needling provides an intuitive basis for the RVE 
width b.  The angular and numerical distribution of fibers throughout the RVE thickness t was 
assumed to be equal. 
    
5.2.2 Theoretical Bounds on the Effective Stiffness of a Nonwoven 
 
 Consider a rectangular specimen (i.e., beam) of nonwoven fabric.  The flexure of a beam 
can be expressed by the well-known Bernoulli-Euler moment-curvature relation [101]: 
 M EI κ= ∆  (3) 
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 in which M is the applied bending moment, E is the effective stiffness, I is the area moment of 
inertia (i.e.,  where w and t are the specimen width and thickness, respectively), and 
∆κ is the resultant change in curvature.  To model the flexural rigidity EI of idealized nonwoven 
fabrics consisting of straight (i.e., not crimped) fibers, Freeston and Platt [146] made simplifying 
assumptions regarding the fibers and fabric (Appendix A). 
3 /12I wt=
 In their seminal work, Freeston and Platt derived analytical models to calculate EI for 
two extreme cases of fiber interaction: 1) “complete freedom” of relative fiber motion (i.e., no 
interaction), and 2) “no freedom” (i.e., fibers rigidly bonded at each cross-over point). 
 In the case of “complete freedom,” EI per RVE can be expressed as (Appendix B): 
 
 
/ 2 4
/ 2
( ) ( ) cosRVE f f fEI N E I R d
π
π−= Φ Φ∫ Φ  (4) 
 
where Nf is the number of fibers per RVE 
 
 f
bN ωλ=  (5) 
 
in terms of the fabric weight per unit area ω, the RVE width b, and the fiber weight per unit 
length λ [148].  The longitudinal fiber stiffness Ef can be measured from uniaxial tensile tests of 
individual fibers (e.g., ASTM D 3379) and If is the fiber area moment of inertia (i.e., 
 where d4 / 64f fI dπ= f is the fiber diameter).  The fiber orientation distribution R(Φ) can be 
expressed according to:   
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where  is the number of fibers oriented within an angular increment ±∆Φ/2 of a particular 
angle Φ.  In the current study R(Φ) was quantified by a small angle light scattering (SALS) 
technique (see Fiber orientation distribution analysis).   
( )fN Φ
 In the case of “no freedom,” EI per RVE can be expressed as (Appendix C): 
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π
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where Af is the fiber cross-sectional area (i.e., ).   2 / 4f fA dπ=
 Multiplication of either Eq. (4) or (7) by the number of RVE per width (i.e., w/b) of a 
particular experimental specimen of nonwoven yields lower or upper bounds on the 
experimentally measured value of EI, respectively.  Division of this result by the appropriate 
value of I yields lower or upper bounds on E. 
 
5.2.3 New Assumptions for Modeling Needled Nonwoven TE Scaffolds 
 
 To the best of our knowledge, the current study is the first to model the mechanics of a 
needled nonwoven TE scaffold.  While Eq. (4) and (7) provide theoretical bounds on EI of 
idealized nonwovens consisting of straight fibers, the unique structure of needled nonwovens 
[97] suggests an intermediate behavior.  For example, in a needled nonwoven the fibers are 
physically bonded at the sites of needling (i.e., EI > “complete freedom”), however the fibers are 
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 not bonded at each fiber-fiber cross-over point (i.e., EI < “no freedom”).  Moreover, segments of 
the crimped fibers spanning between cross-over points are often highly curved, suggesting that 
the effective fiber behavior within the needled nonwoven is more like a spring than a rod. 
 Using Eq. (7) as a basis, we introduced the following new assumptions for modeling the 
flexural mechanics of a needled nonwoven scaffold: 
  
1. Representative volume element (RVE) dimensions depend on needling density.  Needling 
introduces an array of bonds across the horizontal plane of the fiber web (Fig. 1B), thus 
rendering the inter-bond distance an intuitive choice for the width b of the RVE.  This 
basis for b is supported by Hearle and Purdy [98], who demonstrated a positive 
correlation between the initial tensile stiffness of a needled nonwoven and needling 
density.  In the current study the needling density was ~ 155 penetrations/cm2 (Dr. John 
Gray, personal communication), yielding an inter-bond distance of ~ 0.92 mm.  For 
convenience, we set b = 1 mm (i.e., RVE width ≡ unit width).     
2. Fiber slippage is negligible in bending.  Per Hearle and Purdy [98], in the 0-20 % stress-
strain regime needled nonwovens deform by straightening of fiber crimp, with little 
slippage of frictionally-bonded fibers.  This is supported the finding that nonwoven 50:50 
PGA/PLLA does not incur measurable changes in E with 3 weeks cyclic flexure [63].  
3. Vertically-oriented fibers do not contribute directly to EI.  While the loops of vertically-
oriented fibers introduced during needling lend the nonwoven scaffold structural integrity 
[97], their direct contribution to EI was assumed to be negligible.  This assumption is 
supported by Termonia [149], who using a numerical model demonstrated that the 
contribution of out-of-plane fibers to EI is negligible compared to the in-plane fibers. 
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 4. Fiber effective stiffness is governed by fiber crimp.  To account for the crimped fibers in 
the needled nonwoven we adapted a model proposed by Lee and Argon [147].  Crimped 
fibers were assumed to be sinusoidal in the undeformed state with an effective crimp 
amplitude aeff and wavelength Λeff (i.e., sin(2 )eff effy a xπ= Λ ).  By effective crimp we 
refer specifically to the curved geometry of fiber segments spanning between rigidly 
bonded fiber-fiber cross-over points [147], and not to the intrinsic crimp imparted to the 
fibers during scaffold fabrication [135].  The longitudinal fiber stiffness Ef in Eq. (7) was 
thus replaced by an effective fiber stiffness, ( )fE ′  (Appendix D): 
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f
eff f
E
E
a d B B
 (8) 
 
with parameters B1 and B2 given by the expressions: 
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and where κeff is the initial effective curvature of the fiber segment, given by the relation: 
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5.3 MATERIALS AND METHODS 
 
5.3.1 Nonwoven Scaffolds and Fibers 
 
 The scaffolds were needled nonwoven PGA, PLLA, and a 50:50 blend of PGA and 
PLLA fibers (Albany International Research, Mansfield, MA).  A complete description of the 
scaffold manufacturing process was reported by Freed et al. [135], with the exception that the 
scaffolds used in the current study were bonded only by needling (i.e., scaffolds were not further 
bonded by pressing between heated metal plates as described previously [135]).  The key 
properties of these scaffolds relevant to formulating the structural model were quantified in the 
current study (Table 1-4).  Multifilament PGA and PLLA yarns (US Surgical, Norwalk, CT) 
were kindly provided by Dr. John Gray (Biomedical Structures, Inc., Slatersville, RI).  The 
individual PGA and PLLA fibers in the yarn were 2.2 denier (Dr. John Gray, personal 
communication).  The yarns were washed for 20 minutes in isopropyl alcohol in order to remove 
the spin finish and allowed to dry overnight beneath a laminar flow hood prior to use.  The 
washed and dried yarns were separated into individual fibers prior to mechanical testing. 
 
5.3.2 Uniaxial Testing of Single PGA and PLLA Fibers 
 
 Single PGA and PLLA fibers were tested per the guidelines provided in ASTM D 3379.    
Single fibers were center-line mounted on a slotted tab made of 60 grit sandpaper (Gatorgrit® 
multi-purpose sandpaper; Ali Industries, Inc., Fairborn, OH), and were subsequently bonded to 
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 the tab using Surebonder® All Purpose Mini Glue Sticks (FPC Corporation, Wauconda, IL) and 
the high temperature (165°C) setting of a Surebonder® Mini Glue Gun (FPC Corporation, 
Wauconda, IL).  As per ASTM D 3379, a gage length at least 2000 times the diameter of the 
fiber (i.e., 30 mm) was used for all tests.  Fiber diameters were measured from calibrated 
scanning electron micrographs of individual PGA and PLLA fibers (see Scanning electron 
microscopy).  Fiber diameter was measured at 5 points along the length of the fiber using the 
Trace Measurement Mode of SigmaScan Pro (SPSS, Inc., Chicago, IL).  The mean fiber 
diameter was used in the calculation of the fiber cross-sectional area.  Tabs were mounted in the 
grips of an MTS Tytron™ 250 test system (MTS Systems Corporation, Eden Prairie, MN) and 
strained to failure at a rate of 1 mm/min.  Force was recorded using the standard 500 N capacity 
load cell (accuracy ± 5%) and engineering stress was calculated by dividing the force by the 
mean initial cross-sectional area of the fiber.  Engineering strain was calculated by dividing the 
change in fiber length by the original gage length.  The fiber longitudinal stiffness was taken as 
the slope of the stress versus strain curve in the initial elastic region prior to yielding (i.e., ~ 0.6% 
strain).  The tensile strength and strain-to-failure were recorded as the stress and strain at failure, 
respectively. 
 
5.3.3 Effective Stiffness Measurement 
 
 The device and methods used to measure E have been described previously [62, 100].  In 
the current study testing was performed both on dry and 1x phosphate buffered saline (PBS)-
bathed scaffolds.  Rectangular specimens were cut to size (25 x 7.5 x 1 mm) with the long axis 
oriented in either the PD or XD (see Fiber orientation distribution analysis), were marked with 5 
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 to 10 small black dots (~ 0.3 mm2) along one long edge using a permanent marker, and were 
subjected to three-point bending by a calibrated bending bar of known stiffness.  The 
displacements of the specimen markers, the bending bar marker, and a reference marker were 
recorded to video using a high-resolution CCD camera and tracked using a custom C program.  
Based on the resolution, post coordinates, load, displacement, and marker coordinates, the 
program calculated M and the resulting ∆κ of each specimen.  The thickness t was measured 
using a calibrated digital image of each specimen using SigmaScan Pro (SPSS, Inc., Chicago, IL) 
with a resolution of ~30 µm.  The width w was measured using a digital slide caliper (resolution 
± 10 µm; The L.S. Starrett Co., Athol, MA).  Finally, E was calculated via a linear regression 
using Eq. (3) and the value of I calculated using t and w. 
 
5.3.4 Scanning Electron Microscopy 
 
The methods used for scanning electron microscopy (SEM) of nonwoven scaffolds have been 
described previously [62].  In brief, specimens of PGA, PLLA, and 50:50 PGA/PLLA scaffold 
material and individual PGA and PLLA fibers were prepared for SEM.  Dry specimens were 
attached to aluminum specimen stubs and sputter coated with a thin layer of gold-palladium alloy 
(~3 nm thickness) in a 108auto sputter coater with a MTM-20 thickness controller (Cressington 
Scientific Instruments, Inc., Cranberry Twp., PA).  Specimens were imaged at 1800x for fiber 
diameter measurements and 100x for effective crimp quantification at 5 kV on a JEOL JSM-
6330F field emission scanning electron microscope (JEOL USA, Inc., Peabody, MA). 
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 5.3.5 Intrinsic and Effective Crimp Quantification 
 
 During the nonwoven scaffold manufacturing process, the multifilament PGA or PLLA 
yarn is crimped prior to cutting the yarn into 40 mm long fibers [135].  In order to quantify this 
intrinsic crimp, fibers were gently teased from the scaffolds and imaged under low power (40x) 
magnification (Figure 43A).  Six images (1 fiber/image) were calibrated to the fiber diameter 
and the intrinsic crimp Λ and a0 were measured using the Trace Measurement Mode of 
SigmaScan Pro (SPSS, Inc.).  As introduced above in New assumptions for modeling needled 
nonwoven scaffolds, the effective crimp in determining ( )fE ′  in Eq. (8) was assumed to be due 
to the curved geometry of fiber segments spanning between rigidly bonded fiber-fiber cross-over 
points [147].  The effective crimp amplitude aeff and wavelength Λeff were measured for 
individual fiber segments in SEM images based on an idealized crimp structure that we proposed 
(Figure 44A).  Because rigidly bonded fiber-fiber cross-over points cannot be discriminated 
from labile cross-over points via SEM, potential values for aeff and Λeff were measured for fiber 
segments spanning each intervening cross-over point along the length of a particular fiber 
(Figure 44B). 
 Specifically, fibers (n = 6) were selected in SEM images of the PGA, PLLA, and 50:50 
PGA/PLLA scaffolds, and the length of the straight line segment connecting one end of the fiber 
to the furthest observable fiber-fiber cross-over point was recorded as a potential value for 0.5 
Λeff.  The corresponding value of aeff was recorded as the orthogonal distance from the midpoint 
of the 0.5 Λeff line segment to the midpoint of the curved fiber segment.  This procedure was then 
repeated for each intervening cross-over point, yielding a set of approximately six potential 
values for Λeff and aeff for each fiber measured. 
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Figure 44 Schematic depicting the idealized structure used in quantifying the effective crimp 
(A).  For each intervening fiber-fiber cross-over point (e.g., 1, 2, 3), a potential value for the 
effective crimp wavelength Λeff and amplitude aeff were determined from the lengths of the 
dashed line segments.  Schematic showing how the idealized structure (A) was implemented to 
quantify Λeff and aeff in the SEM images (B). 
 
 
5.3.6 Fiber Orientation Distribution Analysis 
  
 Small angle light scattering (SALS) was used to quantify R(Φ).  A detailed description of 
SALS [150], and its application to fibrous PGA scaffolds [151], have been published.  In brief, 
PGA, PLLA, and 50:50 PGA/PLLA scaffolds (10 x 10 mm) were scanned every 1 mm using a 1 
mm diameter Helium-Neon laser beam.  The resultant scattered light intensity distribution, I(Φ), 
recorded at ~ 60 random points within each specimen was averaged and the mean intensity 
distribution, ( )I Φ , was used to obtain R(Φ) by using Eq. (6) with ( )I Φ  analogous to N(Φ) and 
an angular increment ∆Φ of 1 degree.  R(Φ) was fit to the following normalized Gaussian 
distribution using Mathcad 11 (Mathsoft Engineering & Education, Inc., Cambridge, MA). 
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The constant y0 was fit to yield distribution shapes suitable for modeling the experimentally 
measured fiber orientation distribution data.  The normalized Gaussian distribution thus 
permitted simulation of the entire spectrum of possible fiber orientation distributions via 
perturbation of only the standard deviation parameter σ. 
 
5.3.7 Calculating the Number of Fibers per RVE 
 
 To calculate Nf of each scaffold, Eq. (5) was used with b = 1 mm.  The values for ω in 
Eq. (5) were calculated by multiplying the scaffold density reported by Albany International 
(Table 2) by the mean value of the measured scaffold thickness (Table 2) and are summarized in 
Table 3.  The values for λ in Eq. (5) were calculated by multiplying the fiber density ρf by Af 
(Table 3).  The mean value of the reported density range for PGA (1.57 mg/mm3 [135]) was used 
for the PGA fiber density and the mean value of the reported density of amorphous and 100% 
crystalline PLLA (1.269 mg/mm3 [152]) was used for the PLLA fiber density.  The values of Af 
were calculated from the mean values of the measured fiber diameters (Table 1) using 
2 4f fA dπ= .  For the 50:50 PGA/PLLA, ρf, Af, and λ were taken as the average of the PGA and 
PLLA values. 
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 5.3.8 Effective Stiffness Modeling 
   
 Each potential set of aeff and Λeff values was used to calculate a corresponding value of 
( )f 'E  (Eq. (8)) and E (Eq. (7)), and the best-fitting set of aeff and Λeff values (i.e., the set which 
yielded the closest agreement between the measured and predicted value of E ) was determined 
for each of the six fibers imaged.  The mean value of '( )fE  was then calculated from the best-
fitting Λeff and aeff values, and EI of a RVE of PGA, PLLA, and 50:50 PGA/PLLA nonwoven 
scaffold was predicted using the structural model (Eq. (7) and (8)) and divided by the appropriate 
value of I to yield E.  Lower and upper bounds on EI were calculated using the “complete 
freedom” and “no freedom” models (Eq. (4) and (7), respectively), and likewise divided by I to 
yield lower and upper bounds on E.  In order to calculate the values of E for XD specimens, 
cosine was substituted for sine in Eq. (4) and (7).  The values of the parameters used in the 
calculations are summarized in Tables 1-4.  All equations were solved using MathCad 11. 
 
5.3.9 Assessment of General Predictive Capability 
 
 To assess the general predictive capability of the structural model we chose to perturb the 
fiber diameter df.  Because of the spring-like effective fiber behavior, the structural model (Eq. 
(7) and (8)) predicted that E would be highly sensitive to perturbations in df via a cumulative 
fourth-order dependence.  To generate nonwoven PGA scaffolds with reduced fiber diameters, 
we relied on techniques described by Gao et al [107].  Nonwoven PGA scaffolds were incubated 
in 1M NaOH (Sigma) in PBS for 1, 3, and 5 minutes and then characterized by three-point 
bending to measure E and by SEM to measure df.  For each measured value of df, the 
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 corresponding predicted value of ( )f 'E  was calculated using Eq. (8) and the mean values of Λeff 
and aeff for PGA (Table 4).  The predicted values of E were then calculated using Eq. (7) with Ef 
replaced by '( )  and Af calculated using the measured df. fE
 
5.3.10 Sensitivity Analysis 
 
 To assess model sensitivity to key measured parameters, the ratio ( ) /′f fE E  was 
computed for a range of aeff and Λeff values.  The range considered for aeff spanned from 0 (i.e., 
straight fibers) to 0.2 (the intrinsic crimp amplitude a0 was measured to be 0.195 mm).  The 
range considered for Λeff spanned from 0.4 (assuming a minimum value for the average inter-
fiber distance to be 0.2 mm) to 2 (the intrinsic crimp wavelength Λ was measured to be 1.774 
mm).  The minimum value for the average inter-fiber distance was estimated by first calculating 
the number of fibers per hypothetical layer of the nonwoven (i.e., /( / )f fN t d ), and then 
calculating the average inter-fiber distance, assuming that all of the fibers in a hypothetical layer 
are oriented orthogonal to the PD and XD directions in a ratio of 3 to 1.  To assess model 
sensitivity to variations in R(Φ), model predictions for E of the 50:50 PGA/PLLA specimens 
oriented in the PD and XD were calculated for values of σ ranging from 1 to 120 degrees.  
 
5.3.11 Statistics 
 
Data were expressed as mean ± standard error (SEM).  Groups were compared using 
unpaired, two-tail student t-tests.  Differences were considered significant when p < 0.05. 
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5.4 RESULTS 
 
5.4.1 Uniaxial Tensile Tests of PGA and PLLA Fibers 
 
Representative stress versus strain curves for PGA and PLLA fibers are depicted in Figure 
45 and their mechanical properties (mean ± SEM) are listed in Table 3.  The PGA fibers 
exhibited a significantly higher stiffness (+80%) and tensile strength (+51%) than the PLLA 
fibers (p < 0.05), while the PLLA fibers exhibited a significantly higher strain-to-failure (+41%) 
than the PGA fibers (p < 0.05).  The general behavior of the PGA fibers tested in the current 
study compared favorably with a previous report by Slivka et al. [153]. 
 
 
Figure 45 Representative uniaxial stress-strain curves for single PGA (□) and PLLA (?) 
fibers (A).  The longitudinal fiber stiffness was taken as the slope of the initial linear region of 
the stress-strain curve prior to yielding (B).  The PGA fibers exhibited a higher stiffness (p < 
0.05) and tensile strength (p < 0.05) than the PLLA fibers.  The PLLA fibers exhibited a higher 
strain-to-failure (p < 0.05) than the PGA fibers. 
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 Table 3 Measured mechanical properties of individual PGA and PLLA fibers (US 
Surgical).  All properties were measured for dry fibers at room temperature.  Values represent 
mean ± SEM (n=6 fibers). 
Material 
 
Diameter 
(µm) 
Longitudinal Stiffness 
(GPa) 
Tensile Strength 
(MPa) 
Strain to Failure 
(%) 
PGA 12.95 ± 0.02 18.78 ± 3.43 1311.60 ± 203.33 17.29 ± 1.20 
PLLA 16.36 ± 0.02 10.42 ± 1.39 869.85 ± 53.14 24.29 ± 2.25 
  
 
Table 4 Structural properties of PGA, PLLA, and 50:50 PGA/PLLA scaffolds. 
Mean Fiber Orientation Distribution, R(Φ) 
Normalized Gaussian Model (µ = 0) 
Material 
Thickness 
(µm) 
Bulk Density 
(mg/cm3) σ (degrees) yo R2
PGA 948 ± 28 69.0 31.66 25000 0.9951 
PLLA 1153 ± 37 61.9 33.79 20000 0.9986 
50:50 889 ± 6 61.75 32.97 15000 0.9987 
 
 
5.4.2 Intrinsic and Effective Crimp 
   
 The mean values of the intrinsic crimp wavelength Λ and amplitude a0 were 1.774 ± 
0.101 mm and 0.195 ± 0.020 mm.  The best-fitting of the potential effective crimp parameters 
Λeff and aeff (Table 5) were lower, suggesting that the intrinsic crimp imparted to the yarn 
represents an upper limit on the effective crimp parameters and the concomitant values of ( )fE ′ . 
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 Table 5 Best-fitting effective crimp wavelengths Λeff and amplitudes aeff and calculated 
effective fiber stiffnesses ( ) 'fE  for the structural model.  The effective fiber stiffnesses were 
calculated from Eq. (8) and the mean value was used in subsequent modeling calculations using 
Eq. (7). 
Material 
 Λeff 
(mm) 
aeff 
(mm) 
( ) 'fE  
(kPa) 
1.197549 0.09296 7606 
1.703836 0.069814 12940 
1.419725 0.07763 10610 
1.102133 0.067197 14250 
1.736596 0.092093 7525 
PGA 
1.518951 0.063095 15850 
mean ± SEM 1.446465 ± 0.105973 0.077132 ± 0.005241 11464 ± 1418 
1.36339 0.109491 4872 
1.87314 0.127396 3543 
1.557829 0.081312 8536 
1.310796 0.101381 5660 
1.035789 0.090791 7154 
PLLA 
1.632403 0.096241 6140 
mean ± SEM 1.462225 ± 0.118532 0.101102 ± 0.006541 5984 ± 712 
1.23679 0.086656 8171 
0.823824 0.125644 4336 
0.896858 0.071466 12160 
1.080097 0.062754 15355 
1.1924 0.106574 5542 
50:50 
1.080133 0.08935 7813 
mean ± SEM 1.051684 ± 0.066225 0.090407 ± 0.009384 8896 ± 1694 
 
    
5.4.3 Experimental effective stiffness 
 
Mean three-point bending test results are presented for comparison in terms of load-
deflection (Figure 46A-C) and moment-curvature (Figure 46D-F).  Measured values of E for the 
dry PGA, PLLA, and 50:50 PGA/PLLA scaffolds (Table 6) were always higher than for the 1x 
PBS wetted scaffolds (data not shown), however the difference was not statistically significant.  
In contrast, significant differences were found for each material between E of the scaffolds cut in 
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 the PD versus XD directions (p < 0.001).  For the dry scaffolds, the ratios of E in the XD to PD 
were 0.31, 0.35, and 0.38 for PGA, PLLA, and 50:50 PGA/PLLA, respectively.  E results for the 
50:50 PGA/PLLA scaffolds in the PD were comparable to our previously published results [63]. 
 
Table 6 Measured and predicted E of PGA, PLLA, and 50:50 PGA/PLLA scaffolds.    
Measured E values represent mean ± SEM (n=6 measurements).  Predicted E values for the 
structural model were calculated using Eq. (7) with ( ) 'fE  given by Eq. (8).  Lower and upper E 
bounds were predicted using Eq. (4) and (7). 
Material 
Material 
Direction 
E 
Measured 
 (kPa) 
E 
Predicted 
(kPa) 
E 
Lower Bound 
(kPa) 
E 
Upper Bound 
(kPa) 
PD 284 ± 34 306 70 501,000 
XD 88 ± 7 81 18 132,100 PGA 
Random* N/A 189 43 309,500 
PD 171 ± 14 168 44 292,500 
XD 60 ± 6 54 14 94,280 PLLA 
Random* N/A 109 29 190,600 
PD 206 ± 16 222 80 366,000 
XD 78 ± 5 76 27 124,200 50:50 PGA/PLLA 
Random* N/A 147 53 240,800 
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Figure 46 Mean load-deflection curves measured by three-point bending for both dry and 
wet PLLA (A), PGA (B), and 50:50 PGA/PLLA (C) scaffolds (n=6).  Mean moment-curvature 
curves measured by three-point bending for both dry and wet PLLA (D), PGA (E), and 50:50 
PGA/PLLA (F) scaffolds (n=6).  E was calculated for each scaffold specimen via the Bernoulli-
Euler moment-curvature relationship (Eq. (3)) and then averaged to yield the mean value of E 
(Table 5).  Differences between dry and wet scaffolds were not statistically significant.   
 
 
 
 
 
120 
 5.4.4 Fiber Orientation Distribution Analysis 
 
 A normalized Gaussian equation with a mean of zero (Eq. (11)) was found to fit the mean 
experimentally measured orientation distribution (Figure 47) very well, with coefficients of 
determination exceeding 0.99 for PGA, PLLA, and 50:50 PGA/PLLA (Table 4). 
 
 
Figure 47 The fiber orientation distribution (mean ± SEM) for PGA (□), PLLA (?), and 
50:50 PGA/PLLA (○) as measured by SALS.  The distributions were modeling using a 
normalized Gaussian distribution (Eq. (11)) with the mean µ constrained to zero.  Note that the 
distributions depicted for PGA and PLLA were scaled for presentation purposes (baseline 
indicated by dotted line), and that the integral from Φ = -90 to 90 degrees was exactly equal to 1 
for each distribution. 
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 5.4.5 Predicted Effective Stiffness Results 
 
 The values of E predicted by the structural model closely approximated the values 
measured experimentally using the three-point bending test (Table 6).  Representative M-∆κ 
plots are depicted for the PD (Figure 48A) and XD (Figure 48B) specimens.  Using the mean 
values of ( )fE ′  (Table 4), the model estimates were on average within ± 6% of the experimental 
results for the PD specimens and within ± 7% of the experimental results for the XD specimens.  
The predicted ratios of E in the XD to PD were 0.26, 0.32, and 0.34 for PGA, PLLA, and 50:50 
PGA/PLLA, respectively.  The “complete freedom” model underestimated E, yielding a lower 
bound on average 75% lower than the experimentally measured values for the dry scaffolds.  In 
the other extreme case, the “no freedom” model severely overestimated E, yielding upper bounds 
~ 3 orders of magnitude higher than the experimentally measured values for the dry scaffolds. 
 
 
Figure 48 Representative experimental moment-curvature plots for PD (A) and XD (B) 
specimens of 50:50 PGA/PLLA scaffold (○).  The experimental curves were bracketed by the 
lower and upper bounds calculated using Eq. (4) and (7).  The structural model (Eq. (7) and (8)) 
closely matched the experimental data. 
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 5.4.6 Assessment of General Predictive Capability 
 
 The rate of NaOH-mediated fiber surface hydrolysis observed in the current study (1.1 
µm/min) compared favorably with that reported by Gao et al. [107] (0.65 µm/min) (data not 
shown).  Using the same Λeff and aeff values determined previously for the unmodified PGA 
scaffold (Table 5), the structural model simulated the experimentally-measured dependence of E 
on df with a coefficient of determination of 0.987 (Figure 49). 
 
 
Figure 49 E versus df (mean ± SEM) measured for PD specimens of PGA scaffold subjected 
to surface hydrolysis in 1N NaOH solution.  The model predictions were strikingly similar to the 
experimental results, thus providing additional verification of the predictive capacity of the 
model. 
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 5.4.7 Sensitivity Analysis 
 
 The predicted dependence of the ratio ( ) /′f fE E  calculated using Eq. (8) demonstrated a 
much higher sensitivity to aeff than Λeff (Figure 50A).  For straight fibers (i.e., aeff = 0) Eq. (8) 
correctly predicts a ratio ( ) /′f fE E  equal to 1.  The normalized Gaussian distribution shifted 
from a peak at small values of σ (e.g., 10°) to nearly a constant at large values of σ (e.g., 50°), 
thus permitting simulation of the entire spectrum of possible fiber orientation distributions 
(Figure 50B).  The values of E predicted for the PD and XD specimens converged to within 5% 
of the value predicted for a random distribution at a σ value of ~ 90°.  In the σ range of 30° to 
40°, the dependence of E on σ is practically linear, with slopes of -3.4 kPa/degree and 2.7 
kPa/degree in the case of the PD and XD specimens, respectively (R2 > 0.995). 
 
 
Figure 50 Predicted dependency of the ( )fE ′ /Ef ratio (logarithmic scale) on the values of 
aeff and Λeff (A).  Note that in the limit aeff goes to zero (i.e., straight fibers), Eq. (8) correctly 
predicts an ( )fE ′ /Ef ratio of 1.  Predicted dependency of E on the σ parameter of the fiber 
orientation distribution for 50:50 PGA/PLLA scaffolds (B). 
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 5.5 DISCUSSION 
 
Ever since the seminal work of Freed et al. [135], in which bovine articular chondrocytes 
were seeded onto a nonwoven PGA scaffold, the combining of cells with bioresorbable 
nonwovens has yielded valuable insight into the basic science of engineered tissue development.  
While investigators continue to introduce new types of scaffolds, some of which possessing 
potentially attractive properties such as elasticity [154], needled nonwovens continue to serve an 
important role in TE, both as a benchmark for evaluating novel biomaterials, and importantly for 
their own unique capacity to promote tissue formation; the merit of pursuing the application of 
these scaffolds clinically is substantiated by the promising results of several animal studies [32, 
33, 56, 136]. 
However, while the outcomes of these ongoing experiments are encouraging, the underlying 
mechanisms governing the successful development of a functional tissue are not well 
understood.  From a biomechanics perspective, perhaps the most fundamental issue yet to be 
addressed is the lack of information concerning the mechanics of the nonwoven scaffold itself.  
In the current study we focused on this issue, with the caveat that a mathematical model 
describing the scaffold is only the first step toward developing an accurate representation of the 
generally heterogeneous cell-seeded nonwoven scaffold. 
In the current study we developed a structural model to predict E of a nonwoven TE scaffold 
from the fiber properties and the nonwoven structure.  To the best of our knowledge, the current 
study is the first to model the mechanics of a needled nonwoven TE scaffold.  For comparison, 
models developed by Freeston and Platt [146] for the extreme cases of “complete freedom” 
(lower bound) and “no freedom” (upper bound) of relative fiber motion were considered as well. 
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 5.5.1 Predictive Capability of the Structural Constitutive Model 
 
 Overall, the value of E predicted by the model compared favorably with the experimental 
results, both for the PD and XD specimens.  As reported in the results, the PD predictions (± 6%) 
were slightly better than the XD predictions (± 7%).  There are several possible sources of error 
which may have contributed to these small deviations between the predicted and experimental 
results.  First, it should be noted that in most cases the structural model slightly overestimated E 
in the PD and slightly underestimated E in the XD.  This deviation could possibly be explained 
in two ways.  In the SALS method, the scattered light intensity distribution I(Φ) represents the 
average angular orientation of fibers dispersed through the specimen thickness.  This measure is 
thus consistent with the assumption of equal angular distribution through the RVE thickness 
made by Freeston and Platt in deriving their models [146], and also invoked in our structural 
model.  However, based on the complex effects of needling on the vertical and horizontal 
alignment of fibers in needled nonwovens [97], it is possible that the angular orientation varies to 
some degree through the thickness.  Thus, if R(Φ) was broader than that measured by SALS, 
then the values of E predicted for the PD specimens would have been lower and the values for 
the XD specimens higher (see Sensitivity analysis results).  Recent improvements in the spatial 
resolution of x-ray microtomography have allowed for the quantification of through-thickness 
variations in the fiber structure of nonwovens [155], and thus this method may be useful in 
obtaining a more complete characterization of the three-dimensional fiber structure. 
 A second possible source of deviation might be that the effective crimp parameters are a 
function of the angle Φ.  Such a dependence has previously been observed by Hearle and 
Stevenson [143], with fibers in the PD less curved (i.e., effectively stiffer) than fibers in the XD.  
126 
 In the current study we did not account for the orientation of the fibers in measuring the crimp 
parameters.  However, it is unlikely that this effect would help explain the data in the current 
study, as a decrease in fiber curvature in the PD direction and increase in the XD direction would 
produce the opposite effect; the value of E predicted for the PD would be higher and the value 
for the XD lower, thus resulting in an even larger deviation. 
 
5.5.2 Implications of the General Predictive Capability 
 
 The model predictions were strikingly similar to the experimentally measured values of E 
(Figure 49), providing evidence that the structural model can be used to prepare a scaffold 
exhibiting a desired E.  In the study by Gao et al. [107], a linear relationship was found between 
the decrease in df and hydrolysis time (0.65 µm/min).  Furthermore, they demonstrated that the 
bulk properties of the fibers (e.g, molecular weight, crystallinity) had not changed significantly, 
suggesting that the fiber stiffness remained constant.  In the current study, the values of Λeff and 
aeff determined for the virgin scaffold continued to provide reasonable estimates for ( )fE ′  
following NaOH-mediated surface hydrolysis, suggesting that the reduction in df had little effect 
on the integrity of the physical bonds generated during the needling process.  These results may 
prove useful in TEHV design, as the initially high stiffness of TEHV relative to native valvular 
tissue could potentially result in poor opening characteristics or undesirable transvalvular 
pressure gradients during the early phase of implantation prior to scaffold resorption [32, 33].  
Moreover, in contrast to R(Φ), the fiber diameter df (and thus E) can be readily adjusted in the 
lab by surface hydrolysis following procurement of the scaffold.  Interestingly, in a recent study 
by Prabhakar et al. [156], TE arteries created by seeding SMC onto NaOH surface hydrolyzed 
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 nonwoven PGA exhibited enhanced mechanical and phenotypic properties compared with 
untreated, heat-treated, or γ-irradiated PGA scaffolds, suggesting that the increased SMC 
adhesion [107] and decreased effective fiber stiffness may be a beneficial combination. 
 
5.5.3 Small Strain versus Large Strain Behavior of Needled Nonwovens 
 
 Development of the structural model described herein was motivated by our ongoing 
research in the area of TEHV.  Because cyclic flexure is the primary mode of TEHV deformation 
at early time points prior to scaffold degradation [62, 63], in the current study we focused on 
developing a model to predict E measured in bending.  In our three-point bending test the tissue 
strains are typically less than ±7% [157], and thus within the initial stress-strain regime (0-20 %) 
[98] dictated by straightening of crimped fibers [145].  For a material whose tensile and 
compressive stiffnesses are equal, the value of E measured in bending should be equivalent to the 
initial stiffness measured in uniaxial tension.  Such a one-to-one correspondence has previously 
been demonstrated for a wide variety of nonwoven materials [158], suggesting that the 
mechanism of initial deformation is similar in tension and compression.  While previous studies 
have demonstrated that the out-of-plane compressive stiffness of nonwoven PGA scaffolds is 
relatively low (6.7 ± 0.5 kPa [159]), the good correspondence between E measured in bending 
and initial stiffness (gage length > average fiber length; unpublished observations) suggest that 
the in-plane compressive stiffness of the nonwoven scaffold is closer to the in-plane tensile 
stiffness.  In contrast to the small strain behavior, the large deformation behavior of needled 
nonwovens is many-fold more complex.  
128 
  It was demonstrated early on by Hearle and Sultan [145] that the uniaxial stress-strain 
behavior of needled nonwovens is highly nonlinear, exhibiting a sigmoidal shape qualitatively 
resembling that of a typical soft tissue [138].  They proposed that the stiffening observed at large 
strains was due to fiber reorientation and locking, with intermittent fiber slippage.  In a later 
study, Hearle and Sultan [144] proposed initial theoretical models to describe the tensile 
response of needled nonwovens.  While they stressed that the complexity of the needled 
nonwoven structure precluded an exact analysis, they discussed the factors influencing the 
tensile behavior qualitatively and developed a simplified model.  Hearle and Purdy later 
explained that this initial model was inaccurate, owing to the physical implausibility of the 
proposed mechanism of inter-fiber friction development, and developed a more robust model to 
account for slippage effects based on a “capstan” equation [99].  Interestingly, for nonwoven 
50:50 PGA/PLLA scaffolds, the peak tangent stiffness exhibited at larger strains (unpublished 
observations) is comparable to the value of E measured following reinforcement by de novo 
synthesized collagen [63]. 
 
5.5.4 The Effects of Needling Density 
 
 One parameter whose variation was not explored in the current study was needling 
density.  As the needling density is directly related to the inter-bond distance, the effective crimp 
parameters would be expected to depend on the needling density.  The needling density used to 
fabricate the PGA, PLLA, and 50:50 PGA/PLLA scaffolds was ~ 1,000 penetrations/in2 (i.e., ~ 
155 penetrations/cm2; Dr. John Gray, personal communication).  Studies by Hearle and Purdy 
[98] and Hearle et al. [160] have demonstrated an approximately linear increase in initial 
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 stiffness (equivalent to E) with increased needling density up to ~ 1000 pentrations/in2, with a 
gradual decrease at higher needling densities attributed to fiber breakage.  Thus, the needling 
density used for the nonwoven TE scaffolds is likely near the optimal level for maximizing E.  
Studies investigating needled nonwovens generated at different needling densities and different 
bulk densities would be necessary in order to conclusively demonstrate this phenomenon. 
    
5.5.5 Reinforcement Effects in Needled Nonwoven Scaffolds 
 
 In a recent study we investigated the effects of cyclic flexural loading on the mechanical 
and structural properties of PGA and 50:50 PGA/PLLA scaffolds dip-coated with the 
biologically-derived thermoplastic poly-4-hydrobutyrate (P4HB) [62].  After dip-coating, E of 
the 50:50 PGA/PLLA scaffold was 1687 ± 151 kPa (compared with 206 ± 16 for the unmodified 
50:50 PGA/PLLA (Table 5)).  A comparison with the upper bound predicted using the “no 
freedom” model (Eq. (7)) suggests that dip-coating did not result in a switch from spring to rod-
like fiber behavior, as this would suggest an E value of 366,000 kPa (Table 5).  Kim and Mooney 
[114] have also demonstrated experimentally that even under extreme cases of fiber bonding, in 
which the mass of a PLLA binder was 200% of the initial mass of the PGA scaffold, the 
maximum initial stiffness achieved was only ~ 55,000 kPa. 
 In another study we demonstrated a strong positive linear relation between E and 
collagen concentration in a TEHV (Figure 51A) [63].  TEHV constructs were fabricated by 
dynamically seeding ovine vascular SMC onto nonwoven 50:50 PGA/PLLA scaffolds at a 
density of 17 x 106 SMC/cm2.  Immediately following the 30 hour seeding period, at which point 
no collagen could be detected biochemically, no increase in E was detected despite the dense 
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 cellularity (536 ± 38 µg DNA/g wet weight) and substantial accretion of sulfated 
glycosaminoglycans (S-GAG) (1393 ± 145 µg S-GAG/g wet weight).  In identically fabricated 
constructs incubated under static or cyclic flexural loading conditions for 3 weeks, 351% (static) 
and 429% (cyclic flexure) increases in E were observed to correlate strongly with collagen 
concentration. 
 
 
Figure 51 E results for cell-seeded nonwoven 50:50 PGA/PLLA scaffolds plotted versus 
collagen concentration (mean ± SEM, n=6) (A).  Adapted from Engelmayr et al. [63] with 
permission by Elsevier Inc.  Structural model predicted dependence of E on the fiber inter-bond 
arc length (B).  Note that as the number of rigidly bonded fiber-fiber cross-over points increases 
(such as with P4HB dip-coating or collagen accretion), the fiber inter-bond arc length decreases 
and the fiber effective stiffness ( )f 'E  increases.  Values of E for unseeded (short dashed line) 
and 9-week mesenchymal stem cell-seeded (long dashed line) nonwoven 50:50 PGA/PLLA 
scaffolds are indicated for comparison. 
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 Toward explaining these large increases in E, we initially attempted to estimate E of the 
cell-seeded nonwoven scaffolds using a simple rule-of-mixtures (ROM)    
 ( ) 'f f m mE E v E v= +  (12) 
in which E is the effective stiffness of the nonwoven nonwoven-ECM composite, and ( )f 'E , Em, 
vf, and vm are the effective stiffnesses and volume fractions of the scaffold and ECM phases, 
respectively [93].  Equation (12) assumes that all of the scaffold fibers are oriented parallel to the 
loading direction (i.e., overestimates the scaffold contribution to E), and thus given a measured 
value of E should provide a lower bound on Em.  It is evident, however, that higher order 
reinforcement mechanisms must be acting within the nonwoven nonwoven-ECM composite that 
are not predicted by Eq. (12).  For example, assuming an upper bound on vm of 0.96 and a 
constant ( )f 'E  value of 8896 kPa (Table 5), Eq. (12) predicts lower bounds on Em of 648 kPa 
and 410 kPa for the cyclic flexure and static specimens, respectively.  Given the relatively low 
collagen content of these specimens, however, even these lower bounds on Em appear 
unrealistically high.  For example, in similarly fabricated TEHV based on rapidly degrading 
nonwoven PGA scaffolds, the initial stiffness measured in uniaxial tension following 20 weeks 
in vivo maturation and complete scaffold degradation (i.e., E ≡ Em) was only ~ 160 kPa [32].  
Based on the needled nonwoven TE scaffold structural-mechanics elucidated herein, a more 
reasonable explanation is that ( )f 'E  is not a constant, but rather depends on Em. 
 Figure 51B illustrates quantitatively the contribution of rigidly bonded fiber-fiber cross-
over points (Figure 44) to E, with variations in aeff and Λeff expressed in terms of a single arc 
length parameter.  The fiber inter-bond arc length was calculated using the average values of aeff 
and Λeff measured for the 50:50 PGA/PLLA scaffold (Table 5).  Physically, Fig. 10B suggests 
that one of the principal reinforcement mechanisms acting in nonwoven nonwoven-ECM 
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 composites is an increase in the number of rigidly bonded fiber-fiber cross-over points, with a 
concomitant decrease in the arc length of the curved fiber segments spanning between these bond 
points, and thus effectively stiffer fibers.  This unique reinforcement mechanism is dependent on 
both the spring-like tensile response of the crimped fibers, as well as on the splayed distribution 
of fiber orientations (i.e., availability of fiber-fiber cross-over points), and thus would not be 
expected to manifest in traditional unidirectional or straight fiber-reinforced composites [93].  
Indeed, a thorough literature search suggests that this is the first study to report on this unique 
reinforcement mechanism, and the first to explain the large increases in E observed in nonwoven 
50:50 PGA/PLLA scaffolds with tissue formation [63].   
 It must be noted, however, that the sharp increase in E predicted with decreased fiber 
inter-bond arc length (Figure 51B) must inevitably saturate as the fiber inter-bond arc length 
approaches the minimum inter-fiber distance.  The minimum inter-fiber distance is a function of 
the scaffold bulk density (Table 4), and for the 50:50 PGA/PLLA scaffolds considered in the 
current study was estimated to be ~ 200 µm (see Sensitivity analysis methods).  In support of this 
saturation behavior, the structural model predicts an E value of 36,200 kPa for a nonwoven PGA 
scaffold with a fiber inter-bond arc length of 200 µm.  This approaches the maximum E value of 
~ 55,000 kPa mentioned above for PLLA bonded PGA scaffolds [114].           
 In addition to the nonwoven nonwoven-ECM coupling described above, another factor 
which must be accounted for in predicting E of a cell-seeded nonwoven scaffold is the 
transmural distribution of cell and ECM constituents.  As mentioned previously, it remains 
unclear if the quality or organization of the collagen deposited in response to cyclic flexure is 
fundamentally different than that deposited under static conditions, as concurrent changes were 
observed in the transmural cell and ECM distribution [63].  Equation (37) (see Appendix C) 
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 shows how the bending moment of a fiber Mf depends on the distance y the fiber lies from the 
neutral axis.  In Eq. (37) the fiber stiffness Ef (or ( )f 'E ) is considered a constant, however in the 
case of a heterogeneous transmural distribution of collagen, the value of ( )f 'E  accounting for 
the reinforcement mechanism described above would also be expected to vary with y.  Thus, 
these results suggest that an accurate model for E of cell-seeded nonwoven scaffolds will need to 
account for both: (a) the unique coupling between ( )f 'E  and Em and (b) the transmural variation 
of collagen concentration (i.e., Em(y)). 
 
5.5.6 Implications for Cellular and ECM Deformation 
 
 The results of the current study demonstrate that the extension of curved fiber segments is 
fundamental to the deformation of needled nonwoven TE scaffolds.  Thus, it would be expected 
that extension of these curved fiber segments will play an important role in determining the 
micro-scale strains imparted to the cells embedded in their ECM.  Akbarov and coworkers [161] 
have developed rigorous analytical and numerical solutions for the stress distribution in the 
matrix phase surrounding sinusoidal curved fibers in composite engineering materials.  
Tentatively, these results leave open the possibility for significant cell and ECM strain 
amplification, with small longitudinal extensions yielding large transverse deflections in the 
curved fiber segments.  If conclusively demonstrated, such a strain amplification phenomenon 
would have important ramifications for mechanotransduction in cell-seeded nonwoven scaffolds, 
and thus warrants further investigation.  
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 5.5.7 Summary 
 
In the current study we developed and experimentally verified a structural model to predict E 
of a nonwoven TE scaffold in bending.  To the best of our knowledge this is the first study to 
report the following key findings: 
 
? Needled nonwoven scaffolds are not isotropic, but rather exhibit distinct PD and XD fiber 
directions with an E ratio (PD/XD) of ~ 3-to-1. 
? The crimped PGA and PLLA fibers behave like springs rather than straight rods, with 
effective stiffnesses ( )f 'E  that can be calculated using the sinusoidal fiber shapes. 
? The structural model can predict E of the surface hydrolyzed scaffolds described by Gao 
et al. [107], and thus can be used to design scaffolds with E similar to native soft tissues. 
? The primary effect of collagen reinforcement in nonwoven nonwoven-ECM composites 
(i.e., cell-seeded scaffolds) is an increase in the number of rigidly bonded fiber-fiber 
cross-over points with concomitant increases in ( )f 'E .  This higher order reinforcement 
mechanism is dependent on the unique combination of the spring-like fibers and their 
angular dispersion, and precludes the use of simple rule-of-mixtures theory.   
 
The structural model provides a rigorous, tractable mathematical foundation for 
developing a composite model of an engineered tissue based on a needled nonwoven scaffold.  
Toward this goal, concurrent studies are underway in our laboratory to quantify and model the 
interactions between the scaffold and the ECM.   
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6.0 MULTI-SCALE COMPOSITE MODELS FOR PREDICTING THE EFFECTIVE 
STIFFNESS OF ENGINEERED TISSUES BASED ON NONWOVEN SCAFFOLDS 
 
6.1 INTRODUCTION 
 
Tissue engineered heart valves (TEHV) constructed by seeding cells onto porous 
biodegradable scaffolds (e.g., nonwoven polyglycolic acid (PGA)) inherently begin development 
as composite materials.  Prior to scaffold resorption, the effective mechanical properties of these 
constructs will include contributions from both the scaffold and tissue constituents (e.g., 
collagen) [162].  While the ultimate goal following implantation is the development of a 
mechanical stable tissue devoid of scaffold [17], the endpoint of our current in vitro conditioning 
regimens is a construct possessing sufficient extracellular matrix (ECM) and concomitant 
mechanical integrity to support acute hemodynamic function and subsequent in vivo remodeling 
[8, 32].  Thus, during both the in vitro and early in vivo phases of development, mechanical 
interactions between the scaffold and ECM will not only determine the strength and mechanical 
performance of the TEHV, but also the local mechanical environment experienced by the cells. 
As demonstrated above in Section 2.5.8, TEHV specimens incubated under static and 
cyclic flexure conditions exhibit distinct transmural cell and ECM distributions (Figure 52).  In 
Section 5.5.5 we demonstrated how the bending moment of a scaffold fiber depends on its 
distance from the neutral axis, and suggested that an accurate composite model of a cell-seeded 
nonwoven scaffold would need to account for the transmural cell and ECM distribution.  
Moreover, we demonstrated that a simple rule of mixtures approach does not apply to needled 
nonwoven scaffolds.  This was due to the higher order reinforcement mechanism of increased 
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 fiber-fiber bonding with increased matrix stiffness, and suggested that more complex models 
would be needed to accurate reflect this behavior.  In the following sections we describe two 
approaches toward modeling the composite mechanical properties of cell-seeded nonwoven 
scaffolds.  In the first approach, we develop a meso-scale model that accounts for both the 
transmural distribution of collagen, as well as the unique nonwoven-ECM coupling exhibited in 
needled nonwovens.  For this first approach, the transmural collagen concentration distribution is 
quantified by fluorescence image analysis of picro-sirius stained sections, and the nonwoven-
ECM coupling behavior is quantified empirically using physical models of the ECM and the 
nonwoven-ECM composite.  These data are used to retrospectively analyze the static and cyclic 
flexure specimens from our previous study [63].  In the second approach, we develop a micro-
scale model in which we attempt to predict the change in fiber effective stiffness with ECM 
deposition from static equilibrium and strain energy considerations. 
 
 
Figure 52 TEHV specimens cultivated for 3 weeks under static and cyclic flexure conditions 
reconstructed using digital volumetric imaging (RESview™, Resolution Sciences Corp., Corte 
Madera, CA) (A).  Magnified view demonstrating bonded and “bare” fibers (B). 
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6.2 MESO-SCALE MODEL FOR NONWOVEN-ECM COMPOSITES 
 
6.2.1 Mathematical Framework 
 
 One of our primary goals in the current study was to quantify the effective stiffness of the 
de novo synthesized ECM deposited within the scaffold—EECM.  Quantification of EECM requires 
accounting for both nonwoven-ECM coupling, as well the transmural distribution of collagenous 
ECM.  Assuming linear elastic, homogeneous, isotropic (LEHI) material behavior, EI of a 
composite beam exhibiting a transmural effective stiffness distribution E(y) can be expressed in 
the following integral form [163]: 
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= ∫ ∫  (13) 
  
Note that Eq. (13) also assumes E(y) is symmetric about the geometric centerline of the beam 
cross section.  In the case of the TEHV investigated in the current study this assumption has 
proved reasonable.  As demonstrated previously in Section 5.5.5, a standard rule-of-mixtures 
accounting for the volume fractions and stiffnesses of individual composite constituents is 
inadequate to described nonwoven-ECM composites.  Thus, based on the linear relationship we 
observed previously between E and collagen concentration (Figure 25), we initially chose to 
model E(y) by a simple linear model: 
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  ( ) ( )ECM sE y R E y E= ⋅ +  (14) 
 
where R is an empirically-determined nonwoven-ECM coupling parameter, EECM(y) is the ECM 
effective stiffness at a particular distance y from the geometric center of the beam cross section, 
and Es is the effective stiffness of the unseeded scaffold.  Based again on the linear relationship 
between E and collagen concentration (Figure 25), EECM(y) was expressed by the following 
relationship: 
 
 ( ) ( )ECM c cE y C y B E= ⋅ ⋅  (15) 
 
where C(y) is the normalized transmural collagen concentration distribution, Bc is the bulk 
collagen concentration, cE  is the collagen specific stiffness in units of kPa/(µg/g wet weight 
collagen).  Collectively, these terms yield the governing equation: 
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The parameters EI, R, C(y), Bc, and Es are each measured experimentally, yielding one equation 
and one unknown, cE .  The experimental methods used in our laboratory to measure EI and Es 
are described above in Section 2.2.5, and the methods used to measure Bc are described above in 
Section 2.4.6.  The experimental methods used to measure R and C(y) are detailed below.  The 
value of cE  was found via nonlinear regression using the Levenberg-Marquardt method. 
The value of the nonwoven-ECM coupling parameter R was found by analyzing physical 
models of the engineered tissue.  The physical models were constructed as described below in 
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 Section 6.2.4 by infiltrating scaffold specimens with polyacrylamide (Pam) gels (BioRad 
Laboratores, Hercules, CA) formulated at different acrylamide/bis concentrations.  Both E of the 
Pam gel-infiltrated scaffold and EECM of the Pam gel were measured using our three-point 
bending test (Section 2.2.5).  Finally, E was plotted versus EECM and R found by a linear 
regression on the initial linear region of the curve. 
For each TEHV specimen to be analyzed, the effect of the potentially heterogeneous 
distribution of collagenous ECM needed to be accounted for.  The transmural collagen 
concentration distribution C(y) was quantified as described below in Sections 6.2.2 and 6.2.3 
from image analysis of fluorescence micrographs of picro-sirius red stained tissue sections. 
 
6.2.2 Fluorescence microscopy of picro-sirius red stained TEHV sections 
 
 Sections of TEHV were stained by the picro-sirius red method [164] as described 
previously [8].  In brief, samples of TEHV were fixed in 10% buffered formalin and embedded 
in paraffin.  Serial sections (6 µm) were rinsed with distilled water and incubated with 0.1% 
(w/v) Sirius red F3BA (Polyscience, Inc., Warrington, PA) in saturated picric acid (Fisher 
Scientific) for 90 minutes.  Sections were then rinsed twice with 0.01 M HCl for 1 minute and 
immersed in distilled water.  After dehydration with ethanol for 30 seconds, sections were 
coverslipped. 
 In order to specifically detect collagen, picro-sirius red stained sections were observed 
via fluorescence microscopy [165, 166].  Sections were visualized at 100x magnification on a 
Nikon Eclipse E800 microscope.  Epi-fluorescence mode was used with the Nikon TRITC HYQ 
filter set.  1600 x 1200 pixel grayscale images were captured using a Spot RT monochrome CCD 
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 camera with IR filter (model 2.1.1.1) via a 1x C mount coupler (HRD100-CMT) and Spot 
Imaging Software (Diagnostic Instruments, Inc., Sterling Heights, MI).  An exposure time of 1 
second was found to yield peak grayscale intensities of approximately 180 on a 0 to 255 scale, 
thereby avoiding saturation of the intensity scale and providing allowance for potentially higher 
collagen concentrations in future experiments. 
 
6.2.3 Transmural collagen concentration distribution 
 
 A custom program was written in Matlab to analyze the grayscale images.  Prior to image 
analysis, raw grayscale images were rotated and/or cropped such that the edges of the TEHV 
cross-section corresponded with the left and right edges of the image.  Any residual fragments of 
scaffold appearing in the images were manually deleted.  The pixel value of the dark background 
was set to zero by thresholding all pixels with intensity of 50 or less to zero (Corel Photo-Paint 
10; Corel Corp.).  A custom program was written in Matlab to compute the grayscale (0-255) 
intensity distribution across each row of the image (i.e., the tissue cross-section).  The program 
then computes the mean grayscale intensity distribution, averages it and normalizes it to the 
thickness of the tissue cross-section. 
 
6.2.4 Polyacrylamide Gels and Gel-infiltrated Scaffolds 
 
50:50 blend nonwoven PGA/PLLA scaffolds described above in Section 2.4.1 were 
prepared for fabricating polyacrylamide gel infiltrated scaffolds.  For each experiment, 10 ml of 
a particular concentration (Table 7) of acrylamide/bis solution was prepared per the 
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 manufacture’s guidelines (Bio-Rad Laboratories, Hercules, CA).  Note that the 1.5 M TRIS/HCL 
buffer, 10% sodium dodecyl sulfate (SDS), 30% acrylamide/bis, and tetramethylethylenediamine 
(TEMED) were all purchased pre-made from Bio-Rad.  The 10% (w/v) ammonium persulfate 
(APS) solution was made fresh for each experiment by adding 0.5 g of APS to 5 ml of water.  A 
Bio-Rad gel casting module was assembled using 1 mm spacer plates, and approximately 2.5 ml 
of the acrylamide/bis solution was pipetted in between the plates.  Subsequently, nonwoven 
scaffold specimens (n=6) were immersed into the acrylamide/bis solution until saturated (< 30 
sec.), and then slipped between the spacer plates using forceps such that they became immersed 
in the 2.5 ml of acrylamide solution already between the plates.  After the scaffold specimens 
were situated between the spacer plates, the remaining volume of acrylamide/bis solution was 
pipetted on top of the scaffolds such that the scaffolds were entirely immersed.  Finally, ~100 
microliters of 1-butanol (Sigma) saturated with water (e.g., 1 ml of water mixed with 4.5. ml of 
1-butanol) was pipetted on top of the acrylamide solution to aid in acrylamide polymerization, as 
it is inhibited by oxygen.  Acrylamide/bis solutions were allowed to gel for 1 hour at room 
temperature prior to removal from the spacer plates (Figure 53).  After gels were removed, gel-
infiltrated scaffolds and gel specimens (25 x 7.5 x 1 mm) were cut from the gel using a razor and 
then prepared for three point bending testing as described above in Section 2.2.5. 
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 Table 7 Quantities of chemicals used in preparing polyacrylamide gel solutions.  All 
quantities are given in microliters.  Note that APS stands for Ammonium Persulfate and TEMED 
for Tetramethylethylenediamine. 
Material 5.0% 7.5% 10% 11.25% 12.5% 15% 17.5% 18.75% 20.7% 
dH20 5670 4850 4200 3590 3180 2350 1520 1100 450 
1.5 M 
Tris/HCL 
pH 8.8 
2500 2500 2500 2500 2500 2500 2500 2500 2500 
10% SDS 100 100 100 100 100 100 100 100 100 
Acryl/Bis 
(30%) 1670 2500 3250 3750 4170 5000 5830 6250 6900 
 10% 
APS 
(fresh) 
50 50 50 50 50 50 50 50 50 
TEMED 5 5 5 5 5 5 5 5 5 
Total 10000 10000 10000 10000 10000 10000 10000 10000 10000 
 
 
 
Figure 53 Photograph of polyacrylamide gel-infiltrated scaffold preparation. 
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 6.3 Results 
 
6.3.1 Fluorescence Microscopy Results 
 
Fluorescent illumination of picro-sirius stained TEHV sections using the TRITC HYQ 
filter set yielded remarkably clear images of the collagen fibers (Figure 54A).  As described 
previously, staining of the cell cytoplasm by the picric acid resulted in some background 
fluorescence; however the strongest fluorescence was associated with the fibrillar collagen 
network.  Also, some scaffold remnants were found to fluoresce (Figure 54A, black arrow).  
These fluorescently labeled fibers were manually deleted from images prior to analysis.  To 
demonstrate the equivalence between fluorescence intensity and the bulk biochemical collagen 
measurements, the mean normalized fluorescence intensity was plotted versus the bulk collagen 
concentration for each of the 12 specimens (n=6 static, n=6 cyclic flexure) from our previous 
study [63].  A strong positive linear relationship was found (R2=0.915), indicating that the 
measured fluorescence intensities were indeed reflective of the collagen concentrations. 
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Figure 54 Fluorescence micrograph of a picro-sirius red stained TEHV section (A).  The 
collagen fiber network fluoresced intensely compared with the background fluorescence of the 
cytoplasm.  Scale bar = 10 µm. 
 
6.3.2 Transmural Collagen Distribution Results 
 
Fluorescent micrographs from 3 week flexed (Figure 55A) and static control (Figure 
55C) specimens were analyzed by the custom Matlab program, yielding significantly different 
normalized transmural fluorescence intensity distributions (Figure 55B and D, respectively).  
The normalized fluorescence intensity distributions (i.e., C(y), normalized collagen concentration 
distributions) for the flex (n=6) and static (n=6) groups were averaged for implementation in the 
meso-scale model (Figure 56), and fit to quadratic equations of the form  with 
coefficients a = 4.009 and c = 0.667 (R
2( )C y ay c= +
2=0.9326; flex group) and a = 9.946 and c = 0.173 (R2 = 
0.9531; static group). 
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Figure 55 Representative fluorescent micrographs of picro-sirius red stained sections of 
cyclic flexure (A) and static (C) TEHV specimens.  Scale bar = 100 µm.  Normalized 
fluorescence intensity distributions output by the custom Matlab program (B and D, 
respectively).  Normalized fluorescence intensity distributions for individual specimens were 
averaged for the static and cyclic flexure groups in the meso-scale model analysis. 
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Figure 56 Average normalized collagen concentration distributions for the static and cyclic 
flexure groups. 
 
6.3.3 Nonwoven-ECM Coupling Parameter Results 
 
By varying the concentration of acrylamide/bis in fabricating the polyacrylamide gels, the 
effective stiffness of the polyacrylamide gels (i.e., EECM) was varied between 30 kPa (5% 
acryl/bis) and 665 kPa (20.7% acryl/bis) (Figure 57A).  A plot of the effective stiffness of the 
gel-infiltrated scaffolds (E) versus EECM yielded a linear region within the range 0 kPa < EECM < 
271 kPa.  The nonwoven-ECM coupling parameter R was determined within this linear region by 
regression to be 7.444 kPa/kPa (Figure 57B). 
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Figure 57 Effective stiffness of the polyacrylamide gel (i.e., EECM) as a function of percent 
(w/v) acrylamide monomer (A).  The range of EECM values was ~30-665 kPa.  E of the gel 
infiltrated nonwoven scaffolds (i.e., the TEHV analog) versus EECM (B).  The nonwoven-ECM 
coupling parameter determined within the linear region was 7.444 kPa/kPa.  For reference, the 
mean values of E from the flex (978 kPa; long dashed line) and static (748 kPa; short dashed 
line) groups are indicated [63].  The rule-of-mixtures did not fit the data (black dotted line). 
 
 
6.3.4 Meso-Scale Model Results 
 
The values of C(y) and R (7.444 kPa/kPa) measured above in Sections 6.3.2 and 6.3.3, 
respectively were combined with the values of Bc, Es (206 kPa), and E measured in our previous 
study [63] through the meso-scale model (Eq. (16)).  The one unknown parameter, collagen 
specific stiffness Ēc, was solved for via a non-linear regression using the Levenberg-Marquardt 
method.  There was a trend of increased Ēc in the flex versus static group (Table 8), suggesting 
that while cyclic flexure primarily affects collagen content by 3 weeks, it may affect the 
structural-mechanical quality at later time points.  Predicted values of Ēc were then used to plot 
the transmural ECM effective stiffness distribution, EECM(y) (Figure 58).  Predicted values of 
EECM(y) ranged from a minimum of 53.7 kPa (flex) and 7.5 kPa (static) in the center to a 
maximum of 134.4 kPa (flex) and 114.6 kPa (static) at the periphery.  
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 Table 8 Summary of experimental group-specific parameters used and/or predicted by the 
meso-scale model.  Note that E and Bc were obtained above in Sections 2.5.5 and 2.5.6 [63]. 
C(y) =ay2+c Experimental 
Group 
E 
(kPa) 
Bc
(µg/g wet weight) a c 
Ēc
(kPa/( µg/g wet weight) 
Static 748 ± 130 893 ± 133 9.946 0.173 0.0789 
Flex 978 ± 228 546 ± 111 4.009 0.667 0.0904 
 
 
 
Figure 58 Transmural EECM distribution predicted using the meso-scale model (Eq. (16)). 
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 6.4 MICRO-SCALE MODEL FOR NONWOVEN-ECM COMPOSITES 
 
6.4.1 Mathematical Framework 
 
While a fully non-linear approach for solving the problem of a curved fiber embedded in 
an elastic medium has been published by Akbarov and co-workers [167], previous approaches 
were limited to small deformations and only considered a single fiber orientation (i.e., parallel to 
the loading direction), and thus would not be directly applicable to the needled nonwoven-ECM 
composite, whose behavior was shown in Section 5.5.5 to be dominated by variations in fiber-
fiber bonding at cross-over points.  Toward developing a more fundamental understanding of the 
micro-mechanical interactions between needled nonwoven scaffolds and deposited ECM, in the 
current study we developed a simplified micro-scale model in which static equilibrium between 
the fiber and ECM phases, as well as the strain energy generated in the ECM phase in response 
to fiber curvature, were considered. 
The governing equation assumed for the micro-scale model was static equilibrium 
between the needled nonwoven scaffold fibers and the ECM phase (e.g., ECM, polyacrylamide 
gel (ECM analog), expressed here in terms of the bending moments: 
 
 f ECMM M=  (17) 
 
Substituting Eq. (39) for Mf and the Bernoulli-Euler moment-curvature relation (Eq. (1) ) for the 
ECM phase, Eq. (17) can be re-expressed as: 
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( ) 2 / 2 4
/ 2
( ) cos
12
f f f ECM ECM
N E A t E IR d
π
πρ ρ−
′
Φ Φ Φ = ∫  (18) 
 
However, while the right-hand term of Eq. (18) for the ECM phase would be appropriate 
for straight fibers, the actually bending moment generated in the ECM phase embedded with 
curved fibers would be expected to be much higher, given the contribution of strains in the 
transverse (e.g., z-axis) direction induced by straightening of the curved fibers in the longitudinal 
(e.g., x-axis) direction (Figure 59). 
 
 
Figure 59 Schematic illustrating the transverse strains that would develop in the ECM phase 
(black arrows) in response to extension of a curved fiber (solid black curve) in the longitudinal 
direction to the straightened configuration (dashed black line).  Transverse strains would be 
maximal at the maxima and minima of the curve. 
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 Rather than focusing on the development of an exact solution for the transverse strains, 
whose solution is beyond the scope of this work, we estimated the ratio  of the strain energy 
generated in the ECM due to extension of a curved fiber, , to a straight fiber, 
ϒ
curved
ECMU
straight
ECMU , and 
used this ratio as a correction term in Eq. (18): 
 
 
( ) 2 / 2 4
/ 2
( ) cos
12
f f f ECM ECM
N E A t E IR d
π
πρ ρ−
′
Φ Φ Φ = ϒ∫  (19) 
 
By making appropriate substitutions for IECM, Eq. (19) reduces to: 
 
 ( ) / 2 4
/ 2
( ) cos
ECM ECM
f
f f
E AE
N A R d
π
π−
ϒ′ = 
Φ Φ Φ∫  (20) 
 
In which (  can be calculated using Eq. (8) from Section 5.2.3, and each of the terms on the 
right-hand side are known with the exception of 
)fE ′
ϒ . 
To estimate  we used the average effective crimp amplitude aϒ eff (0.090407 mm) and 
wavelength Λeff (1.051684 mm) values measured for the 50:50 PGA/PLLA scaffold (Section 
5.4.2; Table 5) (Note: aeff  = 0.1 mm and Λeff  = 1 mm were used for simplicity).  The arc length 
of one wavelength was calculated by: 
 
 
2
1
0
2 21 cos
x eff
x
eff eff
a xs
π π=
=
⎛ ⎞= + ⎜⎜ Λ Λ⎝ ⎠∫ ⎟⎟  (21) 
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 And thus straightECMU was calculated by: 
 
 212
straight
ECM x ECM x xU U E dε= = V  (22) 
 
where the fiber and ECM strain in the longitudinal (i.e., x-axis) direction is given by: 
 
 effx
eff
sε − Λ= Λ  (23) 
and dVECM was calculated from: 
 
 ( )x eff f effdV d aδ= Λ  (24) 
 
where δ is some multiple of aeff that reflects the range of influence of the curved fiber in the 
transverse direction.  In the micro-scale model the parameter δ was fit, and the fitted value was 
compared with the average inter-fiber distance (see Section 5.3.10) to test for physical 
plausibility. 
The strain energy for the curved fiber case was given as the sum of the strain energy 
generated by longitudinal strains (i.e., ) and 4 times the strain energy generated in the 
transverse direction for a one-quarter wavelength segment of fiber: 
xU
 
  (25) 4curvedECM x yU U= + U
where  was calculated from: yU
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 212y ECM yU E dε= yV∑  (26) 
 
where εy is a function of position x along the length of the one quarter wavelength, and is given 
by: 
 
 oy
o
y y
y
ε −=  (27) 
where yo is given by: 
 
 ( ) 2sino eff eff
eff
xy a a πδ ⎛ ⎞= − ⎜⎜ Λ⎝ ⎠
⎟⎟  (28) 
 
and y is simply given by effaδ .  The one quarter wavelength was discretized into twenty-six 0.01 
mm-wide volume elements dVy given by 0.01dfyo. 
In fitting the micro-scale model to the polyacrylamide gel / gel-infiltrated scaffold results 
presented above for the meso-scale model (Section 6.2), the ratio ϒ was calculated for both the 
PD and XD specimens by fitting individual values for the parameter δ.  The value of δ, which is 
related to the average inter-fiber distance, was assumed to be different for the PD and XD 
directions due to the 3:1 ratio of fibers oriented in those directions, respectively. 
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 6.4.2 Micro-scale model results  
 
The values of δ were found to be 3.52 and 4.90 for the PD and XD specimens, 
respectively.  Physically, δaeff represents the effective height of the rectangular slab in which the 
curved fiber is embedded, and thus for an aeff value of 0.1 mm, the inter-fiber distance for the PD 
specimens would range from a minimum of 152 microns to a maximum of 352 microns, 
depending on whether the fibers were aligned anti-phase or co-phase, respectively.  In Section 
5.3.10, the average inter-fiber distance for the PD specimens was estimated to be ~ 200 microns, 
which falls within the range predicted by the micro-scale model.  For the XD specimens, the 
corresponding minimum and maximum inter-fiber distances would be 290 and 490 microns, 
respectively. That the inter-fiber distance is larger for the XD specimens makes sense intuitively, 
since there are fewer fibers oriented in the XD direction and thus the average distance between 
them should be greater than for the PD direction.  The values of ϒ corresponding with these 
values of δ were found to be 7.35 and 4.10 for the PD and XD specimens, respectively.  
Physically, this means that the strain energy generated in the ECM by extension of a curved fiber 
in the PD direction is 7.35-fold the strain energy associated with extension of a straight fiber.  
This additional strain energy is due to the transverse strains associated with straightening of the 
curved fiber.  The reason why is lower for the XD direction is due to the fact that more ECM 
is associated with each fiber, and thus the difference between extending a straight fiber and 
curved fiber is reduced. 
ϒ
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Figure 60 Micro-scale model results for preferred (PD) and cross-preferred (XD) fiber 
directions. 
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6.5 DISCUSSION 
 
6.5.1 Transmural collagen concentration distribution 
 
 Martin et al. [168] previously reported on an imaging-based method for quantifying the 
transmural distribution of sulfated glycosaminoglycan (S-GAG) concentration in native and 
tissue engineered cartilage.  They identified a pixel parameter (red intensity) that could be 
measured in digitized photomicrographs of Safranin-O stained histological sections and 
subsequently correlated with the biochemically measured S-GAG concentration.  Their method 
was unique in that it allowed not only for binary segmentation of an image into S-GAG positive 
and negative regions, as had been done previously for S-GAG (refs), but also for correlation to 
the S-GAG concentration at a particular position.  Their ability to establish such a strong 
correlation was due in part to the specific and stoichiometric binding of the cationic dye Safranin 
O to the negatively charged groups of chondroitin-6-sulfate or keratan sulfate. 
 In the current study we developed a similar method for quantifying the transmural 
distribution of collagen concentration.  As opposed to previous studies, in which binary 
segmentation based on pixel intensity threshold was used to discriminate collagenous regions 
from non-collagenous regions, the method developed here relates pixel intensity to collagen 
concentration.  As in the case of the study by Martin et al., our ability to establish this relation is 
due to the specificity and stoichiometric binding of Sirius red to fibrillar collagens.  In a previous 
study by Junqueira et al. [169] it was demonstrated that collagen types I, II, and III each bind an 
average of 126 molecules of Sirius red per collagen molecule.  Moreover, they demonstrated a 
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 linear relationship between the optical density at 540 nm (the absorption maxima of Sirius red) 
and collagen concentration.  This is, in fact, the basis of the Sircol® collagen assay kit used in 
our biochemical assays of collagen concentration. 
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7.0 FUTURE DIRECTIONS 
 
The field of heart valve tissue engineering, while no longer in its infancy per se, is still 
remarkably young.  While the first mechanical and bioprosthetic valve replacements were 
introduced over 40 years ago [170], the first attempts to develop a TEHV began only a decade 
ago.  While significant progress has been made, much work remains, both in delineating the 
functional requirements of a TEHV suitable for clinical evaluation, as well as developing the 
means to produce one.  The following sections describe in detail future directions in heart valve 
tissue engineering that may help lead toward this ultimate goal. 
 
7.1 GUIDANCE OF TEHV CELL AND COLLAGEN ORIENTATION 
 
7.1.1 Introduction 
  
The tensile mechanical properties of heart valve leaflets and other load-bearing soft 
tissues are exquisitely sensitive to collagen fiber orientation [48, 171].  In the case of valvular 
tissues, the geometric arrangement of the collagen fiber network is finely tuned to organ-level 
functional requirements [3], and can be remodeled by the resident cells in response to chronic 
shifts in physiological stresses [51].  In developing a functionally-equivalent tissue engineered 
heart valve (TEHV), a primary goal is to recapitulate the essential features of this native 
microstructure for ensuring both robust mechanical function and long-term durability [172].  
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 However, while circumferentially-oriented collagen fibers have been observed in the fibrosa-like 
layer of 20 week explants, the cells and collagen of these TEHV based on bioresorbable 
nonwoven scaffolds do not exhibit a well organized structure during in vitro conditioning and at 
early time points in vivo [8]. 
 Toward enhancing the in vitro stage of tissue formation, pulsatile flow loop bioreactors 
have been designed to develop optimized mechanical conditioning protocols for TEHV [32, 
173].  We recently demonstrated that cyclic flexure, the major mode of TEHV deformation in a 
pulsatile flow loop, can independently enhance collagen synthesis with concomitant increases in 
tissue effective stiffness [62, 63].  However, while these and other studies [61, 64] have clarified 
the role of mechanical forces in stimulating TEHV collagen synthesis, investigators currently 
possess limited data regarding the evolution of TEHV collagen orientation.  Specifically, the 
potential role of initial scaffold microstructure in guiding cell and collagen orientation remains 
unaddressed. 
 Numerous studies have demonstrated the capacity of micro-grooves and other structured 
surface topologies to guide cell and collagen orientation in monolayer tissue culture [174], 
however it is not clear to what degree guidance phenomenon may manifest, or explicitly be 
exploited, in the fully three-dimensional (3-D) tissue engineering (TE) setting.  TE scaffolds 
differ significantly from micro-grooved substrates in that they consist of a 3-D open pore 
network in which multiple layers of cells and extracellular matrix (ECM) span and fill the void 
spaces between scaffold structural members.  In the first study of its kind, we previously utilized 
a small angle light scattering (SALS) technique to quantify the collagen fiber orientation of the 
TE skin equivalent Dermagraft™ [151].  By scanning both cell-seeded and unseeded samples of 
the Vicryl® scaffold, it was possible to optically decouple the collagen fibers from the scaffold 
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 fibers via the principle of superposition, and thereby to establish the orientation of collagen 
fibers to be parallel to the major axis of the diamond-shaped pores. 
 In the current study we extended our previous work [151] by developing an in vitro 
model system in which large-scale (~ 200 µm) open pore structures of varying geometry could 
be rapid-prototyped and systematically evaluated for their cell and collagen orientating capacity.  
Non-degradable scaffolds exhibiting a grid of 200 µm wide rectangular pores (1:1, 2:1, 5:1, and 
10:1 aspect ratios) and diamond-shaped pores (600 x 1000 µm) were fabricated from a 
transparent epoxy resin via high-resolution stereolithography.  The scaffolds were surface 
modified to support cell adhesion by covalently grafting GRGDS peptides, sterilized, and seeded 
with neonatal rat skin fibroblasts.  Following 4 weeks of static incubation, the resultant collagen 
orientation was assessed quantitatively by SALS, and cell orientation was evaluated by laser 
confocal and scanning electron microscopy. 
 
7.1.2 Methods 
 
7.1.2.1 Scaffold Fabrication 
 
Non-degradable scaffolds with rectangular pores (1:1, 2:1, 5:1, and 10:1 aspect ratio) 
were fabricated by high-resolution stereolithography (FineLinePrototyping, Inc., Raleigh, NC) 
using a Viper Si2™ SLA® system (3D Systems Corp., Valencia, CA) and a transparent resin 
(WaterClear™ 10120, DSM Somos®, Newcastle, DE).  The struts of the scaffolds were 
approximately 100 µm wide, and the inside dimensions of a 1:1 aspect ratio pore were 200 x 200 
µm (Figure 61).  To compare results with our previous work [151], we fabricated scaffolds with 
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 a diamond-shaped pore structure similar to that of the Vicryl® scaffold used in manufacturing 
the TE skin equivalent Dermagraft™.  The inside dimensions of the diamond-shaped pores were 
600 x 1000 µm.  The gross dimensions of each of scaffold were 20 x 20 x 0.75 mm.  Scaffolds 
were surface modified to promote cell attachment by adapting a previously described method 
[175]. 
Scaffolds were rinsed in acetone (SIGMA®, Sigma-Aldrich Co., St. Louis, MO), ethanol 
(SIGMA), and deionized water and then immersed in a 4% (v/v) solution of 3-
aminopropyltriethoxysilane (SIGMA) in acetone for 10 minutes.  The scaffolds were then rinsed 
as above and immersed in a 6% (v/v) glutaraldehyde (SIGMA) in a 0.2M TRIS (SIGMA) 
solution for 10 minutes.  The scaffolds were then rinsed in deionized water, placed into sterile 50 
cc centrifuge tubes, and incubated for 16 hours at 8 rpm (Labquake rotisserie rotator, Barnstead-
Thermolyne, Dubuque, IA) in a 0.1 mg/ml solution of GRDGS peptides (SIGMA) in phosphate 
buffered saline (PBS) (GIBCO™, Invitrogen Corporation, Grand Island, NY).  Following the 
GRGDS incubation, scaffolds were rinsed in deionized water and incubated for 16 hours at 8 
rpm (Labquake rotisserie rotator) in 0.1M ethanolamine (SIGMA) in PBS to quench any 
unreacted aldehyde groups.  Scaffolds were sterilized in 70% isopropyl alcohol (LabChem, Inc., 
Pittsburgh, PA) for 30 minutes and rinsed three times with sterile PBS prior to cell seeding. 
 
7.1.2.2 Cell Culture and Seeding 
 
 
In order to compare our new in vitro model system to our previous structural 
investigations on the TE skin equivalent Dermagraft™ [151], in the current study 27FR neonatal 
rat skin fibroblasts (CRL-1213, ATCC, Manassas, VA) were utilized in lieu of the vascular-
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 derived smooth muscle cells (VSMC) and other cell types typically used in TEHV fabrication 
[32].  Cells were expanded in Dulbecco’s Modified Eagle’s Medium with 4.5 g/L glucose and L-
glutamine (GIBCO) supplemented with 10% fetal bovine serum (GIBCO) and 1% antibiotic-
antimycotic (GIBCO).  A total of 10 confluent 185 cm2 flasks (Nuclon™∆ SoLo flask; Nalgene 
Labware) of cells (Passage 19) were trypsinized (0.25% trypsin, 1 mM EDTA; GIBCO) and 
resuspended in 300 ml of culture medium to yield a seeding solution of approximately 3 x 105 
cells/ml, as determined by cell counts with a hemacytometer (Hausser Scientific, Horsham, PA).   
The general seeding techniques have been described previously [63].  One scaffold was 
placed into each of 30 seeding tubes.  Each seeding tube consisted of a 50 cc centrifuge tube 
(Product # 91050; TPP, Trasadingen, Switzerland) fitted with a vent filter cap from a 50 cc tissue 
culture tube (Product # 91253; TPP), thereby allowing for gas exchange during seeding.  Seeding 
solution (10 ml) was added to each tube to yield a seeding density of approximately 7.5 x 105 
cells/cm2 (i.e., 3 x 106 cells / 4 cm2 scaffold).  The tubes were rotated at 8 rpm (Labquake 
rotisserie rotator) inside an incubator operating at 37°C and 5% CO2 for 30 hours.  Following 
seeding, scaffolds were incubated under static conditions for 28 days in 6 ml of medium in 6-
well plates (Costar Ultra Low Attachment; Corning, Corning, NY).  The culture medium was 
changed daily throughout the course of the study.  Unmodified scaffolds (i.e., lacking the 
GRGDS surface modification) pre-incubated for 16 hours in culture medium served as controls. 
 
7.1.2.3 Small Angle Light Scattering 
 
Small angle light scattering (SALS) was used to quantify the orientation of the de novo 
synthesized collagen.  A detailed description of the SALS device and analysis methods [150], as 
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 well as its application to fibrous PGA scaffolds [151], have been published previously.  In brief, 
1 scaffold sample (20 x 20 mm) was scanned at discrete intervals (1 mm) using a 1 mm diameter 
Helium-Neon laser beam.  The resultant scattered light intensity distribution at each point was 
averaged and normalized for both unseeded and seeded scaffolds and the preferred fiber 
direction (distribution centroid) and orientation index (OI, a measure of the degree of orientation) 
were calculated.  SALS data were expressed as mean ± standard error (SEM).  Test groups were 
analyzed by ANOVA and Tukey HSD multiple comparison test using SYSTAT 10 (SPSS, Inc., 
Chicago, Il).  Differences between test groups were considered statistically significant when p < 
0.05. 
 
7.1.2.4 Multiphoton Laser Scanning Confocal Microscopy. 
 
To evaluate cellular orientation, one scaffold sample representing each pore aspect ratio 
was prepared for laser confocal microscopy by labeling for F-actin.  In brief, scaffold samples 
were removed from culture, rinsed 3 times in PBS, and fixed for 2 hours in fresh 4% (w/v) 
paraformaldehyde (Fischer Chemicals, Fair Lawn, NJ)) in PBS.  Fixed scaffolds were then 
washed 3 times in PBS, extracted for 3 minutes in 0.1% (v/v) Triton X-100 (Sigma) in PBS, 
washed 3 more times with PBS, pre-incubated in 1% (w/v) bovine serum albumin (Sigma) in 
PBS (BSA buffer) for 20 minutes, and then incubated for 1 hour in Alexa Fluor® 568-Phalloidin 
(2:150 (v/v) dilution; Molecular Probes).   Following labeling, scaffold samples were washed 3 
times in BSA buffer, 3 times in PBS, and then stored in PBS at 2-8°C prior to laser confocal 
imaging.  Samples were imaged using a multiphoton laser scanning confocal microscope system 
comprising a titanium-sapphire ultrafast tunable laser system (Coherent Mira Model 900-F; 
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 Coherent, Inc., Santa Clara, CA), Olympus Fluoview confocal scanning electronics (Olympus 
America, Inc., Melville, NY), an Olympus IX70 inverted system microscope, and custom built 
input-power attenuation and external photomultiplier detection systems.  Z-axis image 
acquisition utilized two-photon excitation at 850nm with an Olympus water-immersion objective 
(40X UApo 1.15NA).  Red fluorescence emission detection utilized a HQ610/75m emission 
filter (Chroma Technology Corp., Rockingham, VT).  Individual images planes (1024x1024 
pixel resolution) were acquired at 2µm z-axis intervals. 
 
7.1.2.5 Scanning Electron Microscopy. 
 
One scaffold sample representing each pore aspect ratio was prepared for scanning 
electron microscopy (SEM).  Samples were fixed for 1 hour in 2.5% (v/v) glutaraldehyde 
(SIGMA), washed 3 times in 1x PBS (15 minutes each), fixed for 1 hour in 1% (w/v) Osmium 
Tetraoxide (SIGMA), washed 3 more times in 1x PBS, and then dehydrated by stepping through 
graded ethanol (SIGMA) solutions (30%, 50%, 70%, 90%, 100%) for 15 minutes each.  The 
fixed and dehydrated samples were critical point dried using an EMscope critical point dryer 750 
(EMscope Laboratories, Ashford, Kent, U.K.).  Critical point dried samples were attached to 
aluminum sample stubs and were sputter coated with a thin layer of gold-palladium alloy (~3 nm 
thickness) in a Cressington 108auto sputter coater with a Cressington MTM-20 thickness 
controller (Cressington Scientific Instruments, Inc., Cranberry Twp., PA).  Each scaffold sample 
was imaged at 5 kV on a JEOL JSM-6330F field emission scanning electron microscope (JEOL 
USA, Inc., Peabody, MA).  To quantify intra-pore cellular orientation, SEM micrographs were 
converted to binary images by contrast enhancement and thresholding (Corel Photo-Paint 10; 
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 Corel Corp., Ottawa, Canada) and the median of the cell major axis angular orientation was 
quantified using the fill measurement option of SigmaScan Pro (SPSS, Inc.). 
 
7.1.3 Results 
 
 Scaffold fabrication via high-resolution stereolithography proved to be a simple, 
relatively inexpensive method for prototyping a variety of pore shapes (Figure 62A).  Pre-
incubation of unmodified scaffolds in serum-supplemented culture medium was insufficient to 
promote cellular attachment.  In contrast, the GRGDS surface modification strategy employed 
herein was inexpensive and straight forward, allowing for robust cellular attachment with no 
observable toxicity.  Periodic evaluation of the scaffolds by light microscopy revealed that the 
cells attached to the struts of the scaffolds and proceeded to span the pores in a generally 
circumferential pattern (Figure 62B).  The majority of pores were completely spanned by a 30-
50 µm thick tissue layer following 4 weeks incubation, as illustrated via light and laser confocal 
microscopy for a 1:1 aspect ratio pore (Figure 63A and C, respectively) and one half of a 2:1 
aspect ratio pore (Figure 63B and D, respectively).  No consistent variations in cellular 
orientation were detected through the 30-50 µm thickness of the tissue layers via examination of 
the individual 2 µm thick laser confocal planes (data not shown). 
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Figure 61 Schematic illustrating the three-dimensional macroscopic structure of one quarter 
of a 2:1 aspect ratio scaffold (A).  The entire lateral area of each scaffold specimen was 2 x 2 
cm2.  High magnification schematic depicting a small region of a 2:1 aspect ratio scaffold (B).  
The thickness t of each scaffold specimen was approximately 750 µm.  The struts of the pores 
were 100 µm wide, and the 2:1 aspect ratio pores were completely open from the top to bottom 
surface of the scaffold with a lateral area of 200 x 400 µm (Scale bar = 200 µm). 
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Figure 62 Light micrograph of an unseeded 5:1 aspect ratio scaffold (scale bar = 200 µm) 
(A).  Light micrograph of a seeded 5:1 aspect ratio scaffold following 1 week incubation (scale 
bar = 200 µm) (B).  While cells spanned the 1:1 aspect ratio pores in a generally circumferential 
pattern (not shown), the 5:1 aspect ratio pores (and the 2:1 and 10:1) were spanned in an 
elliptical pattern with the long axis of the ellipse aligned to the long strut axis.  In some isolated 
pores, the cells did not attach uniformly around the perimeter of the pore during seeding and 
ultimately assumed a preferred orientation orthogonal to the long strut (black arrow). 
 
  
SALS of unseeded scaffolds revealed the characteristic scattered light signatures of 
orthogonal two strut systems, with distinct peaks located ~90 degrees apart and the area under 
each peak proportional to the relative strut length oriented in that direction (Figure 64A).  The 
preferred strut directions for the unseeded scaffolds (Figure 64B, black bars) did not differ 
significantly from their theoretical values calculated based on the additive contribution of each 
strut.  SALS results for the seeded scaffolds demonstrated broader distributions (Figure 64A), 
with the median of the distribution shifted toward the angular orientation of the long-strut axis 
(Figure 64B, gray bars).  Physically, this result suggests that the overall orientation achieved by 
the collagen fibers (and cells) within a high aspect ratio pore coincides with the long strut axis. 
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Figure 63 Light micrographs depicting a single 1:1 aspect ratio pore (A) and one half of a 
2:1 (B) aspect ratio pore following 4 weeks incubation (scale bars = 100 µm).  While the 
orientation of cells within the 1:1 aspect ratio pores was effectively random (A), 2:1 aspect ratio 
pores exhibited preferential cellular orientation along the long strut axis (black dashed line) (B).  
Laser scanning confocal microscopy conducted on scaffolds fluorescently labeled with Alexa 
Fluor® 568-Phalloidin (2:150 (v/v) dilution; Molecular Probes) for the intracellular filament F-
actin (C, D) corroborated light microscopy observations (scale bars = 100 µm).  The thicknesses 
of the tissue layers (measured using the confocal microscope) were typically 30 to 50 µm on 
both sides of the scaffold. 
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  Orientation maps of the SALS scans revealed a heterogeneous spatial distribution of 
orientations (black vectors) and orientation index (OI) over the lateral surface of the 1:1 aspect 
ratio scaffolds, with decreased OI variability and magnitude with increasing aspect ratio up to 
10:1 (Figure 65).  This result suggests an improved alignment of the collagen fibers with 
increasing pore aspect ratio beyond the alignment contributions due to the pore geometry itself. 
 
 
Figure 64 Representative SALS results for unseeded (●) and seeded (?) 2:1 aspect ratio 
scaffolds (A).  Subtraction of the scaffold signal via the principal of optical superposition 
revealed that the preferred collagen fiber orientation was approximately 108 degrees for this 
particular sample (black dashed line).  For the seeded scaffolds (white bars), the 2:1, 5:1, and 
10:1 aspect ratio pores each demonstrated a marked capacity for guiding collagen fiber 
orientation (B). Preferred directions progressively aligned toward the 135 degree orientation of 
the long strut axis (black dashed line).  Asterisks indicate statistically significant comparisons (p 
< 0.05) as found by the Tukey HSD test.  N.S. indicates nonsignificant comparisons. 
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Figure 65 Representative SALS orientation maps for 1:1 (A), 2:1 (B), 5:1 (C), and 10:1 (D) 
aspect ratio scaffolds depicting the local preferred direction (black vectors) and the orientation of 
the long strut axis (white dashed line) overlaid upon the orientation index (OI).  OI is a measure 
of the degree of orientation, with the lowest OI values (white) indicating the highest degree of 
orientation.  Scaffolds exhibiting 1:1 aspect ratio pores (A) showed evidence of heterogeneous 
collagen orientation, with a high degree of spatial variability both in preferred direction and OI.  
A progressive decrease in OI variability and magnitude was observed with increasing pore aspect 
ratio (B, C, and D).  Orientation maps for unseeded scaffolds were uniformly homogenous with 
low (> 30) OI values (data not shown). 
 
 
Scanning electron micrographs for a representative 5:1 aspect ratio scaffold overall 
supported this observation (Figure 66), with intra-pore orientation of the cells parallel to the 
long strut axis (dashed black line) observed at low magnification (300x) (Figure 66A).  At 
higher magnification (950x) individual cells and ECM could be discerned at the surface of the 
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 30-50 µm thick tissue layer (Figure 66B).  While the structure of the collagen embedded within 
the tissue layers could not be observed via SEM, in some cases where the tissue layer separated 
from the scaffold struts it was possible to observe collagen fibers (~ 100-300 nm diameter) 
spanning the gap (Figure 66C).  It should be noted that the observed separation of the tissue 
layer from the scaffold struts is an artifact of critical point drying (Figure 66C). 
 
 
Figure 66 Scanning electron micrographs (SEM) from a representative 5:1 aspect ratio 
scaffold.  At lower magnification (300x) it was possible to distinguish the orientation of cells 
parallel to the long strut axis (black dashed line) (A).  Note that while the bulk of tissue 
deposition was confined within the pores, cells (inscribed by black circle) were often observed 
bridging the short struts (black arrow) between adjacent pores, generally retaining their bulk 
orientation.  At higher magnification (950x) individual cells and collagen could be discerned at 
the surface of the 30-50 µm thick tissue layer (B).  While the structure of the collagen embedded 
within the tissue layer could not be observed via SEM, in some cases where the tissue layer 
separated from the scaffold struts it was possible to observe collagen fibers (~ 100-300 nm 
diameter) spanning the gap (C). 
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 To quantify the observed intra-pore cellular orientations, image analysis was conducted 
on SEM images.  While cellular orientation results generally corroborated our SALS findings for 
collagen fiber orientation (data not shown), isolated pores were found to exhibit significant intra-
pore variability in cellular orientation, as depicted for a 10:1 aspect ratio pore (Figure 67). 
 
 
Figure 67 Panoramic scanning electron micrograph of a 10:1 aspect ratio pore (scale bar = 
100 µm) (A).  The image was reconstructed by concatenating several overlapping SEM images 
using Image Expert 2000 (Jasc Software, Inc., Eden Prairie, MN).  Note the shifting orientation 
of the cells along the long axis, as highlighted in the contrast enhanced binary image (B).  The 
median of the cell major axis angular orientation was quantified using the fill measurement 
option of SigmaScan Pro (SPSS, Inc.) (C).  The left-most dashed line represents the angular 
orientation of the short strut (90 degrees) and the right-most dashed line represents the 
orientation of the long strut (135 degrees). 
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Figure 68 Light micrographs depicting the evolution of cellular orientation with time in 2:1 
aspect ratio pores for cases of: uniform initial cell attachment around the pore perimeter (A-C), 
and non-uniform cell attachment (D-F).  Cells typically attached uniformly around the pore 
perimeter (A), with successive growth fronts spanning the pore in a circumferential pattern (B), 
ultimately yielding preferential cellular alignment roughly parallel to the long strut axis (C).  In 
isolated atypical pores, cells attached non-uniformly around the pore perimeter during seeding 
(D), with successive growth fronts spanning back-and-forth across the short strut axis (E), and 
ultimately yielding preferential cellular alignment roughly parallel to the short strut axis (F).  
Scale bars = 200 µm 
 
 
By examining the evolution of cellular orientation over time in individual pores, it was 
found that the spatial uniformity of cellular attachment around each pore perimeter achieved 
during seeding significantly influenced the ultimate cellular orientation (Figure 68).  In the case 
that cells initially attached uniformly around the pore perimeter (Figure 68A), cells proceeded to 
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 span the pore in the typical circumferential pattern via an elliptical growth front whose major 
axis was oriented roughly parallel to the long strut axis (Figure 68B), and ultimately yielded 
preferential cellular alignment parallel to the long strut axis (Figure 68C).  In contrast, some 
isolated pores were observed in which initial cellular attachment following seeding was not 
uniform around the pore perimeter, but rather localized either to the strut intersections or the 
short struts (Figure 68D).  In these isolated pores, cells proceeded to span the pore in an atypical 
back-and-forth pattern across the short strut axis (Figure 68E), ultimately yielding preferential 
cellular alignment orthogonal to the typical preferred direction (Figure 68F).  We previously 
quantified the structure of diamond-shaped pores (Figure 69A) and the resultant preferred 
direction of the collagen fibers using SALS [176].  Scanning electron microscopy confirmed that 
the predominant orientation of cells is parallel to the major axis (black dashed line) of the 
diamond-shaped pores (Figure 69B).  In contrast to rectangular pores, in isolated diamond-
shaped pores where initial cellular attachment was not uniform around the pore perimeter, 
diamond-shaped pores were observed to maintain an elliptical growth front whose major axis 
(black arrow) was nearly parallel to the major axis of the pore (Figure 69C). 
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Figure 69 Light micrograph of a scaffold exhibiting a diamond-shaped pore structure similar 
to the Vicryl® scaffold used previously for manufacturing Dermagraft™ (scale bar = 200 µm) 
(A).  Scanning electron micrograph (190X) of a cell seeded scaffold showing the intersection of 
four diamond-shaped pores (B).  Note the predominant orientation of cells parallel to the major 
axis (black dashed line) of the diamond-shaped pores.  Light micrograph of a single diamond-
shaped pore following 1 week incubation (scale bar = 200 µm) (C).  Note that despite an initially 
non-uniform distribution of cells around the pore perimeter, the diamond-shaped pore maintained 
the long axis of the growth front (black arrow) nearly parallel to the major axis of the pore. 
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 7.1.4 Discussion 
 
 In developing a functionally-equivalent TEHV, the geometric arrangement attained by 
the collagen fiber network following both in vitro and in vivo remodeling is perhaps the single 
most important structural end-point to be matched to the native tissue.  For the native aortic 
valve, we previously demonstrated that collagen fiber orientation dictates local and global tissue 
anisotropy [177].  Using a structural constitutive model, we demonstrated that the full spectrum 
of biaxial mechanical behavior, including axial coupling, could be accurately modeled and 
predicted by incorporating the experimentally measured collagen fiber orientation distribution 
[138].  However, while investigators recognize the critical importance of collagen fiber 
orientation in the mechanics and durability of load-bearing soft tissues, methods to guide the 
development of a functional collagen fiber network have yet to be delineated for engineered 
tissues based on synthetic scaffolds. 
 In the current study we investigated the ability of large-scale (200 µm) high aspect ratio 
open pore structures to guide engineered tissue cell and collagen orientation.  Non-degradable 
scaffolds exhibiting a grid of 200 µm wide rectangular pores (1:1, 2:1, 5:1, and 10:1 aspect 
ratios) and diamond-shaped pores (600 x 1000 µm) were fabricated from a transparent epoxy 
resin via high-resolution stereolithography.  Scaffolds were surface modified to support cell 
adhesion and evaluated for their capacity to promote the orientation of neonatal rat skin 
fibroblasts and their de novo synthesized collagen.  In contrast to square pores, which yielded an 
effectively random cell and collagen orientation, preferential alignment parallel to the long strut 
axis and decreased spatial variability were observed to occur with increasing pore aspect ratio 
following 4 weeks of static incubation.  Moreover, diamond-shaped pores exhibited an enhanced 
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 capacity to guide cellular orientation due to their relative insensitivity to the uniformity of initial 
cellular attachment around the pore perimeter. 
 
7.1.4.1 Guidance of Collagen Orientation in Engineered Tissues 
 
Depending upon the particular TE paradigm, distinct methods may be used to guide the 
development of an appropriate collagen fiber orientation.  For example, in the case of collagen 
gel based TE constructs, collagen orientation and tissue anisotropy can be achieved by a variety 
of means, including magnetic forces [178], gel boundary conditions [123], substratum topology 
[179], and mechanical loading [180].  However, while the methods to guide collagen fiber 
orientation in these collagen gel based systems are well established, collagen gel based TE 
constructs continue to suffer from relatively low mechanical stiffness and strength.  TE 
constructs based on synthetic bioresorbable scaffolds tend to offer improved mechanical 
performance over collagen gel based constructs; however it is less clear how to ensure the 
development of appropriately oriented cells and collagen fibers.  While mechanical stimulation 
in the form of tension [64, 114], flexure [63], and flow [61] has been shown to enhance the 
synthesis of collagen on synthetic bioresorbable nonwoven scaffolds, the role of the scaffold 
microstructure in guiding the orientation of the deposited collagen has yet to be delineated.  Of 
potential use in guiding cell and collagen orientation, the synthetic bioresorbable nonwoven 
scaffolds currently used to construct TEHV do exhibit a distinct preferred fiber direction that can 
be quantified by SALS, with an ~ 3-fold decrease in effective stiffness going from the preferred 
to the orthogonal cross-preferred fiber direction [181].  Nonwovens, however, are not the first 
178 
 choice for fundamental investigations of scaffold-mediated guidance due to spatial variations in 
effective pore size and shape. 
 
7.1.4.2 Fabrication of Scaffolds with Well-Defined Microstructure. 
 
Rapid-prototyping methods such as fused deposition modeling and stereolithography 
offer the possibility of fabricating geometrically well-defined scaffold microstructures [182].  
While the spatial resolution of standard rapid-prototyping technologies is currently limited to 
about 50 µm [183], we have previously shown that the large scale (280 x 400 µm) diamond-
shaped pores of a woven bioresorbable Vicryl® scaffold can significantly influence engineered 
tissue collagen fiber orientation [151].  For the purposes of evaluating candidate scaffold 
designs, the non-degradable epoxy resin scaffolds developed in the current study are 
advantageous because the intrinsic orienting capacity of the microstructure is decoupled from the 
potentially confounding effects of scaffold degradation.  Moreover, because the epoxy resin 
scaffold does not intrinsically support cellular attachment, cell specificity and behavior can 
potentially be modulated via the surface modification.  For example a recent study demonstrated 
significant differences in the physiology of neonatal cardiac myocytes when seeded on RGD 
versus YIGSR-modified substrates [184].  For ultimately translating the results of the current 
study to degradable polymers, as well as to create smaller feature sizes, a  recently described 
microsyringe deposition technique may be useful [185].  Using the microsyringe technique, 
Vozzi et al. achieved spatial resolutions on the order of 10 µm using bioresorbable poly(DL-
lactide-co-glycolide) (PLGA). 
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 7.1.4.3 Mechanisms Governing Large-Scale Orientation. 
 
In the current study, we demonstrated that scaffold pore structures over an order of 
magnitude larger than the cells could direct cell and collagen orientation.  The mechanisms 
governing cellular and fiber alignment on these scaffolds are likely very distinct from the contact 
guidance phenomena observed on micro-grooved substrates.  For example, while several 
mechanisms have been postulated to explain contact guidance on micro-grooved substrates, 
ranging from bending restrictions imposed on lamellipodia to selective protein adsorption due to 
differences in groove and ridge surface free energies [174], each of these mechanisms would 
invariably affect the orientation of individual cells.  In contrast, the orienting capacity of large-
scale open pore structures likely depends on the coordinated behavior of groups of hundreds of 
cells.  Based on observations made on micro-grooved substrates [186], the orientation of 
collagen fibers within our system is likely concomitant to cellular orientation.   
In light of the different mechanisms responsible for cellular and collagen orientation in 
large-scale open pores versus micro-grooves, it is not surprising that differences are observed in 
the orienting capacity.  While micro-grooved substrates appear to ubiquitously align cells along 
their long axis, we observed here that the orienting capacity of open pore structures depends in 
part on the spatial uniformity of initial cellular attachment around the perimeter of the pores.  For 
example, while the 10:1 aspect ratio pores were highly effective in guiding global collagen 
orientation, scanning electron microscopy revealed isolated pores in which cells switched 
orientation by nearly 90 degrees over the pore length (Figure 67).  Such intra-pore variations in 
orientation were observed to depend on the uniformity of initial cellular attachment around the 
pore perimeter, with uniform cellular attachment leading to the typically observed preferential 
alignment parallel to the long strut axis, and non-uniform attachment resulting in the atypical 
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 orthogonal alignment (Figure 68).  Because the cells did ultimately span the majority of the 
pores, observed cases of non-uniform initial cell attachment were likely a consequence of the 
seeding process, not the surface modification.  Based on light microscopic observations made 
during the 4 weeks incubation period (Figure 68), we developed schematics illustrating the 
distinct patterns of cellular growth front propagation observed depending on the uniformity of 
initial cellular attachment around the pore perimeter (Figure 70).  In the case that cells (small 
ellipses) were uniformly distributed around the perimeter of the pore (Figure 70A), successive 
growth fronts (gray ellipses) spanned the pore in an elliptical pattern with the major axis of the 
ellipse (black arrow) oriented parallel to the long strut axis.  In the case of that cells attached 
non-uniformly around the pore perimeter, cells attached preferentially to the strut intersections 
with successive growth fronts (gray curves) spanning the pore back-and-forth across the short 
strut axis (black arrow) (Figure 70B). 
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Figure 70 Schematic illustrating the distinct patterns of growth front propagation observed 
in 2:1 aspect ratio pores.  In the case that cells (small ellipses) were initially distributed 
homogeneously around the perimeter of the pore (A), successive growth fronts (gray ellipses) 
filled the pore in an elliptical pattern with the major axis of the ellipse (black arrow) oriented 
parallel to the long strut axis (A).  In the case that cells were initially distributed heterogeneously 
around the perimeter of the pore (B), cells were observed to attach preferentially to the strut 
intersections with successive growth fronts (gray curves) filling the pore back-and-forth across 
the short strut axis (black arrows) (B).  In the case of heterogeneous cell attachment to a 2:1 
aspect ratio diamond-shaped pore (C), cells were observed to attach preferentially at the tight V-
shaped strut intersections and successive growth fronts filled the pore back-and-forth across the 
minor axis direction.  However, as opposed to the rectangular pore, the slope of the struts 
ultimately induced the formation of an elliptical growth front (dashed ellipse) oriented parallel to 
the major axis (black arrow) as the two growth fronts approached from either side of the pore. 
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  Our findings thus far suggest that diamond-shaped pores may be less sensitive to the 
spatial uniformity of initial cellular attachment (Figure 69).  In the case that cells initially 
attached non-uniformly around the perimeter of a 2:1 aspect ratio diamond-shaped pore (Figure 
69C), cells attached preferentially at the tight V-shaped strut intersections with successive 
growth fronts initially spanning the pore back-and-forth across the minor axis direction.  
However, as opposed to the rectangular pore, the slope of the struts ultimately induced the 
formation of an elliptical growth front (dashed ellipse) oriented parallel to the major axis (black 
arrow) as the two growth fronts approximated the gap from either side of the pore (Figure 70C).  
Because cells tended to aggregate more prevalently at the strut intersections, the geometry of 
these intersections may play a key role in guiding subsequent cellular and collagen orientation. 
     
7.1.4.4 Combinations of Large-Scale, Micro-Scale, and Mechanical 
Guidance. 
 
It may be possible to develop scaffolds whose structural members (e.g., fibers, struts) 
possess an additional level of controlled surface topology to aid in the guidance of cellular and 
collagen orientation.  In a previous study [187], multi-grooved substrates were fabricated 
exhibiting 90-degree V-shaped micro-grooves of 2 µm pitch and 1 µm depth and 50 µm wide by 
25 µm deep macro-grooves.  The micro-grooves were found to be sufficient for cellular 
orientation, while the macro-grooves appeared to promote collagen secretion and orientation.  
Hypothetically, a scaffold could be designed in which the struts of the open pore structure are 
micro-grooved to enhance the orientation of cells along a particular axis. 
 To combine mechanical with structural guidance, elastomeric scaffolds need to be 
fabricated.  Recent studies on micro-grooved elastomeric substrates suggest a significant degree 
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 of coupling between cellular orientation and response to stretch [188].  Electrospinning 
elastomers such as poly(ester urethane)urea (PEUU) represents one possible method for 
generating elastomeric scaffolds with oriented nano-scale structures [189].  Recent studies have 
demonstrated that highly aligned poly-L-lactic acid fibers can be electrospun by optimizing the 
spinning conditions [190].  However, while the average fiber orientation can be controlled, local 
variations are inherent due to the stochastic nature of the electrospinning process.  Larger scale 
oriented pore structures have recently been fabricated from PEUU by thermally-induced phase 
separation (TIPS) [191].  Thus using PEUU it may be possible to incorporate large-scale, micro-
scale, and mechanical guidance in a scaffold design via the combination of electrospinning with 
TIPS. 
 
7.1.4.5 Summary. 
 
In the current study, we developed an in vitro model system in which arbitrary large-scale 
(~200 µm) open pore structures could be rapid-prototyped and systematically evaluated for their 
cell and collagen orientating capacity.  Non-degrading scaffolds with high aspect ratio 
rectangular pores were fabricated by stereolithography and demonstrated a significant capacity to 
guide global cell and collagen fiber orientation compared with square pores.  Preferential 
alignment parallel to the long strut axis and decreased spatial variability were observed to occur 
with increasing pore aspect ratio.  The mechanisms governing cell and collagen orientation 
within these large-scale open pore structures likely depends on the coordinated behavior of large 
groups of cells and fibers, as opposed to the phenomenon of contact guidance on micro-grooved 
substrates which can affect individual cells.  A comparison of cellular growth front propagation 
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 patterns in rectangular versus diamond-shaped pores suggest that diamond-shaped pores are less 
sensitive to the spatial uniformity of initial cellular attachment, and thus represent an attractive 
structural motif for mediating guidance in TE scaffold designs. 
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APPENDIX A 
 
 
 
 
FREESTON AND PLATT’S GENERAL ASSUMPTIONS 
FOR MODELING NONWOVENS 
 
 
 
 
 The general assumptions invoked by Freeston and Platt [146] in their unit cell (i.e., RVE) 
representation are paraphrased below, with each assumption followed by a justification of its 
applicability to the materials considered in the current study. 
 
1. Fibers are linear elastic, homogenous, and isotropic.  At very small strains (~0.6%) the 
PGA and PLLA fibers investigated herein were linear elastic (Figure 45).  While the 
fibers were melt extruded and likely transversely isotropic, we measured the longitudinal 
fiber stiffness, which is the stiffness governing the flexural behavior of the fibers. 
2. RVE boundaries are orthogonal to the direction of applied stress (i.e., no fabric shear).  
Scaffold specimens were cut orthogonal to the PD and XD fiber directions, ensuring that 
the RVE boundaries were orthogonal to the direction of applied stress when tested in 
three-point bending.  Moreover, the shear stiffness of needled nonwovens is relatively 
high and thus shear deformations would be expected to be negligible.  In the case of a 
needled nonwoven PGA scaffold, the shear stiffness was reported by Shum et al. to be 
763 kPa [192] (i.e., ~ 2.5-fold the measured value of E (Table 6)). 
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 3. Fiber diameter is small compared with fiber length (i.e., fiber shear is negligible).  The 
fibers within the needled nonwoven were 40-50 mm long [135], compared with a fiber 
diameter of 0.01295 mm in the case of PGA and 0.01636 mm for PLLA (Table 3).  Thus 
the fiber diameters were small (~ 3/10000) compared with the fiber length. 
4. Fiber cross-section is circular and fiber diameter does not vary along fiber length.  The 
fiber diameters were measured via an image analysis technique.  The fiber diameter was 
measured at five points along the fiber length for each PGA (n=6) and PLLA (n=6) fiber 
with a standard error of 0.02 µm.  Thus the fiber diameter did not vary significantly along 
the fiber length. 
5. Fiber diameter and fabric thickness are small compared to the radius of curvature.  The 
minimum radius of curvature achieved in the three point bending tests was approximately 
10 mm.  Therefore the fiber diameters (0.01295 for PGA and 0.01636 for PLLA) and the 
fabric thickness (~ 1mm) were each small relative to the minimum radius of curvature. 
6. Cross-sections initially plane and normal to the fiber centerline remain so after bending.  
As stated above, the shear stiffness of needled nonwoven scaffolds is relatively high, and 
thus shear deformations within the scaffold would be expected to be small in bending. 
7. Fibers do not buckle.  In the case of straight fibers, the assumption of no fiber buckling is 
a necessary simplification in the absence of data regarding the strain criterion for fiber 
buckling within the nonwoven fabric.  This assumption was thus invoked in calculating 
the lower and upper bounds on E (Table 6).  However, in formulating the structural 
model for the needled nonwoven scaffold, fiber buckling is explicitly assumed; the 
effective longitudinal stiffness of the crimped fibers is assumed to be governed by the 
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 bending and extension of their sinusoidal curved structure (see New assumptions for 
modeling needled nonwoven scaffolds). 
8. Fiber angular and numerical distribution is equal through the thickness of the RVE.  
While it is possible that minor through-thickness variations in the angular distribution are 
generated during the needling process [97], structural model implementation of R(Φ) 
determined by our effectively 2D SALS technique yielded E predictions in close 
agreement with experimental measures for both PD and XD specimens (Table 6). 
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APPENDIX B 
 
 
 
 
DERIVATION OF FREESTON AND PLATT’S “COMPLETE FREEDOM” MODEL 
 
 
 
 
 In Freeston and Platt’s “complete freedom” model, individual fibers of the nonwoven are 
assumed to bend independently of one another.  Thus the net moment required to bend this 
hypothetical fabric about an arbitrary axis (e.g., the k
?
-axis) is simply the sum of the individual 
fiber bending moments about this axis.  The k
?
-component of the bending moment vector for a 
fiber initially oriented at an angle Φ to the orthogonal axis (e.g., the i? -axis) is given by: 
   
 ( )f f f kM E I T K= × ?? ?  (29) 
 
in which T  and 
?
K
?
 are the unit tangent and curvature vectors of the fiber, respectively.  T
?
 and 
K
?
 can be calculated from the relations: 
 
 dR dT
dR d
θ
θ=
?? ?  (30) 
 
 
/
dT dK
dR d
θ
θ=
?? ?  (31) 
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 where the position vector, R
?
, to any point on the axis of a bent fiber is given by: 
 ( cos ) ( sin ) ( tan )R i j kρ θ ρ θ ρθ= + − Φ?? ? ?  (32) 
 
where ρ is the radius of curvature (i.e., 1/∆κ).  Upon substitution of Eq. (32), (31), and (30) into 
Eq. (29) and simplification via the appropriate trigonometric identities, Eq. (29) reduces to: 
 
 3cosf ff
E I
M ρ= Φ  (33) 
 
The relative frequency of fibers parallel to the i
?
-axis is ( ) cosR Φ Φ  (Eq. (6)), and thus the net 
bending moment is given by: 
 
 
/ 2 4
/ 2
( ) cosf f fRVE
N E I
M R
π
πρ −= Φ∫ dΦ Φ  (34) 
 
Multiplication of Eq. (34) by ρ yields Eq. (4), the expression for EI per RVE.  
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APPENDIX C 
 
 
 
 
DERIVATION OF FREESTON AND PLATT’S “NO FREEDOM” MODEL 
 
 
 
 
 Freeston and Platt’s “no freedom” model is based on the assumption that the individual 
fibers are rigidly bonded at each cross-over point, thus giving rise to continuum plate behavior.  
The fabric strain along the -axis direction is thus given by: i
?
 
 /i yε ρ=?  (35) 
 
where y is the distance from the neutral axis of the fabric.  Invoking small strain and first order 
approximations applied to nonwovens by Backer and Petterson [140], the fiber strain is given by 
 
 ( )2 2cos cos /ε ε= Φ = Φ?f i y ρ  (36) 
 
Thus, the -component of the bending moment of a fiber is given by k
?
 
 ( )2 3cos cos /f f f fM F y E A y ρ= Φ = Φ  (37) 
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 where Ff is the force on a fiber.  This equation is analogous to Eq. (33) in the “complete 
freedom” model described above.  The relative frequency of fibers per unit cross-sectional area 
parallel to the -axis is given by i
?
 
 ( ) cosRP
bt
Φ Φ=  (38) 
Thus, the sum of all the moments about the k
?
-axis is given by: 
 
 { } 2/ 2 / 2 / 2 / 2 4/ 2 / 2 / 2 / 2 ( ) cos12t b f f fRVE f ft b N E A tM N P M dxdy d R dπ ππ πρ− − − −= Φ =∫ ∫ ∫ ∫ Φ Φ Φ  (39) 
 
Multiplication of Eq. (39) by ρ yields Eq. (7), the expression for EI per RVE. 
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APPENDIX D 
 
 
 
 
DERIVATION OF LEE AND ARGON’S EFFECTIVE FIBER STIFFNESS MODEL 
 
 
 
 
 To derive their effective fiber stiffness model, Lee and Argon considered a one 
wavelength-long segment of a sinusoidal shaped fiber (Figure 43A).  Expressions were 
developed for the strain energy U due to axial tension and bending under an applied load F and 
applied bending moment M.  The strain energy due to bending Ub can be expressed as: 
    
 
2
3 / 4
/ 4
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2 21 cos
2
eff
eff
eff
eff eff
b
eff eff
xM Fa
a xU d
EI
π
π πΛ
−Λ
⎧ ⎫⎛ ⎞⎪ ⎪− +⎜ ⎟⎨ ⎬⎜ ⎟Λ ⎛ ⎞⎪ ⎪⎝ ⎠⎩ ⎭= + ⎜⎜ Λ Λ⎝ ⎠∫ x⎟⎟  (40) 
 
and the strain energy due to tension Ut can be expressed as: 
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∫ 2ff x⎟⎟  (41) 
where the total strain energy is the arithmetic sum of tension and bending: 
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  bU U Ut= +  (42) 
  
To facilitate subsequent derivations, Lee and Argon transformed the independent variable x to 
the dummy variable z = (π/2Λeff) x + π/8 and also utilized Eq. (10) to describe the initial effective 
curvature of the fiber segment.  The moment M could then be found from the condition of no end 
rotation (i.e., ) as / 0dU dM = effM Fa= .  The displacement δ of the fiber end could then be 
found from Castigliano’s second theorem: 
 
 
2
1
4 4eff eff
eff
f f f f
adU
2F BdF E I A E
δ ⎛ ⎞Λ= = Λ +⎜⎜⎝ ⎠
B ⎟⎟  (43) 
 
where the parameters B1 and B2 are given by Eq. (9).  Finally, the effective fiber stiffness ( )fE ′  
is found by the relationship: 
 
 
2
1 2
( ) 4( / ) 4
f
f
ff eff
eff
f
EFE AA a B B
I
δ′ = =Λ +
 (44) 
 
which reduces to Eq. (8) upon substituting the appropriate values for If and Af.
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